Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Browse by Research Team

Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Source
Jump to: ACS Sensors | Acta Biomaterialia | Acta Neurologica Belgica | Acta Neurologica Scandinavica | Acta Neuropathologica | Acta Neuropathologica Communications | Acta Physiologica | Advances in Predictive, Preventive and Personalised Medicine | Aktuelle Neurologie | American Journal of Clinical Nutrition | American Journal of Neuroradiology | Annals of Clinical and Translational Neurology | Annals of Neurology | Archives of Neurology | Archives of Physical Medicine and Rehabilitation | Autoimmunity Reviews | BMC Medical Imaging | BMC Neurology | BMC Neuroscience | BMC Research Notes | BMJ Case Reports | BMJ Open | BioMed Research International | Biological Psychiatry | Biology of Sex Differences | Biomedical Optics Express | Brain | Brain Behavior and Immunity | Brain Communications | Brain, Behavior & Immunity - Health | British Journal of Ophthalmology | Case Reports in Neurological Medicine | Cell | Cell Reports | Cephalalgia | Cerebellum | Clinical Neurology and Neurosurgery | Clinical Neurophysiology | Clinical and Experimental Immunology | Clinical and Experimental Neuroimmunology | Computers in Biology and Medicine | Contemporary Clinical Trials | Current Treatment Options in Neurology | Degenerative Neurological and Neuromuscular Disease | Developmental Medicine and Child Neurology | Diagnostics | Drug Safety | Drugs of Today | EBioMedicine | EClinicalMedicine | EPMA Journal | European Journal of Immunology | European Journal of Integrative Medicine | European Journal of Neurology | European Journal of Neuroscience | European Journal of Nuclear Medicine and Molecular Imaging | European Journal of Pharmacology | European Neurological Review | European Neurology | European Radiology | Experimental Neurology | Expert Opinion on Biological Therapy | Expert Opinion on Emerging Drugs | Expert Opinion on Investigational Drugs | Expert Opinion on Pharmacotherapy | Expert Review of Clinical Immunology | Expert Review of Neurotherapeutics | Fortschritte der Neurologie Psychiatrie | Frontiers in Aging Neuroscience | Frontiers in Immunology | Frontiers in Medicine | Frontiers in Neurology | Frontiers in Neuroscience | Frontiers in Physiology | Gait & Posture | Genetic Epidemiology | Genome Biology | Genome Medicine | Glia | Health and quality of life outcomes | Human Brain Mapping | International Journal of Biological Macromolecules | International Journal of Environmental Research and Public Health | International Journal of MS Care | International Journal of Molecular Sciences | International Symposium on Biomedical Imaging (ISBI) | Investigative Ophthalmology & Visual Science | Investigative Radiology | JAMA Neurology | JCI Insight | JMIR Human Factors | Journal fuer Neurologie Neurochirurgie und Psychiatrie | Journal of Biological Chemistry | Journal of Biomedical Optics | Journal of Cerebral Blood Flow and Metabolism | Journal of Clinical Investigation | Journal of Clinical Medicine | Journal of Imaging | Journal of Immunology | Journal of Magnetic Resonance Imaging | Journal of Natural Products | Journal of Neural Transmission | Journal of Neuro-Ophthalmology | Journal of Neuroengineering and Rehabilitation | Journal of Neuroimaging | Journal of Neuroimmune Pharmacology | Journal of Neuroimmunology | Journal of Neuroinflammation | Journal of Neurology | Journal of Neurology Neurosurgery and Psychiatry | Journal of Neurology, Neurosurgery, and Psychiatry | Journal of Neuroscience Methods | Journal of Neurotrauma | Journal of Translational Medicine | Journal of Visualized Experiments | Journal of the Neurological Sciences | Klinische Monatsblaetter fuer Augenheilkunde | Klinische Monatsblatter fur Augenheilkunde | Klinische Neurophysiologie | Lancet | Lancet Digital Health | Lancet Neurology | Lancet Psychiatry | Life | Magnetic Resonance Materials in Physics Biology and Medicine | Magnetic Resonance in Medicine | Molecular Neurodegeneration | Movement Disorders | Movement Disorders Clinical Practice | Multiple Sclerosis | Multiple Sclerosis International | Multiple Sclerosis Journal | Multiple Sclerosis Journal Experimental Translational and Clinical | Multiple Sclerosis and Related Disorders | Nanomedicine: Nanotechnology, Biology and Medicine | Nature Communications | Nature Reviews Disease Primers | Nature Reviews Neurology | Nature and Science of Sleep | Nervenarzt | Nervenheilkunde | NeuroImage | NeuroImage: Clinical | Neurobiology of Stress | Neurochemistry International | Neurodegenerative Disease Management | Neurology | Neurology Neuroimmunology & Neuroinflammation | Neurology and Therapy | Neuropathology and Applied Neurobiology | Neuropsychiatric Disease and Treatment | Neuropsychobiology | Neuroscience | Neurotherapeutics | Ophthalmologe | Oxidative Medicine and Cellular Longevity | PLoS Computational Biology | PLoS ONE | Pain | Patient preference and adherence | Physical Therapy | Proceedings of SPIE | Proceedings of the National Academy of Sciences of the United States of America | Radiology | Retina | Science | Science Advances | Science Translational Medicine | Scientific Reports | Seizure | Seminars in Immunopathology | Sensors | Sleep & Breathing | Sleep Disorders | Sleep Medicine | Symmetry | Theranostics | Therapeutic Advances in Chronic Disease | Therapeutic Advances in Neurological Disorders | Tomography | Traffic | Trials | Vaccines | arXiv | bioRxiv | iScience | medRxiv

ACS Sensors

Pentafluorosulfanyl (SF(5)) as a superior (19)F magnetic resonance reporter group: signal detection and biological activity of teriflunomide derivatives.
Prinz, C. and Starke, L. and Ramspoth, T.F. and Kerkering, J. and Martos Riaño, V. and Paul, J. and Neuenschwander, M. and Oder, A. and Radetzki, S. and Adelhoefer, S. and Ramos Delgado, P. and Aravina, M. and Millward, J.M. and Fillmer, A. and Paul, F. and Siffrin, V. and von Kries, J.P. and Niendorf, T. and Nazaré, M. and Waiczies, S.
ACS Sensors 6 (11): 3948–3956. 26 November 2021

Acta Biomaterialia

In vivo stiffness of multiple sclerosis lesions is similar to that of normal-appearing white matter.
Herthum, H. and Hetzer, S. and Scheel, M. and Shahryari, M. and Braun, J. and Paul, F. and Sack, I.
Acta Biomaterialia 138 : 410-421. 15 January 2022

Acta Neurologica Belgica

Longitudinal analysis of primary and secondary factors related to fatigue in multiple sclerosis.
Schließeit, J. and Oertel, F.C. and Cooper, G. and Brandt, A.U. and Bellmann-Strobl, J.
Acta Neurologica Belgica 121 (1): 271-274. February 2021

Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders.
Gkaniatsou, T. and Papadopoulou, A. and Paul, F. and Brandt, A.U. and Oertel, F.C.
Acta Neurologica Belgica 120 (1): 223-225. February 2020

Acta Neurologica Scandinavica

Optical coherence tomography in acute optic neuritis: a population-based study.
Soelberg, K. and Specovius, S. and Zimmermann, H.G. and Grauslund, J. and Mehlsen, J.J. and Olesen, C. and Neve, A.S.B. and Paul, F. and Brandt, A.U. and Asgari, N.
Acta Neurologica Scandinavica 138 (6): 566-573. December 2018

Perceptions on the value of bodily functions in multiple sclerosis.
Heesen, C. and Haase, R. and Melzig, S. and Poettgen, J. and Berghoff, M. and Paul, F. and Zettl, U. and Marziniak, M. and Angstwurm, K. and Kern, R. and Ziemssen, T. and Stellmann, J.P.
Acta Neurologica Scandinavica 137 (3): 356-362. March 2018

Pathology and MRI: exploring cognitive impairment in MS.
Paul, F.
Acta Neurologica Scandinavica 134 (Suppl 200): 24-33. September 2016

Acta Neuropathologica

Cortical matrix remodeling as a hallmark of relapsing-remitting neuroinflammation in MR elastography and quantitative MRI.
Silva, R.V. and Morr, A.S. and Herthum, H. and Koch, S.P. and Mueller, S. and Batzdorf, C.S. and Bertalan, G. and Meyer, T. and Tzschätzsch, H. and Kühl, A.A. and Boehm-Sturm, P. and Braun, J. and Scheel, M. and Paul, F. and Infante-Duarte, C. and Sack, I.
Acta Neuropathologica 147 (1): 8. 4 January 2024

Antibody signatures in patients with histopathologically defined multiple sclerosis patterns.
Stork, L. and Ellenberger, D. and Ruprecht, K. and Reindl, M. and Beißbarth, T. and Friede, T. and Kümpfel, T. and Gerdes, L.A. and Gloth, M. and Liman, T. and Paul, F. and Brück, W. and Metz, I.
Acta Neuropathologica 139 (3): 547-564. March 2020

Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation.
Mossakowski, A.A. and Pohlan, J. and Bremer, D. and Lindquist, R. and Millward, J.M. and Bock, M. and Pollok, K. and Mothes, R. and Viohl, L. and Radbruch, M. and Gerhard, J. and Bellmann-Strobl, J. and Behrens, J. and Infante-Duarte, C. and Mähler, A. and Boschmann, M. and Rinnenthal, J.L. and Füchtemeier, M. and Herz, J. and Pache, F.C. and Bardua, M. and Priller, J. and Hauser, A.E. and Paul, F. and Niesner, R. and Radbruch, H.
Acta Neuropathologica 130 (6): 799-814. December 2015

Acta Neuropathologica Communications

Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles.
Aschman, T. and Wyler, E. and Baum, O. and Hentschel, A. and Rust, R. and Legler, F. and Preusse, C. and Meyer-Arndt, L. and Büttnerova, I. and Förster, A. and Cengiz, D. and Teixeira Alves, L.G. and Schneider, J. and Kedor, C. and Bellmann-Strobl, J. and Sanchin, A. and Goebel, H.H. and Landthaler, M. and Corman, V. and Roos, A. and Heppner, F.L. and Radbruch, H. and Paul, F. and Scheibenbogen, C. and Dengler, N.F. and Stenzel, W.
Acta Neuropathologica Communications 11 (1): 193. 8 December 2023

The chronically inflamed central nervous system provides niches for long-lived plasma cells.
Pollok, K. and Mothes, R. and Ulbricht, C. and Liebheit, A. and Gerken, J.D. and Uhlmann, S. and Paul, F. and Niesner, R. and Radbruch, H. and Hauser, A.E.
Acta Neuropathologica Communications 5 (1): 88. 25 November 2017

Acta Physiologica

Multiple sclerosis and circadian rhythms: Can diet act as a treatment?
Pivovarova-Ramich, O. and Zimmermann, H.G. and Paul, F.
Acta Physiologica 237 (4): e13939. April 2023

Advances in Predictive, Preventive and Personalised Medicine

Flammer syndrome and autoimmune inflammatory conditions of the central nervous system: multifactorial interrelations.
Paul, F.
Advances in Predictive, Preventive and Personalised Medicine 11 : 145-163. 2019

Aktuelle Neurologie

Warum die Deutsche Gesellschaft für Neurologie einen industrieunabhängigen Kongress braucht [Why German neurology needs an annual meeting without industry sponsorship].
Lempert, T. and Janzen, R. and Diehl, R. and Stark, E. and Paul, F. and Wilke, C. and Tavakolian, R. and Völzke, E. and von Brevern, M. and Möller, P.
Aktuelle Neurologie 45 (6): 429-433. August 2018

Untersuchungen des visuellen Systems in der Neurologie: aktuelle Forschung und klinische Relevanz [Investigation of the visual system in neurology: Current research and clinical relevance].
Brandt, A. and Zimmermann, H. and Scheel, M. and Finke, C. and Albrecht, P. and Paul, F.
Aktuelle Neurologie 44 (1): 27-45. 2017

Immunmodulatorische Therapie mit Interferon β-1b bei klinisch isoliertem Syndrom [Immunomodulatory therapy with interferon β-1b in clinically isolated syndrome.
Paul, F.
Aktuelle Neurologie 39 (S1): S16-S18. 22 May 2012

Neuromyelitis optica.
Wildemann, B. and Jarius, S. and Paul, F.
Aktuelle Neurologie 39 (1): 33-41. February 2012

Chronisch venoese Insuffizienz als Ursache der Multiplen Sklerose? [Is chronic cerebrospinal venous insufficiency a cause of multiple sclerosis?].
Doepp, F. and Paul, F. and Valdueza, J.M. and Schreiber, S.J.
Aktuelle Neurologie 38 (7): 332-338. 24 October 2011

American Journal of Clinical Nutrition

Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial.
Mähler, A. and Steiniger, J. and Bock, M. and Klug, L. and Parreidt, N. and Lorenz, M. and Zimmermann, B.F. and Krannich, A. and Paul, F. and Boschmann, M.
American Journal of Clinical Nutrition 101 (3): 487-495. March 2015

American Journal of Neuroradiology

Considerations for mean upper cervical cord area implementation in a longitudinal MRI setting: methods, interrater reliability, and MRI quality control.
Chien, C. and Juenger, V. and Scheel, M. and Brandt, A.U. and Paul, F.
American Journal of Neuroradiology 41 (2): 343-350. 1 February 2020

MRI-based methods for spinal cord atrophy evaluation: a comparison of cervical cord cross-sectional area, cervical cord volume, and full spinal cord volume in patients with aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders.
Chien, C. and Brandt, A.U. and Schmidt, F. and Bellmann-Strobl, J. and Ruprecht, K. and Paul, F. and Scheel, M.
American Journal of Neuroradiology 39 (7): 1362-1368. 1 July 2018

Iron and non-iron-related characteristics of multiple sclerosis and neuromyelitis optica lesions at 7T MRI.
Chawla, S. and Kister, I. and Wuerfel, J. and Brisset, J.C. and Liu, S. and Sinnecker, T. and Dusek, P. and Haacke, E.M. and Paul, F. and Ge, Y.
American Journal of Neuroradiology 37 (7): 1223-1230. July 2016

Annals of Clinical and Translational Neurology

Interactions of optic radiation lesions with retinal and brain atrophy in early multiple sclerosis.
Lin, T.Y. and Chien, C. and Kuchling, J. and Asseyer, S. and Motamedi, S. and Bellmann-Strobl, J. and Schmitz-Hübsch, T. and Ruprecht, K. and Brandt, A.U. and Zimmermann, H.G. and Paul, F.
Annals of Clinical and Translational Neurology 11 (1): 45-56. January 2024

Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism.
Kim, H.J. and Aktas, O. and Patterson, K.R. and Korff, S. and Kunchok, A. and Bennett, J.L. and Weinshenker, B.G. and Paul, F. and Hartung, H.P. and Cimbora, D. and Smith, M.A. and Mittereder, N. and Rees, W.A. and She, D. and Cree, B.A.C.
Annals of Clinical and Translational Neurology 10 (12): 2413-2420. December 2023

Disease progression of spinocerebellar ataxia types 1, 2, 3 and 6 before and after ataxia onset.
Jacobi, H. and Schaprian, T. and Schmitz-Hübsch, T. and Schmid, M. and Klockgether, T.
Annals of Clinical and Translational Neurology 10 (10): 1833-1843. October 2023

Prior optic neuritis detection on peripapillary ring scans using deep learning.
Motamedi, S. and Yadav, S.K. and Kenney, R.C. and Lin, T.Y. and Kauer-Bonin, J. and Zimmermann, H.G. and Galetta, S.L. and Balcer, L.J. and Paul, F. and Brandt, A.U.
Annals of Clinical and Translational Neurology 9 (11): 1682-1691. November 2022

Optical coherence tomography in multiple sclerosis: a 3-year prospective multicenter study.
Paul, F. and Calabresi, P.A. and Barkhof, F. and Green, A.J. and Kardon, R. and Sastre-Garriga, J. and Schippling, S. and Vermersch, P. and Saidha, S. and Gerendas, B.S. and Schmidt-Erfurth, U. and Agoropoulou, C. and Zhang, Y. and Seifer, G. and Petzold, A.
Annals of Clinical and Translational Neurology 8 (12): 2235-2251. 14 December 2021

Artificial intelligence extension of the OSCAR-IB criteria.
Petzold, A. and Albrecht, P. and Balcer, L. and Bekkers, E. and Brandt, A.U. and Calabresi, P.A. and Deborah, O.G. and Graves, J.S. and Green, A. and Keane, P.A. and Nij Bijvank, J.A. and Sander, J.W. and Paul, F. and Saidha, S. and Villoslada, P. and Wagner, S.K. and Yeh, E.A.
Annals of Clinical and Translational Neurology 8 (7): 1528-1542. July 2021

Spinocerebellar ataxia type 14: refining clinicogenetic diagnosis in a rare adult-onset disorder.
Schmitz-Hübsch, T. and Lux, S. and Bauer, P. and Brandt, A.U. and Schlapakow, E. and Greschus, S. and Scheel, M. and Gärtner, H. and Kirlangic, M.E. and Gras, Vi. and Timmann, D. and Synofzik, M. and Giorgetti, A. and Carloni, P. and Shah, J.N. and Schöls, L. and Kopp, U. and Bußenius, L. and Oberwahrenbrock, T. and Zimmermann, H. and Pfueller, C. and Kadas, E.M. and Rönnefarth, M. and Grosch, A.S. and Endres, M. and Amunts, K. and Paul, F. and Doss, S. and Minnerop, M.
Annals of Clinical and Translational Neurology 8 (4): 774-789. April 2021

Effect of vitamin D supplementation on N-glycan branching and cellular immunophenotypes in MS.
Bäcker-Koduah, P. and Infante-Duarte, C. and Ivaldi, F. and Uccelli, A. and Bellmann-Strobl, J. and Wernecke, K.D. and Sy, M. and Demetriou, M. and Dörr, J. and Paul, F. and Brandt, A.U.
Annals of Clinical and Translational Neurology 7 (9): 1628-1641. September 2020

7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions.
Behrens, J.R. and Wanner, J. and Kuchling, J. and Ostendorf, L. and Harms, L. and Ruprecht, K. and Niendorf, T. and Jarius, S. and Wildemann, B. and Gieß, R.M. and Scheel, M. and Bellmann-Strobl, J. and Wuerfel, J. and Paul, F. and Sinnecker, T.
Annals of Clinical and Translational Neurology 5 (8): 900-912. August 2018

Altered paired associative stimulation-induced plasticity in NMDAR encephalitis.
Volz, M.S. and Finke, C. and Harms, L. and Jurek, B. and Paul, F. and Flöel, A. and Prüss, H.
Annals of Clinical and Translational Neurology 3 (2): 101-113. February 2016

High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types.
Doss, S. and Wandinger, K.P. and Hyman, B.T. and Panzer, J.A. and Synofzik, M. and Dickerson, B. and Mollenhauer, B. and Scherzer, C.R. and Ivinson, A.J. and Finke, C. and Schöls, L. and Müller vom Hagen, J. and Trenkwalder, C. and Jahn, H. and Höltje, M. and Biswal, B.B. and Harms, L. and Ruprecht, K. and Buchert, R. and Höglinger, G.U. and Oertel, W.H. and Unger, M.M. and Körtvélyessy, P. and Bittner, D. and Priller, J. and Spruth, E.J. and Paul, F. and Meisel, A. and Lynch, D.R. and Dirnagl, U. and Endres, M. and Teegen, B. and Probst, C. and Komorowski, L. and Stöcker, W. and Dalmau, J. and Pruess, H.
Annals of Clinical and Translational Neurology 1 (10): 822-832. October 2014

Annals of Neurology

Time to disability milestones and annualized relapse rates in NMOSD and MOGAD.
Duchow, A. and Bellmann-Strobl, J. and Friede, T. and Aktas, O. and Angstwurm, K. and Ayzenberg, I. and Berthele, A. and Dawin, E. and Engels, D. and Fischer, K. and Flaskamp, M. and Giglhuber, K. and Grothe, M. and Havla, J. and Hümmert, M.W. and Jarius, S. and Kaste, M. and Kern, P. and Kleiter, I. and Klotz, L. and Korporal-Kuhnke, M. and Kraemer, M. and Krumbholz, M. and Kümpfel, T. and Lohmann, L. and Ringelstein, M. and Rommer, P. and Schindler, P. and Schubert, C. and Schwake, C. and Senel, M. and Bergh, F.T. and Tkachenko, D. and Tumami, H. and Trebst, C. and Vardakas, I. and Walter, A. and Warnke, C. and Weber, M.S. and Wickel, J. and Wildemann, B. and Winkelmann, A. and Paul, F. and Stellmann, J.P. and Häußler, V.
Annals of Neurology 95 (4): 720-732. April 2024

Do early relapses predict the risk of long-term relapsing disease in an adult and paediatric cohort with MOGAD?
Chen, B. and Gomez-Figueroa, E. and Redenbaugh, V. and Francis, A. and Satukijchai, C. and Wu, Y. and Messina, S. and Sa, M. and Woodhall, M. and Paul, F. and Robertson, N.P. and Lim, M. and Wassmer, E. and Kneen, R. and Huda, S. and Blain, C. and Halfpenny, C. and Hemingway, C. and O'Sullivan, E. and Hobart, J. and Fisniku, L.K. and Martin, R.J. and Dobson, R. and Cooper, S.A. and Williams, V. and Waters, P. and Chen, J.J. and Pittock, S.J. and Ramdas, S. and Leite, M.I. and Flanagan, E.P. and Geraldes, R. and Palace, J.
Annals of Neurology 94 (3): 508-517. September 2023

Ravulizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
Pittock, S.J. and Barnett, M. and Bennett, J.L. and Berthele, A. and de Seze, J. and Levy, M. and Nakashima, I. and Oreja-Guevara, C. and Palace, J. and Paul, F. and Pozzilli, C. and Yountz, M. and Allen, K. and Mashhoon, Y. and Kim, H.J.
Annals of Neurology 93 (6): 1053-1068. June 2023

Longitudinal retinal changes in MOGAD.
Oertel, F.C. and Sotirchos, E.S. and Zimmermann, H.G. and Motamedi, S. and Specovius, S. and Asseyer, E.S. and Chien, C. and Cook, L. and Vasileiou, E. and Filippatou, A. and Calabresi, P.A. and Saidha, S. and Pandit, L. and D'Cunha, A. and Outteryck, O. and Zéphir, H. and Pittock, S. and Flanagan, E.P. and Bhatti, M.T. and Rommer, P.S. and Bsteh, G. and Zrzavy, T. and Kuempfel, T. and Aktas, O. and Ringelstein, M. and Albrecht, P. and Ayzenberg, I. and Pakeerathan, T. and Knier, B. and Aly, L. and Asgari, N. and Soelberg, K. and Marignier, R. and Tilikete, C.F. and Calvo, A.C. and Villoslada, P. and Sanchez-Dalmau, B. and Martinez-Lapiscina, E.H. and Llufriu, S. and Green, A.J. and Yeaman, M.R. and Smith, T.J. and Brandt, A.U. and Chen, J. and Paul, F. and Havla, J.
Annals of Neurology 92 (3): 476-485. September 2022

Subcortical volumes as early predictors of fatigue in multiple sclerosis.
Fleischer, V. and Ciolac, D. and Gonzalez-Escamilla, G. and Grothe, M. and Strauss, S. and Molina Galindo, L.S. and Radetz, A. and Salmen, A. and Lukas, C. and Klotz, L. and Meuth, S.G. and Bayas, A. and Paul, F. and Hartung, H.P. and Heesen, C. and Stangel, M. and Wildemann, B. and Bergh, F.T. and Tackenberg, B. and Kümpfel, T. and Zettl, U.K. and Knop, M. and Tumani, H. and Wiendl, H. and Gold, R. and Bittner, S. and Zipp, F. and Groppa, S. and Muthuraman, M.
Annals of Neurology 91 (2): 192-202. February 2022

Serum glial fibrillary acidic protein: a neuromyelitis optica spectrum disorder biomarker.
Aktas, O. and Smith, M.A. and Rees, W.A. and Bennett, J.L. and She, D. and Katz, E. and Cree, B.A.C.
Annals of Neurology 89 (5): 895-910. May 2021

Identifying progression in multiple sclerosis: new perspectives.
Filippi, M. and Preziosa, P. and Langdon, D. and Lassmann, H. and Paul, F. and Rovira, À. and Schoonheim, M.M. and Solari, A. and Stankoff, B. and Rocca, M.A.
Annals of Neurology 88 (3): 438-452. September 2020

Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: an international study.
Nolan, R.C. and Liu, M. and Akhand, O. and Calabresi, P.A. and Paul, F. and Petzold, A. and Balk, L. and Brandt, A.U. and Martínez-Lapiscina, E.H. and Saidha, S. and Villoslada, P. and Abu Al-Hassan, A. and Behbehani, R. and Frohman, E.M. and Frohman, T. and Havla, J. and Hemmer, B. and Jiang, H. and Knier, B. and Korn, T. and Leocani, L. and Papadopoulou, A. and Pisa, M. and Zimmermann, H. and Galetta, S.L. and Balcer, L.J.
Annals of Neurology 85 (5): 618-629. May 2019

Neuromyelitis optica: evaluation of 871 attacks and 1153 treatment courses.
Kleiter, I. and Gahlen, A. and Borisow, N. and Fischer, K. and Wernecke, K.D. and Wegner, B. and Hellwig, K. and Pache, F. and Ruprecht, K. and Havla, J. and Krumbholz, M. and Kümpfel, T. and Aktas, O. and Hartung, H.P. and Ringelstein, M. and Geis, C. and Kleinschnitz, C. and Berthele, A. and Hemmer, B. and Angstwurm, K. and Stellmann, J.P. and Schuster, S. and Stangel, M. and Lauda, F. and Tumani, H. and Mayer, C. and Zeltner, L. and Ziemann, U. and Linker, R. and Schwab, M. and Marziniak, M. and Bergh, F.T. and Hofstadt-van Oy, U. and Neuhaus, O. and Winkelmann, A. and Marouf, W. and Faiss, J. and Wildemann, B. and Paul, F. and Jarius, S. and Trebst, C.
Annals of Neurology 79 (2): 206-216. February 2016

Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis.
Finke, C. and Kopp, U.A. and Scheel, M. and Pech, L.M. and Soemmer, C. and Schlichting, J. and Leypoldt, F. and Brandt, A.U. and Wuerfel, J. and Probst, C. and Ploner, C.J. and Prüss, H. and Paul, F.
Annals of Neurology 74 (2): 284-296. August 2013

No cerebrocervical venous congestion in patients with multiple sclerosis.
Doepp, F. and Paul, F. and Valdueza, J.M. and Schmierer, K. and Schreiber, S.J.
Annals of Neurology 68 (2): 173-183. August 2010

Archives of Neurology

Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
Sinnecker, T. and Mittelstaedt, P. and Doerr, J. and Pfueller, C.F. and Harms, L. and Niendorf, T. and Paul, F. and Wuerfel, J.
Archives of Neurology 69 (6): 739-745. June 2012

Failure of natalizumab to prevent relapses in neuromyelitis optica.
Kleiter, I. and Hellwig, K. and Berthele, A. and Kuempfel, T. and Linker, R.A. and Hartung, H.P. and Paul, F. and Aktas, O.
Archives of Neurology 69 (2): 239-245. February 2012

Archives of Physical Medicine and Rehabilitation

Frailty and falls in people living with multiple sclerosis.
Zanotto, T. and Galperin, I. and Mirelman, A. and Yehezkiyahu, S. and Estes, J. and Chen, L. and Regev, K. and Karni, A. and Schmitz-Hübsch, T. and Paul, F. and Lynch, S.G. and Akinwuntan, A.E. and Devos, H. and Hausdorff, J.M. and Sosnoff, J.J.
Archives of Physical Medicine and Rehabilitation 103 (5): 952-957. 24 November 2021

Autoimmunity Reviews

Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome - State of the art: Report of the 2nd international meeting at the Charité fatigue center.
Steiner, S. and Fehrer, A. and Hoheisel, F. and Schoening, S. and Aschenbrenner, A. and Babel, N. and Bellmann-Strobl, J. and Finke, C. and Fluge, Ø. and Froehlich, L. and Goebel, A. and Grande, B. and Haas, J.P. and Hohberger, B. and Jason, L.A. and Komaroff, A.L. and Lacerda, E. and Liebl, M. and Maier, A. and Mella, O. and Nacul, L. and Paul, F. and Prusty, B.K. and Puta, C. and Riemekasten, G. and Ries, W. and Rowe, P.C. and Sawitzki, B. and Shoenfeld, Y. and Schultze, J.L. and Seifert, M. and Sepúlveda, N. and Sotzny, F. and Stein, E. and Stingl, M. and Ufer, F. and Veauthier, C. and Westermeier, F. and Wirth, K. and Wolfarth, B. and Zalewski, P. and Behrends, U. and Scheibenbogen, C.
Autoimmunity Reviews 22 (11): 103452. November 2023

BMC Medical Imaging

Central intra-lesional iron deposits as a possible novel imaging marker at 7 Tesla MRI in Susac Syndrome - an exploratory study.
Strunk, D. and Sinnecker, T. and Kleffner, I. and Doerr, J. and Ringelstein, M. and Gross, C.C. and Deuschl, C. and Maderwald, S. and Quick, H.H. and Yamac, E. and Wrede, K.H. and Kraemer, M.
BMC Medical Imaging 24 (1): 4. 2 January 2024

BMC Neurology

Berlin Registry of Neuroimmunological entities (BERLimmun): protocol of a prospective observational study.
Sperber, P.S. and Brandt, A.U. and Zimmermann, H.G. and Bahr, L.S. and Chien, C. and Rekers, S. and Mähler, A. and Böttcher, C. and Asseyer, S. and Duchow, A.S. and Bellmann-Strobl, J. and Ruprecht, K. and Paul, F. and Schmitz-Hübsch, T.
BMC Neurology 22 (1): 479. 14 December 2022

Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial.
Albert, C. and Mikolajczak, J. and Liekfeld, A. and Piper, S.K. and Scheel, M. and Zimmermann, H.G. and Nowak, C. and Dörr, J. and Bellmann-Strobl, J. and Chien, C. and Brandt, A.U. and Paul, F. and Hoffmann, O.
BMC Neurology 20 (1): 75. 3 March 2020

Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.
Klehmet, J. and Beutner, S. and Hoffmann, S. and Dornauer, M. and Paul, F. and Reilmann, R. and Brandt, A.U. and Meisel, A.
BMC Neurology 19 (1): 118. 8 June 2019

Subjective and objective assessment of physical activity in multiple sclerosis and their relation to health-related quality of life.
Krüger, T. and Behrens, J.R. and Grobelny, A. and Otte, K. and Mansow-Model, S. and Kayser, B. and Bellmann-Strobl, J. and Brandt, A.U. and Paul, F. and Schmitz-Hübsch, T.
BMC Neurology 17 (1): 10. 13 January 2017

Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study.
Hoffmann, S. and Siedler, J. and Brandt, A.U. and Piper, S.K. and Kohler, S. and Sass, C. and Paul, F. and Reilmann, R. and Meisel, A.
BMC Neurology 15 (1): 265. 23 December 2015

Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis.
Schinzel, J. and Zimmermann, H. and Paul, F. and Ruprecht, K. and Hahn, K. and Brandt, A.U. and Dörr, J.
BMC Neurology 14 : 31. 20 February 2014

Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study.
Wieder, L. and Gäde, G. and Pech, L.M. and Zimmermann, H. and Wernecke, K.D. and Dörr, J.M. and Bellmann-Strobl, J. and Paul, F. and Brandt, A.U.
BMC Neurology 13 : 167. 8 November 2013

Environmental factors in early childhood are associated with multiple sclerosis: a case-control study.
Conradi, S. and Malzahn, U. and Schroeter, F. and Paul, F. and Quill, S. and Spruth, E. and Harms, L. and Then Bergh, F. and Ditzenbach, A. and Georgi, T. and Heuschmann, P. and Rosche, B.
BMC Neurology 11 : 123. 6 October 2011

BMC Neuroscience

The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice.
Siegert, E. and Paul, F. and Rothe, M. and Weylandt, K.H.
BMC Neuroscience 18 (1): 19. 24 January 2017

BMC Research Notes

Camera-based objective measures of Parkinson's disease gait features.
van Kersbergen, J. and Otte, K. and de Vries, N.M. and Bloem, B.R. and Röhling, H.M. and Mansow-Model, S. and van der Kolk, N.M. and Overeem, S. and Zinger, S. and van Gilst, M.M.
BMC Research Notes 14 (1): 329. 26 August 2021

BMJ Case Reports

Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?
Borisow, N. and Meyer, T. and Paul, F.
BMJ Case Reports 2013 23 January 2013

BMJ Open

Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO).
Specovius, S. and Zimmermann, H.G. and Oertel, F.C. and Chien, C. and Bereuter, C. and Cook, L.J. and Lana Peixoto, M.A. and Fontenelle, M.A. and Kim, H.J. and Hyun, J.W. and Jung, S.K. and Palace, J. and Roca-Fernandez, A. and Diaz, A.R. and Leite, M.I. and Sharma, S.M. and Ashtari, F. and Kafieh, R. and Dehghani, A. and Pourazizi, M. and Pandit, L. and Dcunha, A. and Aktas, O. and Ringelstein, M. and Albrecht, P. and May, E. and Tongco, C. and Leocani, L. and Pisa, M. and Radaelli, M. and Martinez-Lapiscina, E.H. and Stiebel-Kalish, H. and Hellmann, M. and Lotan, I. and Siritho, S. and de Seze, J. and Senger, T. and Havla, J. and Marignier, R. and Tilikete, C. and Cobo Calvo, A. and Bichuetti, D.B. and Tavares, I.M. and Asgari, N. and Soelberg, K. and Altintas, A. and Yildirim, R. and Tanriverdi, U. and Jacob, A. and Huda, S. and Rimler, Z. and Reid, A. and Mao-Draayer, Y. and de Castillo, I.S. and Yeaman, M.R. and Smith, T.J. and Brandt, A.U. and Paul, F.
BMJ Open 10 (10): e035397. 29 October 2020

BioMed Research International

No evidence for retinal damage evolving from reduced retinal blood flow in carotid artery disease.
Heßler, H. and Zimmermann, H. and Oberwahrenbrock, T. and Kadas, E.M. and Mikolajczak, J. and Brandt, A.U. and Kauert, A. and Paul, F. and Schreiber, S.J.
BioMed Research International 2015 : 604028. 2015

Biological Psychiatry

Structural hippocampal damage following anti-N-methyl-D-aspartate receptor encephalitis.
Finke, C. and Kopp, U.A. and Pajkert, A. and Behrens, J.R. and Leypoldt, F. and Wuerfel, J.T. and Ploner, C.J. and Prüss, H. and Paul, F.
Biological Psychiatry 79 (9): 727-734. 1 May 2016

Biology of Sex Differences

Sex differences in brain atrophy in multiple sclerosis.
Voskuhl, R.R. and Patel, K. and Paul, F. and Gold, S.M. and Scheel, M. and Kuchling, J. and Cooper, G. and Asseyer, S. and Chien, C. and Brandt, A.U. and Meyer, C.E. and MacKenzie-Graham, A.
Biology of Sex Differences 11 (1): 49. 28 August 2020

Biomedical Optics Express

Active contour method for ILM segmentation in ONH volume scans in retinal OCT.
Gawlik, K. and Hausser, F. and Paul, F. and Brandt, A.U. and Kadas, E.M.
Biomedical Optics Express 9 (12): 6497. 1 December 2018

CuBe: parametric modeling of 3D foveal shape using cubic Bézier.
Yadav, S.K. and Motamedi, S. and Oberwahrenbrock, T. and Oertel, F.C. and Polthier, K. and Paul, F. and Kadas, E.M. and Brandt, A.U.
Biomedical Optics Express 8 (9): 4181-4199. 1 September 2017

Brain

Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
Cortese, R. and Battaglini, M. and Prados, F. and Bianchi, A. and Haider, L. and Jacob, A. and Palace, J. and Messina, S. and Paul, F. and Wuerfel, J. and Marignier, R. and Durand-Dubief, F. and de Medeiros Rimkus, C. and Callegaro, D. and Sato, D.K. and Filippi, M. and Rocca, M.A. and Cacciaguerra, L. and Rovira, A. and Sastre-Garriga, J. and Arrambide, G. and Liu, Y. and Duan, Y. and Gasperini, C. and Tortorella, C. and Ruggieri, S. and Amato, M.P. and Ulivelli, M. and Groppa, S. and Grothe, M. and Llufriu, S. and Sepulveda, M. and Lukas, C. and Bellenberg, B. and Schneider, R. and Sowa, P. and Celius, E.G. and Proebstel, A.K. and Yaldizli, Ö. and Müller, J. and Stankoff, B. and Bodini, B. and Carmisciano, L. and Sormani, M.P. and Barkhof, F. and De Stefano, N. and Ciccarelli, O.
Brain 146 (6): 2489-2501. June 2023

Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis.
Petrou, P. and Kassis, I. and Levin, N. and Paul, F. and Backner, Y. and Benoliel, T. and Oertel, F.C. and Scheel, M. and Hallimi, M. and Yaghmour, N. and Hur, T.B. and Ginzberg, A. and Levy, Y. and Abramsky, O. and Karussis, D.
Brain 143 (12): 3574-3588. December 2020

Aggressive multiple sclerosis - a matter of measurement and timing.
Ellenberger, D. and Flachenecker, P. and Fneish, F. and Frahm, N. and Hellwig, K. and Paul, F. and Stahmann, A. and Warnke, C. and Rommer, P.S. and Zettl, U.K.
Brain 143 (11): e97. November 2020

Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.
Dietrich, M. and Koska, V. and Hecker, C. and Göttle, P. and Hilla, A.M. and Heskamp, A. and Lepka, K. and Issberner, A. and Hallenberger, A. and Baksmeier, C. and Steckel, J. and Balk, L. and Knier, B. and Korn, T. and Havla, J. and Martínez-Lapiscina, E.H. and Solà-Valls, N. and Manogaran, P. and Olbert, E.D. and Schippling, S. and Cruz-Herranz, A. and Yiu, H. and Button, J. and Caldito, N.G. and von Gall, C. and Mausberg, A.K. and Stettner, M. and Zimmermann, H.G. and Paul, F. and Brandt, A.U. and Küry, P. and Goebels, N. and Aktas, O. and Berndt, C. and Saidha, S. and Green, A.J. and Calabresi, P.A. and Fischer, D. and Hartung, H.P. and Albrecht, P.
Brain 143 (4): 1127-1142. April 2020

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.
Filippi, M. and Preziosa, P. and Banwell, B.L. and Barkhof, F. and Ciccarelli, O. and De Stefano, N. and Geurts, J.J.G. and Paul, F. and Reich, D.S. and Toosy, A.T. and Traboulsee, A. and Wattjes, M.P. and Yousry, T.A. and Gass, A. and Lubetzki, C. and Weinshenker, B.G. and Rocca, M.A.
Brain 142 (7): 1858-1875. July 2019

Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis.
Kreye, J. and Wenke, N.K. and Chayka, M. and Leubner, J. and Murugan, R. and Maier, N. and Jurek, B. and Ly, L.T. and Brandl, D. and Rost, B.R. and Stumpf, A. and Schulz, P. and Radbruch, H. and Hauser, A.E. and Pache, F. and Meisel, A. and Harms, L. and Paul, F. and Dirnagl, U. and Garner, C. and Schmitz, D. and Wardemann, H. and Prüss, H.
Brain 139 (10): 2641-2652. 1 October 2016

Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography.
Brandt, A.U. and Oberwahrenbrock, T. and Ringelstein, M. and Young, K.L. and Tiede, M. and Hartung, H.P. and Martin, R. and Aktas, O. and Paul, F. and Schippling, S.
Brain 134 (Pt 11): e193. November 2011

Brain Behavior and Immunity

Immune signature of multiple sclerosis-associated depression.
Brasanac, J. and Ramien, C. and Gamradt, S. and Tänzer, A. and Glau, L. and Ritter, K. and Patas, K. and Agorastos, A. and Wiedemann, K. and Demiralay, C. and Fischer, F. and Otte, C. and Bellmann-Strobl, J. and Friese, M.A. and Tolosa, E. and Paul, F. and Heesen, C. and Weygandt, M. and Gold, S.M.
Brain Behavior and Immunity 100 : 174-182. February 2022

Synapsin-antibodies in psychiatric and neurological disorders: prevalence and clinical findings.
Höltje, M. and Mertens, R. and Schou, M.B. and Saether, S.G. and Kochova, E. and Jarius, S. and Prüss, H. and Komorowski, L. and Probst, C. and Paul, F. and Bellmann-Strobl, J. and Gitler, D. and Benfenati, F. and Piepgras, J. and Ahnert-Hilger, G. and Ruprecht, K.
Brain Behavior and Immunity 66 : 125-134. November 2017

Brain Communications

Increased flexibility of brain dynamics in patients with multiple sclerosis.
von Schwanenflug, N. and Koch, S.P. and Krohn, S. and Broeders, T.A.A. and Lydon-Staley, D.M. and Bassett, D.S. and Schoonheim, M.M. and Paul, F. and Finke, C.
Brain Communications 5 (3): fcad143. 3 May 2023

Prefrontal-amygdala emotion regulation and depression in multiple sclerosis.
Meyer-Arndt, L. and Kuchling, J. and Brasanac, J. and Hermann, A. and Asseyer, S. and Bellmann-Strobl, J. and Paul, F. and Gold, S.M. and Weygandt, M.
Brain Communications 4 (3): fcac152. 13 June 2022

Central stress processing, T-cell responsivity to stress hormones, and disease severity in multiple sclerosis.
Brasanac, J. and Hetzer, S. and Asseyer, S. and Kuchling, J. and Bellmann-Strobl, J. and Ritter, K. and Gamradt, S. and Scheel, M. and Haynes, J.D. and Brandt, A.U. and Paul, F. and Gold, S.M. and Weygandt, M.
Brain Communications 4 (2): fcac086. 4 April 2022

State-dependent signatures of anti-N-methyl-d-aspartate receptor encephalitis.
von Schwanenflug, N. and Krohn, S. and Heine, J. and Paul, F. and Prüss, H. and Finke, C.
Brain Communications 4 (1): fcab298. 1 February 2022

Imaging markers of disability in aquaporin-4 immunoglobulin G seropositive neuromyelitis optica: a graph theory study.
Chien, C. and Oertel, F.C. and Siebert, N. and Zimmermann, H. and Asseyer, S. and Kuchling, J. and Scheel, M. and Ruprecht, K. and Bellmann-Strobl, J. and Paul, F. and Brandt, A.U.
Brain Communications 1 (1): fcz026. 16 October 2019

Brain, Behavior & Immunity - Health

Synapsin autoantibodies during pregnancy are associated with fetal abnormalities.
Bünger, I. and Talucci, I. and Kreye, J. and Höltje, M. and Makridis, K.L. and Foverskov Rasmussen, H. and van Hoof, S. and Cordero-Gomez, C. and Ullrich, T. and Sedlin, E. and Kreissner, K.O. and Hoffmann, C. and Milovanovic, D. and Turko, P. and Paul, F. and Meckies, J. and Verlohren, S. and Henrich, W. and Chaoui, R. and Maric, H.M. and Kaindl, A.M. and Prüss, H.
Brain, Behavior & Immunity - Health 33 : 100678. November 2023

British Journal of Ophthalmology

Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis.
Bock, M. and Brandt, A.U. and Kuchenbecker, J. and Doerr, J. and Pfueller, C.F. and Weinges-Evers, N. and Gaede, G. and Zimmermann, H. and Bellmann-Strobl, J. and Ohlraun, S. and Zipp, F. and Paul, F.
British Journal of Ophthalmology 96 (1): 62-67. January 2012

Case Reports in Neurological Medicine

Leptomeningeal and intraparenchymal blood barrier disruption in a MOG-IgG-positive patient.
Mohseni, S.H. and Skejoe, H.P.B. and Wuerfel, J. and Paul, F. and Reindl, M. and Jarius, S. and Asgari, N.
Case Reports in Neurological Medicine 2018 : 1365175. 9 December 2018

Progressive multifocal leukoencephalopathy in a multiple Sclerosis patient diagnosed after switching from natalizumab to fingolimod.
Sinnecker, T. and Othman, J. and Kühl, M. and Metz, I. and Niendorf, T. and Kunkel, A. and Paul, F. and Wuerfel, J. and Faiss, Juergen
Case Reports in Neurological Medicine 2016 : 5876798. 22 November 2016

Cell

Low-frequency and rare-coding variation contributes to multiple sclerosis risk.
Cotsapas, C.
Cell 175 (6): 1679-1687. 29 November 2018

Cell Reports

A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms.
Choi, I.Y. and Piccio, L. and Childress, P. and Bollman, B. and Ghosh, A. and Brandhorst, S. and Suarez, J. and Michalsen, A. and Cross, A.H. and Morgan, T.E. and Wei, M. and Paul, F. and Bock, M. and Longo, V.D.
Cell Reports 15 (10): 2136-2146. 7 June 2016

Cephalalgia

Temporal retinal nerve fibre layer thinning in cluster headache patients detected by optical coherence tomography.
Ewering, C. and Haşal, N. and Alten, F. and Clemens, C.R. and Eter, N. and Oberwahrenbrock, T. and Kadas, E.M. and Zimmermann, H. and Brandt, A.U. and Osada, N. and Paul, F. and Marziniak, M.
Cephalalgia 35 (11): 946-958. October 2015

Cerebellum

Quantitative gait and balance outcomes for ataxia trials: consensus recommendations by the Ataxia Global Initiative Working Group on Digital-Motor Biomarkers.
Ilg, W. and Milne, S. and Schmitz-Hübsch, T. and Alcock, L. and Beichert, L. and Bertini, E. and Mohamed Ibrahim, N. and Dawes, H. and Gomez, C.M. and Hanagasi, H. and Kinnunen, K.M. and Minnerop, M. and Németh, A.H. and Newman, J. and Ng, Y.S. and Rentz, C. and Samanci, B. and Shah, V.V. and Summa, S. and Vasco, G. and McNames, J. and Horak, F.B.
Cerebellum 13 November 2023 (In Press)

Digital motor biomarkers of cerebellar ataxia using an RGB-Depth camera-based motion analysis system.
Suzuki, M. and Hirano, S. and Otte, K. and Schmitz-Hübsch, T. and Izumi, M. and Tamura, M. and Kuroiwa, R. and Sugiyama, A. and Mori, M. and Röhling, H.M. and Brandt, A.U. and Murata, A. and Paul, F. and Kuwabara, S:
Cerebellum 18 September 2023 (In Press)

Health-related quality of life in patients with spinocerebellar ataxia: a validation study of the EQ-5D-3L.
Buchholz, M. and Weber, N. and Rädke, A. and Faber, J. and Schmitz-Hübsch, T. and Jacobi, H. and Xie, F. and Klockgether, T. and Michalowsky, B.
Cerebellum 15 September 2023 (In Press)

Neurochemical differences in spinocerebellar ataxia type 14 and 1.
Grosch, A.S. and Rinnenthal, J.L. and Rönnefarth, M. and Lux, S. and Scheel, M. and Endres, M. and Brandt, A.U. and Paul, F. and Schmitz-Hübsch, T. and Minnerop, M. and Doss, S.
Cerebellum 20 (2): 169-178. April 2021

Investigation of visual system involvement in spinocerebellar ataxia type 14.
Ihl, T. and Kadas, E.M. and Oberwahrenbrock, T. and Endres, M. and Klockgether, T. and Schroeter, J. and Brandt, A.U. and Paul, F. and Minnerop, M. and Doss, S. and Schmitz-Hübsch, T. and Zimmermann, H.G.
Cerebellum 19 (4): 469-482. August 2020

Dysphagia affecting quality of life in cerebellar ataxia - a large survey.
Rönnefarth, M. and Hanisch, N. and Brandt, A.U. and Mähler, A. and Endres, M. and Paul, F. and Doss, S.
Cerebellum 19 (3): 437-445. June 2020

Increased catabolic state in spinocerebellar ataxia type 1 patients.
Mähler, A. and Steiniger, J. and Endres, M. and Paul, F. and Boschmann, M. and Doss, S.
Cerebellum 13 (4): 440-446. August 2014

Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.
Doss, S. and Brandt, A.U. and Oberwahrenbrock, T. and Endres, M. and Paul, F. and Rinnenthal, J.L.
Cerebellum 13 (2): 199-206. April 2014

Clinical Neurology and Neurosurgery

Treatment of sleep disorders may improve fatigue in multiple sclerosis.
Veauthier, C. and Gaede, G. and Radbruch, H. and Gottschalk, S. and Wernecke, K.D. and Paul, F.
Clinical Neurology and Neurosurgery 115 (9): 1826-1830. September 2013

Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients.
Bock, M. and Brandt, A.U. and Doerr, J. and Kraft, H. and Weinges-Evers, N. and Gaede, G. and Pfueller, C.F. and Herges, K. and Radbruch, H. and Ohlraun, S. and Bellmann-Strobl, J. and Kuchenbecker, J. and Zipp, F. and Paul, F.
Clinical Neurology and Neurosurgery 112 (8): 647-652. October 2010

Clinical Neurophysiology

Axonal damage in papilledema linked to idiopathic intracranial hypertension as revealed by multifocal visual evoked potentials.
Hartmann, C.J. and Klistorner, A.I. and Brandt, A.U. and Schroeder, K. and Kolbe, R. and Cohn, E. and Goebels, N. and Guthoff, R. and Aktas, O. and Hartung, H.P. and Albrecht, P.
Clinical Neurophysiology 126 (10): 2040-2041. October 2015

Clinical and Experimental Immunology

Clinical and neuroimaging findings in MOGAD - MRI and OCT.
Bartels, F. and Lu, A. and Oertel, F.C. and Finke, C. and Paul, F. and Chien, C.
Clinical and Experimental Immunology 206 (3): 266-281. December 2021

Neuromyelitis optica: clinical features, immunopathogenesis and treatment.
Jarius, S. and Wildemann, B. and Paul, F.
Clinical and Experimental Immunology 176 (2): 149-164. May 2014

Clinical and Experimental Neuroimmunology

Accelerating clinical research in neuromyelitis optica spectrum disorders.
Oertel, F.C. and Paul, F.
Clinical and Experimental Neuroimmunology 12 (2): 89-91. May 2021

Practical recognition tools of immunoglobulin G serum antibodies against the myelin oligodendrocyte glycoprotein‐positive optic neuritis and its clinical implications.
Lotan, I. and Oertel, F.C. and Chien, C. and Asseyer, S. and Paul, F. and Stiebel‐Kalish, H.
Clinical and Experimental Neuroimmunology 12 (1): 42-53. February 2021

Computers in Biology and Medicine

Modular deep neural networks for automatic quality control of retinal optical coherence tomography scans.
Kauer-Bonin, J. and Yadav, S.K. and Beckers, I. and Gawlik, K. and Motamedi, S. and Zimmermann, H.G. and Kadas, E.M. and Haußer, F. and Paul, F. and Brandt, A.U.
Computers in Biology and Medicine 141 : 104822. 1 February 2022

Contemporary Clinical Trials

A multi-modal virtual reality treadmill intervention for enhancing mobility and cognitive function in people with multiple sclerosis: protocol for a randomized controlled trial.
Hsieh, K.L. and Mirelman, A. and Shema-Shiratzky, S. and Galperin, I. and Regev, K. and Shen, S. and Schmitz-Hübsch, T. and Karni, A. and Paul, F. and Devos, H. and Sosnoff, J.J. and Hausdorff, J.M.
Contemporary Clinical Trials 97 : 106122. October 2020

Current Treatment Options in Neurology

The transition from first-line to second-line therapy in multiple sclerosis.
Dörr, J. and Paul, F.
Current Treatment Options in Neurology 17 (6): 354. June 2015

Degenerative Neurological and Neuromuscular Disease

Optimal management of multiple sclerosis during pregnancy: current perspectives.
Borisow, N. and Paul, F. and Doerr, J.
Degenerative Neurological and Neuromuscular Disease 4 : 111-120. 5 August 2014

Developmental Medicine and Child Neurology

The use of magnetic resonance imaging in the diagnosis of paediatric transverse myelitis.
Paul, F.
Developmental Medicine and Child Neurology 61 (9): 1001. September 2019

Diagnostics

Differentiation between Parkinson’s disease and the parkinsonian subtype of multiple system atrophy using the magnetic resonance T1w/T2w ratio in the middle cerebellar peduncle.
Wang, J. and Sugiyama, A. and Yokota, H. and Hirano, S. and Yamamoto, T. and Yamanaka, Y. and Araki, N. and Ito, S. and Paul, F. and Kuwabara, S.
Diagnostics 14 (2): 201. January 2024

Drug Safety

Chances and challenges of registry-based pharmacovigilance in multiple sclerosis: lessons learnt from the implementation of the multicenter REGIMS registry.
Simbrich, A. and Thibaut, J. and Khil, L. and Maximov, S. and Wiendl, H. and Berger, K.
Drug Safety 44 (1): 7-15. January 2021

Drugs of Today

Inebilizumab in AQP4-Ab-positive neuromyelitis optica spectrum disorder.
Siebert, N. and Duchow, A. and Paul, F. and Infante-Duarte, C. and Bellmann-Strobl, J.
Drugs of Today 57 (5): 321-336. May 2021

EBioMedicine

Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial.
Bennett, J.L. and Aktas, O. and Rees, W.A. and Smith, M.A. and Gunsior, M. and Yan, L. and She, D. and Cimbora, D. and Pittock, S.J. and Weinshenker, B.G. and Paul, F. and Marignier, R. and Wingerchuk, D. and Cutter, G. and Green, A. and Hartung, H.P. and Kim, H.J. and Fujihara, K. and Levy, M. and Katz, E. and Cree, B.A.C.
EBioMedicine 86 : 104321. December 2022

Clinical implications of serum neurofilament in newly diagnosed MS patients: a longitudinal multicentre cohort study.
Bittner, S. and Steffen, F. and Uphaus, T. and Muthuraman, M. and Fleischer, V. and Salmen, A. and Luessi, F. and Berthele, A. and Klotz, L. and Meuth, S.G. and Bayas, A. and Paul, F. and Hartung, H.P. and Linker, R. and Heesen, C. and Stangel, M. and Wildemann, B. and Then Bergh, F. and Tackenberg, B. and Kuempfel, T. and Weber, F. and Zettl, U.K. and Ziemann, U. and Tumani, H. and Groppa, S. and Mühlau, M. and Lukas, C. and Hemmer, B. and Wiendl, H. and Gold, R. and Zipp, F.
EBioMedicine 56 : 102807. June 2020

EClinicalMedicine

Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort.
Legler, F. and Meyer-Arndt, L. and Mödl, L. and Kedor, C. and Freitag, H. and Stein, E. and Hoppmann, U. and Rust, R. and Wittke, K. and Siebert, N. and Behrens, J. and Thiel, A. and Konietschke, F. and Paul, F. and Scheibenbogen, C. and Bellmann-Strobl, J.
EClinicalMedicine 63 : 102146. 19 August 2023

Structural brain changes in patients with post-COVID fatigue: a prospective observational study.
Heine, J. and Schwichtenberg, K. and Hartung, T.J. and Rekers, S. and Chien, C. and Boesl, F. and Rust, R. and Hohenfeld, C. and Bungenberg, J. and Costa, A.S. and Scheibenbogen, C. and Bellmann-Strobl, J. and Paul, F. and Franke, C. and Reetz, K. and Finke, C.
EClinicalMedicine 58 : 101874. April 2023

EPMA Journal

The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.
Golubnitschaja, O. and Polivka, J. and Potuznik, P. and Pesta, M. and Stetkarova, I. and Mazurakova, A. and Lackova, L. and Kubatka, P. and Kropp, M. and Thumann, G. and Erb, C. and Fröhlich, H. and Wang, W. and Baban, B. and Kapalla, M. and Shapira, N. and Richter, K. and Karabatsiakis, A. and Smokovski, I. and Schmeel, L.C. and Gkika, E. and Paul, F. and Parini, P. and Polivka, J.
EPMA Journal 15 (1): 1-23. March 2024

Caution, "normal" BMI: health risks associated with potentially masked individual underweight - EPMA position paper 2021.
Golubnitschaja, O. and Liskova, A. and Koklesova, L. and Samec, M. and Biringer, K. and Büsselberg, D. and Podbielska, H. and Kunin, A.A. and Evsevyeva, M.E. and Shapira, N. and Paul, F. and Erb, C. and Dietrich, D.E. and Felbel, D. and Karabatsiakis, A. and Bubnov, R. and Polivka, J. and Polivka, J.J. and Birkenbihl, C. and Fröhlich, H. and Hofmann-Apitius, M. and Kubatka, P.
EPMA Journal 12 (3): 243-264. September 2021

Cultural bias in motor function patterns: potential relevance for predictive, preventive, and personalized medicine.
Otte, K. and Ellermeyer, T. and Suzuki, M. and Röhling, H.M. and Kuroiwa, R. and Cooper, G. and Mansow-Model, S. and Mori, M. and Zimmermann, H. and Brandt, A.U. and Paul, F. and Hirano, S. and Kuwabara, S. and Schmitz-Hübsch, T.
EPMA Journal 12 (1): 91-101. March 2021

Suggestions for improving the design of clinical trials in multiple sclerosis - results of a systematic analysis of completed phase III trials.
Gehr, S. and Kaiser, T. and Kreutz, R. and Ludwig, W.D. and Paul, F.
EPMA Journal 10 (4): 425-436. December 2019

Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies.
Borisow, N. and Hellwig, K. and Paul, F.
EPMA Journal 9 (3): 249-256. September 2018

Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy.
Oertel, F.C. and Zimmermann, H. and Paul, F. and Brandt, A.U.
EPMA Journal 9 (1): 21-33. March 2018

Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases.
Koduah, P. and Paul, F. and Dörr, J.M.
EPMA Journal 8 (4): 313-325. December 2017

Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.
Kuchling, J. and Brandt, A.U. and Paul, F. and Scheel, M.
EPMA Journal 8 (3): 279-294. September 2017

The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue.
Veauthier, C. and Hasselmann, H. and Gold, S.M. and Paul, F.
EPMA Journal 7 : 25. 24 November 2016

Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management.
Sinnecker, T. and Kuchling, J. and Dusek, P. and Dörr, J. and Niendorf, T. and Paul, F. and Wuerfel, J.
EPMA Journal 6 (1): 16. 27 August 2015

Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases.
Mähler, A. and Mandel, S. and Lorenz, M. and Ruegg, U. and Wanker, E.E. and Boschmann, M. and Paul, F.
EPMA Journal 4 (1): 5. 18 February 2013

Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Dörr, J. and Döring, A. and Paul, F.
EPMA Journal 4 : 4. 29 January 2013

Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy.
Borisow, N. and Doering, A. and Pfueller, C.F. and Paul, F. and Doerr, J. and Hellwig, K.
EPMA Journal 3 (1): 9. 22 June 2012

Exercise in multiple sclerosis - an integral component of disease management.
Doering, A. and Pfueller, C.F. and Paul, F. and Doerr, J.
EPMA Journal 3 : 2. 24 December 2011

The German healthcare system.
Doering, A. and Paul, F.
EPMA Journal 1 (4): 535-547. December 2010

European Journal of Immunology

Discriminating promiscuous from target-specific autoantibodies in COVID-19.
Lebedin, M. and Vazquez Garcia, C. and Spatt, L. and Ratswohl, C. and Thibeault, C. and Ostendorf, L. and Alexander, T. and Paul, F. and Sander, L.E. and Kurth, F. and de la Rosa, K.
European Journal of Immunology 53 (5): e2250210. May 2023

Bin-based visualization of cytokine-co-expression patterns of IL-10-producing CD4 T cell subsets.
Mohr, E. and Hinnenthal, T. and Gryzik, S. and Hoang, Y. and Lischke, T. and Retzlaff, J. and Mekonnen, A. and Paul, F. and Valleriani, A. and Radbruch, A. and Vera, J. and Baumgrass, R.
European Journal of Immunology 52 (10): 1684-1687. October 2022

European Journal of Integrative Medicine

The effectiveness of acupuncture and mindfulness-based stress reduction (MBSR) for patients with multiple sclerosis associated fatigue: a study protocol and its rationale for a randomized controlled trial.
Bellmann-Strobl, J. and Pach, D. and Chang, Y. and Pasura, L. and Liu, B. and Jäger, S.F. and Loerch, R. and Jin, L. and Blödt, S. and Brinkhaus, B. and Ortiz, M. and Reinhold, T. and Roll, S. and Binting, S. and Paul, F. and Witt, C.M. and Shi, X.
European Journal of Integrative Medicine 20 : 6-15. June 2018

European Journal of Neurology

Retinal ganglion cell loss is associated with future disability worsening in early relapsing remitting multiple sclerosis.
Wauschkuhn, J. and Solorza Buenrostro, G. and Aly, L. and Asseyer, S. and Wicklein, R. and Hartberger, J.M. and Ruprecht, K. and Mühlau, M. and Schmitz-Hübsch, T. and Chien, C. and Berthele, A. and Brandt, A.U. and Korn, T. and Paul, F. and Hemmer, B. and Zimmermann, H.G. and Knier, B.
European Journal of Neurology 30 (4): 982-990. April 2023

Early spinal cord pseudoatrophy in interferon-beta treated multiple sclerosis.
Matusche, B. and Litvin, L. and Schneider, R. and Bellenberg, B. and Mühlau, M. and Pongratz, V. and Berthele, A. and Groppa, S. and Muthuraman, M. and Zipp, F. and Paul, F. and Wiendl, H. and Meuth, S.G. and Sämann, P. and Weber, F. and Linker, R.A. and Kümpfel, T. and Gold, R. and Lukas, C.
European Journal of Neurology 30 (2): 453-462. February 2023

Retinoids are not linked to risk of multiple sclerosis: a Danish nationwide cohort study.
Cortes-Figueiredo, F. and Nielsen, N.M. and Stenager, E. and Paul, F. and Hallas, J. and Kristensen, K.B.
European Journal of Neurology 2 (1): 247-256. 18 January 2022

Foveal changes in aquaporin‐4 antibody seropositive neuromyelitis optica spectrum disorder are independent of optic neuritis and not overtly progressive.
Roca-Fernández, A. and Oertel, F.C. and Yeo, T and Motamedi, S. and Probert, F. and Craner, M.J. and Sastre-Garriga, J. and Zimmermann, H.G. and Asseyer, S. and Kuchling, J. and Bellmann-Strobl, J. and Ruprecht, K. and Leite, M.I. and Paul, F. and Brandt, A.U. and Palace, J.
European Journal of Neurology 28 (7): 2280-2293. July 2021

Pain, depression and quality of life in adults with MOG-antibody associated disease.
Asseyer, S. and Henke, E. and Trebst, C. and Hümmert, M.W. and Wildemann, B. and Jarius, S. and Ringelstein, M. and Aktas, O. and Pawlitzki, M. and Korsen, M. and Klotz, L. and Siebert, N. and Ruprecht, K. and Bellmann-Strobl, J. and Wernecke, K.D. and Häußler, V. and Havla, J. and Gahlen, A. and Gold, R. and Paul, F. and Kleiter, I. and Ayzenberg, I.
European Journal of Neurology 28 (5): 1645-1658. May 2021

Emotional experience in patients with clinically isolated syndrome and early multiple sclerosis.
Hälbig, T.D. and Wüstenberg, T. and Giess, R.M. and Kunte, H. and Bellmann-Strobl, J. and Ruprecht, K. and Paul, F.
European Journal of Neurology 27 (8): 1537-1545. August 2020

Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis.
Behrens, J.R. and Rasche, L. and Giess, R.M. and Pfuhl, C. and Wakonig, K. and Freitag, E. and Deuschle, K. and Bellmann-Strobl, J. and Paul, F. and Ruprecht, K. and Doerr, J.
European Journal of Neurology 23 (1): 62-67. January 2016

Optical coherence tomography in patients with a history of juvenile multiple sclerosis reveals early retinal damage.
Huhn, K. and Lämmer, R. and Oberwahrenbrock, T. and Lämmer, A. and Waschbisch, A. and Gosar, D. and Brandt, A. and Paul, F. and Linker, R.A. and Lee, D.H.
European Journal of Neurology 22 (1): 86-92. January 2015

Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis.
Roth, N.M. and Saidha, S. and Zimmermann, H. and Brandt, A.U. and Oberwahrenbrock, T. and Maragakis, N.J. and Tumani, H. and Ludolph, A.C. and Meyer, T. and Calabresi, P.A. and Paul, F.
European Journal of Neurology 20 (8): 1170-1176. August 2013

Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.
Young, K.L. and Brandt, A.U. and Petzold, A. and Reitz, L.Y. and Lintze, F. and Paul, F. and Martin, R. and Schippling, S.
European Journal of Neurology 20 (5): 803-811. May 2013

European Journal of Neuroscience

An exploratory research report on brain mineralization in postoperative delirium and cognitive decline.
Lammers-Lietz, F. and Borchers, F. and Feinkohl, I. and Hetzer, S. and Kanar, C. and Konietschke, F. and Lachmann, G. and Chien, C. and Spies, C. and Winterer, G. and Zaborszky, L. and Zacharias, N. and Paul, F.
European Journal of Neuroscience 21 February 2024 (In Press)

European Journal of Nuclear Medicine and Molecular Imaging

Fibrin-targeting molecular MRI in inflammatory CNS disorders.
Lohmeier, J. and Silva, R.V. and Tietze, A. and Taupitz, M. and Kaneko, T. and Prüss, H. and Paul, F. and Infante-Duarte, C. and Hamm, B. and Caravan, P. and Makowski, M.R.
European Journal of Nuclear Medicine and Molecular Imaging 49 (11): 3692–3704. September 2022

European Journal of Pharmacology

The activity of catechol-O-methyltransferase (COMT) is not impaired by high doses of epigallocatechin-3-gallate (EGCG) in vivo.
Lorenz, M. and Paul, F. and Moobed, M. and Baumann, G. and Zimmermann, B.F. and Stangl, K. and Stangl, V.
European Journal of Pharmacology 740 : 645-651. 5 October 2014

European Neurological Review

Treatment of multiple sclerosis - relationship between vitamin d and interferon β-1b.
Taylor, B. and Moses, H. and Paul, F. and Suarez, G. and Rametta, M.
European Neurological Review 10 (2): 124-130. 2015

European Neurology

Cognitive impairment in multiple system atrophy is related to white matter damage detected by the T1-weighted/T2-weighted ratio.
Sugiyama, A. and Cooper, G. and Hirano, S. and Yokota, H. and Mori, M. and Shimizu, K. and Yakiyama, M. and Finke, C. and Brandt, A.U. and Paul, F. and Kuwabara, S.
European Neurology 84 (6): 435-443. November 2021

European Radiology

Magnetic resonance T1w/T2w ratio in the middle cerebellar peduncle might be a sensitive biomarker for multiple system atrophy.
Sugiyama, A. and Yokota, H. and Hirano, S. and Cooper, G. and Mukai, H. and Koide, K. and Wang, J. and Ito, S. and Finke, C. and Brandt, A.U. and Paul, F. and Kuwabara, S.
European Radiology 31 (6): 4277-4284. June 2021

Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders.
Juenger, V. and Cooper, G. and Chien, C. and Chikermane, M. and Oertel, F.C. and Zimmermann, H. and Ruprecht, K. and Jarius, S. and Siebert, N. and Kuchling, J. and Papadopoulou, A. and Asseyer, S. and Bellmann-Strobl, J. and Paul, F. and Brandt, A.U. and Scheel, M.
European Radiology 30 (9): 5048-5058. September 2020

Multifrequency magnetic resonance elastography of the brain reveals tissue degeneration in neuromyelitis optica spectrum disorder.
Streitberger, K.J. and Fehlner, A. and Pache, F. and Lacheta, A. and Papazoglou, S. and Bellmann-Strobl, J. and Ruprecht, K. and Brandt, A. and Braun, J. and Sack, I. and Paul, F. and Wuerfel, J.
European Radiology 27 (5): 2206-2215. May 2017

Brain parenchymal damage in neuromyelitis optica spectrum disorder - a multimodal MRI study.
Pache, F. and Zimmermann, H. and Finke, C. and Lacheta, A. and Papazoglou, S. and Kuchling, J. and Wuerfel, J. and Hamm, B. and Ruprecht, K. and Paul, F. and Brandt, A.U. and Scheel, M.
European Radiology 26 (12): 4413-4422. December 2016

Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning - an ultrahigh-field MR pilot study.
Sinnecker, T. and Oberwahrenbrock, T. and Metz, I. and Zimmermann, H. and Pfueller, C.F. and Harms, L. and Ruprecht, K. and Ramien, C. and Hahn, K. and Brück, W. and Niendorf, T. and Paul, F. and Brandt, A.U. and Dörr, J. and Wuerfel, J.
European Radiology 25 (1): 122-131. January 2015

Experimental Neurology

Overnight unilateral withdrawal of thalamic deep brain stimulation to identify reversibility of gait disturbances.
Kroneberg, D. and Al-Fatly, B. and Schmitz-Hübsch, T. and Gandor, F. and Gruber, D. and Ebersbach, G. and Horn, A. and Kühn, A.A.
Experimental Neurology 355 : 114135. September 2022

Oxidative damage to mitochondria at the nodes of Ranvier precedes axon degeneration in ex vivo transected axons.
Bros, H. and Millward, J.M. and Paul, F. and Niesner, R. and Infante-Duarte, C.
Experimental Neurology 261 (11): 127-135. November 2014

Expert Opinion on Biological Therapy

Current and emerging biologics for the treatment of neuromyelitis optica spectrum disorders.
Duchow, A. and Paul, F. and Bellmann-Strobl, J.
Expert Opinion on Biological Therapy 20 (9): 1061-1072. September 2020

Expert Opinion on Emerging Drugs

Emerging drugs for the treatment of neuromyelitis optica.
Duchow, A. and Chien, C. and Paul, F. and Bellmann-Strobl, J.
Expert Opinion on Emerging Drugs 25 (3): 285-297. September 2020

Expert Opinion on Investigational Drugs

Investigational drugs in development to prevent neuromyelitis optica relapses.
Paul, F. and Murphy, O. and Pardo, S. and Levy, M.
Expert Opinion on Investigational Drugs 27 (3): 265-271. March 2018

Expert Opinion on Pharmacotherapy

Ozanimod for the treatment of relapsing remitting multiple sclerosis.
Rasche, L. and Paul, F.
Expert Opinion on Pharmacotherapy 19 (18): 2073-2086. December 2018

Expert Review of Clinical Immunology

Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current review.
Schindler, P. and Aktas, O. and Ringelstein, M. and Wildemann, B. and Jarius, S. and Paul, F. and Ruprecht, K.
Expert Review of Clinical Immunology 19 (1): 71-91. January 2023

Expert Review of Neurotherapeutics

Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review.
Lin, T.Y. and Chien, C. and Lu, A. and Paul, F. and Zimmermann, H.G.
Expert Review of Neurotherapeutics 21 (10): 1101-1123. October 2021

Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis.
Oertel, F.C. and Zimmermann, H.G. and Brandt, A.U. and Paul, F.
Expert Review of Neurotherapeutics 19 (1): 31-43. 2 January 2019

Fortschritte der Neurologie Psychiatrie

Neuromyelitis optica.
Pache, F. and Wildemann, B. and Paul, F. and Jarius, S.
Fortschritte der Neurologie Psychiatrie 85 (2): 100-114. February 2017

Frontiers in Aging Neuroscience

Walking parameters of older adults from a lower back inertial measurement unit, a 6-year longitudinal observational study.
Elshehabi, M. and Del Din, S. and Hobert, M.A. and Warmerdam, E. and Sünkel, U. and Schmitz-Hübsch, T. and Behncke, L.M. and Heinzel, S. and Brockmann, K. and Metzger, F.G. and Schlenstedt, C. and Rochester, L. and Hansen, C. and Berg, D. and Maetzler, W.
Frontiers in Aging Neuroscience 14 : 789220. 8 September 2022

Less is more - estimation of the number of strides required to assess gait variability in spatially confined settings.
Kroneberg, D. and Elshehabi, M. and Meyer, A.C. and Otte, K. and Doss, S. and Paul, F. and Nussbaum, S. and Berg, D. and Kühn, A.A. and Maetzler, W. and Schmitz-Hübsch, T.
Frontiers in Aging Neuroscience 10 : 435. 21 January 2019

Frontiers in Immunology

Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity.
Sotzny, F. and Filgueiras, I.S. and Kedor, C. and Freitag, H. and Wittke, K. and Bauer, S. and Sepúlveda, N. and Mathias da Fonseca, D.L. and Baiocchi, G.C. and Marques, A.H.C. and Kim, M. and Lange, T. and Plaça, D.R. and Luebber, F. and Paulus, F.M. and De Vito, R. and Jurisica, I. and Schulze-Forster, K. and Paul, F. and Bellmann-Strobl, J. and Rust, R. and Hoppmann, U. and Shoenfeld, Y. and Riemekasten, G. and Heidecke, H. and Cabral-Marques, O. and Scheibenbogen, C.
Frontiers in Immunology 13 : 981532. 27 September 2022

Alterations of NK cell phenotype during pregnancy in multiple sclerosis.
Wisgalla, A. and Ramien, C. and Streitz, M. and Schlickeiser, S. and Lupu, A.R. and Diemert, A. and Tolosa, E. and Arck, P.C. and Bellmann-Strobl, J. and Siebert, N. and Heesen, C. and Paul, F. and Friese, M.A. and Infante-Duarte, C. and Gold, S.M.
Frontiers in Immunology 13 : 907994. 4 July 2022

Low-density granulocytes are a novel immunopathological feature in both multiple sclerosis and neuromyelitis optica spectrum disorder.
Ostendorf, L. and Mothes, R. and van Koppen, S. and Lindquist, R.L. and Bellmann-Strobl, J. and Asseyer, S. and Ruprecht, K. and Alexander, T. and Niesner, R.A. and Hauser, A.E. and Paul, F. and Radbruch, H.
Frontiers in Immunology 10 : 2725. 29 November 2019

Metabolic, mental and immunological effects of normoxic and hypoxic training in multiple sclerosis patients: a pilot study.
Mähler, A. and Balogh, A. and Csizmadia, I. and Klug, L. and Kleinewietfeld, M. and Steiniger, J. and Šušnjar, U. and Müller, D.N. and Boschmann, M. and Paul, F.
Frontiers in Immunology 9 : 2819. November 2018

Pro-inflammatory monocyte phenotype and cell-specific steroid signaling alterations in unmedicated patients with major depressive disorder.
Hasselmann, H. and Gamradt, S. and Taenzer, A. and Nowacki, J. and Zain, R. and Patas, K. and Ramien, C. and Paul, F. and Wingenfeld, K. and Piber, D. and Gold, S.M. and Otte, C.
Frontiers in Immunology 9 : 2693. November 2018

Omics-based approach reveals complement-mediated inflammation in chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).
Blaabjerg, M. and Hemdrup, A.L. and Drici, L. and Ruprecht, K. and Garred, P. and Höftberger, R. and Kristensen, B.W. and Kondziella, D. and Sejbaek, T. and Hansen, S.W. and Nielsen, H.H. and Jensen, P. and Meyer, M. and Paul, F. and Lassmann, H. and Larsen, M.R. and Illes, Z.
Frontiers in Immunology 9 : 741. 23 April 2018

Longitudinal intravital imaging of the retina reveals long-term dynamics of immune infiltration and its effects on the glial network in experimental autoimmune uveoretinitis, without evident signs of neuronal dysfunction in the ganglion cell layer.
Bremer, D. and Pache, F. and Guenther, R. and Hornow, J. and Andresen, V. and Leben, R. and Mothes, R. and Zimmermann, H. and Brandt, A.U. and Paul, F. and Hauser, A.E. and Radbruch, H. and Niesner, R.
Frontiers in Immunology 7 : 642. 23 December 2016

Frontiers in Medicine

Fighting post-COVID and ME/CFS - development of curative therapies.
Scheibenbogen, C. and Bellmann-Strobl, J.T. and Heindrich, C. and Wittke, K. and Stein, E. and Franke, C. and Prüss, H. and Preßler, H. and Machule, M.L. and Audebert, H. and Finke, C. and Zimmermann, H.G. and Sawitzki, B. and Meisel, C. and Toelle, M. and Krueger, A. and Aschenbrenner, A.C. and Schultze, J.L. and Beyer, M.D. and Ralser, M. and Mülleder, M. and Sander, L.E. and Konietschke, F. and Paul, F. and Stojanov, S. and Bruckert, L. and Hedderich, D.M. and Knolle, F. and Riemekasten, G. and Vehreschild, M.J.G.T. and Cornely, O.A. and Behrends, U. and Burock, S.
Frontiers in Medicine 10 2023

Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial – Protocol of a multicenter, randomized, double-blind, placebo-controlled proof-of-concept phase-2 clinical trial.
Huehnchen, P. and Bangemann, N. and Lischewski, S. and Märschenz, S. and Paul, F. and Schmitz-Hübsch, T. and Blohmer, J.U. and Eberhardt, C. and Rauch, G. and Flöel, A. and Adam, S. and Schwenkenbecher, P. and Meinhold-Heerlein, I. and Hoffmann, O. and Ziemssen, T. and Endres, M. and Boehmerle, W.
Frontiers in Medicine 9 : 967964. 11 August 2022

Frontiers in Neurology

Regional spinal cord volumes and pain profiles in AQP4-IgG + NMOSD and MOGAD.
Asseyer, S. and Zmira, O. and Busse, L. and Pflantzer, B. and Schindler, P. and Schmitz-Hübsch, T. and Paul, F. and Chien, C.
Frontiers in Neurology 15 : 1308498. 26 January 2024

Delimiting MOGAD as a disease entity using translational imaging.
Oertel, F.C. and Hastermann, M. and Paul, F.
Frontiers in Neurology 14 : 1216477. 7 December 2023

Progression events defined by home-based assessment of motor function in multiple sclerosis: protocol of a prospective study.
Dorsch, E.M. and Röhling, H.M. and Zocholl, D. and Hafermann, L. and Paul, F. and Schmitz-Hübsch, T.
Frontiers in Neurology 14 : 1258635. 10 October 2023

The Acute Optic Neuritis Network (ACON): study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis.
Asseyer, S. and Asgari, N. and Bennett, J. and Bialer, O. and Blanco, Y. and Bosello, F. and Camos-Carreras, A. and Carnero Contentti, E. and Carta, S. and Chen, J. and Chien, C. and Chomba, M. and Dale, R.C. and Dalmau, J. and Feldmann, K. and Flanagan, E.P. and Froment Tilikete, C. and Garcia-Alfonso, C. and Havla, J. and Hellmann, M. and Kim, H.J. and Klyscz, P. and Konietschke, F. and La Morgia, C. and Lana-Peixoto, M. and Leite, M.I. and Levin, N. and Levy, M. and Llufriu, S. and Lopez, P. and Lotan, I. and Lugaresi, A. and Marignier, R. and Mariotto, S. and Mollan, S.P. and Ocampo, C. and Oertel, F.C. and Olszewska, M. and Palace, J. and Pandit, L. and Peralta Uribe, J.L. and Pittock, S. and Ramanathan, S. and Rattanathamsakul, N. and Saiz, A. and Samadzadeh, S. and Sanchez-Dalmau, B. and Saylor, D. and Scheel, M. and Schmitz-Hübsch, T. and Shifa, J. and Siritho, S. and Sperber, P.S. and Subramanian, P.S. and Tiosano, A. and Vaknin-Dembinsky, A. and Mejia Vergara, A.J. and Wilf-Yarkoni, A. and Zarco, L.A. and Zimmermann, H.G. and Paul, F. and Stiebel-Kalish, H.
Frontiers in Neurology 14 : 1102353. 24 February 2023

Neural processes of psychological stress and relaxation predict the future evolution of quality of life in multiple sclerosis.
Meyer-Arndt, L. and Schmitz-Hübsch, T. and Bellmann-Strobl, J. and Brandt, A.U. and Haynes, J.D. and Gold, S.M. and Paul, F. and Weygandt, M.
Frontiers in Neurology 12 : 753107. 23 November 2021

Retinal thickness analysis in progressive multiple sclerosis patients treated with epigallocatechin gallate: optical coherence tomography results from the SUPREMES study.
Klumbies, K. and Rust, R. and Dörr, J. and Konietschke, F. and Paul, F. and Bellmann-Strobl, J. and Brandt, A.U. and Zimmermann, H.G.
Frontiers in Neurology 12 : 615790. 28 April 2021

Anti-aquaporin 4 IgG is not associated with any clinical disease characteristics in Neuromyelitis Optica Spectrum Disorder.
Schmetzer, O. and Lakin, E. and Roediger, B. and Duchow, A. and Asseyer, S. and Paul, F. and Siebert, N.
Frontiers in Neurology 12 : 635419. 12 March 2021

New algorithms improving PML risk stratification in MS patients treated with natalizumab.
Toboso, I. and Tejeda-Velarde, A. and Alvarez-Lafuente, R. and Arroyo, R. and Hegen, H. and Deisenhammer, F. and Sainz de la Maza, S. and Alvarez-Cermeño, J.C. and Izquierdo, G. and Paramo, D. and Oliva, P. and Casanova, B. and Agüera-Morales, E. and Franciotta, D. and Gastaldi, M. and Fernández, O. and Urbaneja, P. and Garcia-Dominguez, J.M. and Romero, F. and Laroni, A. and Uccelli, A. and Perez-Sempere, A. and Saiz, A. and Blanco, Y. and Galimberti, D. and Scarpini, E. and Espejo, C. and Montalban, X. and Rasche, L. and Paul, F. and González, I. and Álvarez, E. and Ramo, C. and Caminero, A.B. and Aladro, Y. and Calles, C. and Eguía, P. and Belenguer-Benavides, A. and Ramió-Torrentà, L. and Quintana, E. and Martínez-Rodríguez, J.E. and Oterino, A. and López de Silanes, C. and Casanova, L.I. and Landete, L. and Frederiksen, J. and Bsteh, G. and Mulero, P. and Comabella, M. and Hernández, M.A. and Espiño, M. and Prieto, J.M. and Pérez, D. and Otano, M. and Padilla, F. and García-Merino, J.A. and Navarro, L. and Muriel, A. and Frossard, L.C. and Villar, L.M.
Frontiers in Neurology 11 : 579438. 17 December 2020

Altered coupling of psychological relaxation and regional volume of brain reward areas in multiple sclerosis.
Wakonig, K. and Eitel, F. and Ritter, K. and Hetzer, S. and Schmitz-Hübsch, T. and Bellmann-Strobl, J. and Haynes, J.D. and Brandt, A.U. and Gold, S.M. and Paul, F. and Weygandt, M.
Frontiers in Neurology 11 : 568850. 6 October 2020

Differences in advanced magnetic resonance imaging in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorders: a comparative study.
Schmidt, F.A. and Chien, C. and Kuchling, J. and Bellmann-Strobl, J. and Ruprecht, K. and Siebert, N. and Asseyer, S. and Jarius, S. and Brandt, A.U. and Scheel, M. and Paul, F.
Frontiers in Neurology 11 : 499910. 30 September 2020

Pain in NMOSD and MOGAD: a systematic literature review of pathophysiology, symptoms, and current treatment strategies.
Asseyer, S. and Cooper, G. and Paul, F.
Frontiers in Neurology 11 : 778. 21 August 2020

Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide.
Hor, J.Y. and Asgari, N. and Nakashima, I. and Broadley, S.A. and Leite, M.I. and Kissani, N. and Jacob, A. and Marignier, R. and Weinshenker, B.G. and Paul, F. and Pittock, S.J. and Palace, J. and Wingerchuk, D.M. and Behne, J.M. and Yeaman, M.R. and Fujihara, K.
Frontiers in Neurology 11 : 501. 26 June 2020

Visualizing the central nervous system: imaging tools for multiple sclerosis and neuromyelitis optica spectrum disorders.
Kuchling, J. and Paul, F.
Frontiers in Neurology 11 : 450. 17 June 2020

Association between fatigue and motor exertion in patients with multiple sclerosis - a prospective study.
Drebinger, D. and Rasche, L. and Kroneberg, D. and Althoff, P. and Bellmann-Strobl, J. and Weygandt, M. and Paul, F. and Brandt, A.U. and Schmitz-Hübsch, T.
Frontiers in Neurology 11 : 208. 15 April 2020

Vitamin D and disease severity in multiple sclerosis-baseline data from the randomized controlled trial (EVIDIMS).
Bäcker-Koduah, P. and Bellmann-Strobl, J. and Scheel, M. and Wuerfel, J. and Wernecke, K.D. and Dörr, J. and Brandt, A.U. and Paul, F.
Frontiers in Neurology 11 : 129. 25 February 2020

Normative data and minimally detectable change for inner retinal layer thicknesses using a semi-automated OCT image segmentation pipeline.
Motamedi, S. and Gawlik, K. and Ayadi, N. and Zimmermann, H.G. and Asseyer, S. and Bereuter, C. and Mikolajczak, J. and Paul, F. and Kadas, E.M. and Brandt, A.U.
Frontiers in Neurology 10 : 1117. November 2019

Cognitive impairment in neuromyelitis optica spectrum disorders: a review of clinical and neuroradiological features.
Oertel, F.C. and Schließeit, J. and Brandt, A.U. and Paul, F.
Frontiers in Neurology 10 : 608. 12 June 2019

Olfactory and gustatory dysfunction in patients with autoimmune encephalitis.
Geran, R. and Uecker, F.C. and Prüss, H. and Haeusler, K.G. and Paul, F. and Ruprecht, K. and Harms, L. and Schmidt, F.A.
Frontiers in Neurology 10 : 480. May 2019

Vision and vision-related measures in progressive multiple sclerosis.
Backner, Y. and Petrou, P. and Glick-Shames, H. and Raz, N. and Zimmermann, H. and Jost, R. and Scheel, M. and Paul, F. and Karussis, D. and Levin, N.
Frontiers in Neurology 10 : 455. May 2019

Standardization of T1w/T2w ratio improves detection of tissue damage in multiple sclerosis.
Cooper, G. and Finke, C. and Chien, C. and Brandt, A.U. and Asseyer, S. and Ruprecht, K. and Bellmann-Strobl, J. and Paul, F. and Scheel, M.
Frontiers in Neurology 10 : 334. April 2019

CSF-progranulin and neurofilament light chain levels in patients with radiologically isolated syndrome - sign of inflammation.
Pawlitzki, M. and Sweeney-Reed, C.M. and Bittner, D. and Lux, A. and Vielhaber, S. and Schreiber, S. and Paul, F. and Neumann, J.
Frontiers in Neurology 9 : 1075. December 2018

Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis.
Borisow, N. and Mori, M. and Kuwabara, S. and Scheel, M. and Paul, F.
Frontiers in Neurology 9 : 888. October 2018

Disease modification in multiple sclerosis by flupirtine - results of a randomized placebo controlled phase II trial.
Dörr, J. and Wernecke, K.D. and Würfel, J. and Bellmann-Strobl, J. and Siffrin, V. and Sättler, M.B. and Simons, M. and Linsa, A. and Tumani, H. and Paul, F.
Frontiers in Neurology 9 : 842. October 2018

MRI markers and functional performance in patients with CIS and MS: a cross-sectional study.
Rasche, L. and Scheel, M. and Otte, K. and Althoff, P. and van Vuuren, A.B. and Gieß, R.M. and Kuchling, J. and Bellmann-Strobl, J. and Ruprecht, K. and Paul, F. and Brandt, A.U. and Schmitz-Hübsch, T.
Frontiers in Neurology 9 : 718. August 2018

Frontiers in Neuroscience

Quantitative multi-parameter mapping optimized for the clinical routine.
Cooper, G. and Hirsch, S. and Scheel, M. and Brandt, A.U. and Paul, F. and Finke, C. and Boehm-Sturm, P. and Hetzer, S.
Frontiers in Neuroscience 14 : 611194. 7 December 2020

Frontiers in Physiology

Hypoxia differentially affects healthy men and women during a daytime nap with a dose-response relationship: a randomized, cross-over pilot study.
Riveros-Rivera, A. and Penzel, T. and Gunga, H.C. and Opatz, O. and Paul, F. and Klug, L. and Boschmann, M. and Mähler, A.
Frontiers in Physiology 13 : 899636. 24 May 2022

Gait & Posture

Accuracy and repeatability of two methods of gait analysis - GaitRite(TM) und Mobility Lab(TM) - in subjects with cerebellar ataxia.
Schmitz-Hübsch, T. and Brandt, A.U. and Pfueller, C. and Zange, L. and Seidel, A. and Kühn, A.A. and Paul, F. and Minnerop, M. and Doss, S.
Gait & Posture 48 : 194-201. July 2016

Genetic Epidemiology

Successful replication of GWAS hits for multiple sclerosis in 10,000 Germans using the exome array.
Dankowski, T. and Buck, D. and Andlauer, T.F.M. and Antony, G. and Bayas, A. and Bechmann, L. and Berthele, A. and Bettecken, T. and Chan, A. and Franke, A. and Gold, R. and Graetz, C. and Haas, J. and Hecker, M. and Herms, S. and Infante-Duarte, C. and Jöckel, K.H. and Kieseier, B.C. and Knier, B. and Knop, M. and Kümpfel, T. and Lichtner, P. and Lieb, W. and Lill, C.M. and Limmroth, V. and Linker, R.A. and Loleit, V. and Meuth, S.G. and Moebus, S. and Müller-Myhsok, B. and Nischwitz, S. and Nöthen, M.M. and Paul, F. and Puetz, M. and Ruck, T. and Salmen, A. and Stangel, M. and Stellmann, J.P. and Strauch, K. and Stürner, K.H. and Tackenberg, B. and Then Bergh, F. and Tumani, H. and Waldenberger, M. and Weber, F. and Wiendl, H. and Wildemann, B. and Zettl, U.K. and Ziemann, U. and Zipp, F. and Hemmer, B. and Ziegler, A.
Genetic Epidemiology 39 (8): 601-608. December 2015

Genome Biology

A blood based 12-miRNA signature of Alzheimer disease patients.
Leidinger, P. and Backes, C. and Deutscher, S. and Schmitt, K. and Mueller, S.C. and Frese, K. and Haas, J. and Ruprecht, K. and Paul, F. and Stähler, C. and Lang, C.J.G. and Meder, B. and Bartfai, T. and Meese, E. and Keller, A.
Genome Biology 14 (7): R78. 29 July 2013

Genome Medicine

Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosis.
Bernardo-Faura, M. and Rinas, M. and Wirbel, J. and Pertsovskaya, I. and Pliaka, V. and Messinis, D.E. and Vila, G. and Sakellaropoulos, T. and Faigle, W. and Stridh, P. and Behrens, J.R. and Olsson, T. and Martin, R. and Paul, F. and Alexopoulos, L.G. and Villoslada, P. and Saez-Rodriguez, J.
Genome Medicine 13 (1): 117. 16 July 2021

Glia

HIF prolyl hydroxylase 2/3 deletion disrupts astrocytic integrity and exacerbates neuroinflammation.
Rosiewicz, K.S. and Muinjonov, B. and Kunz, S. and Radbruch, H. and Chen, J. and Jüttner, R. and Kerkering, J. and Ucar, J. and Crowley, T. and Wielockx, B. and Paul, F. and Alisch, M. and Siffrin, V.
Glia 71 (8): 2024-2044. August 2023

Health and quality of life outcomes

Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.
Chorschew, A. and Kesgin, F. and Bellmann-Strobl, J. and Flachenecker, P. and Schiffmann, I. and Rosenthal, F. and Althoff, P. and Drebinger, D. and Arsenova, R. and Rasche, L. and Dorsch, E.M. and Heesen, C. and Paul, F. and Stellmann, J.P. and Schmitz-Hübsch, T.
Health and quality of life outcomes 21 (1): 110. 9 October 2023

Human Brain Mapping

Anatomical and functional visual network patterns in progressive multiple sclerosis.
Backner, Y. and Zamir, S. and Petrou, P. and Paul, F. and Karussis, D. and Levin, N.
Human Brain Mapping 43 (5): 1590-1597. 1 April 2022

Single-subject independent component analysis-based intensity normalization in non-quantitative multi-modal structural MRI.
Papazoglou, S. and Würfel, J. and Paul, F. and Brandt, A.U. and Scheel, M.
Human Brain Mapping 38 (7): 3615-3622. July 2017

International Journal of Biological Macromolecules

Brain inflammation induces alterations in glycosaminoglycan metabolism and subsequent changes in CS-4S and hyaluronic acid.
Silva, R.V. and Biskup, K. and Zabala-Jouvin, J.K. and Batzdorf, C.S. and Stellmach, C. and Morr, A.S. and Sack, I. and Ludwig, A. and Blanchard, V. and Infante-Duarte, C.
International Journal of Biological Macromolecules 230 : 123214. March 2023

International Journal of Environmental Research and Public Health

RGB-Depth camera-based assessment of motor capacity: normative data for six standardized motor tasks.
Röhling, H.M. and Otte, K. and Rekers, S. and Finke, C. and Rust, R. and Dorsch, E.M. and Behnia, B. and Paul, F. and Schmitz-Hübsch, T.
International Journal of Environmental Research and Public Health 19 (24): 16989. 17 December 2022

International Journal of MS Care

An international standardized magnetic resonance imaging protocol for diagnosis and follow-up of patients with multiple sclerosis.
Saslow, L. and Li, D.K.B. and Halper, J. and Banwell, B. and Barkhof, F. and Barlow, L. and Costello, K. and Damiri, P. and Dunn, J. and Giri, S. and Maes, M. and Morrow, S.A. and Newsome, S.D. and Oh, J. and Paul, F. and Quarterman, P. and Reich, D.S. and Shewchuk, J.R. and Shinohara, R.T. and Van Hecke, W. and van de Ven, K. and Wallin, M.T. and Wolinsky, J.S. and Traboulsee, A.
International Journal of MS Care 22 (5): 226-232. 27 October 2020

International Journal of Molecular Sciences

Teriflunomide preserves neuronal activity and protects mitochondria in brain slices exposed to oxidative stress.
Malla, B. and Liotta, A. and Bros, H. and Ulshöfer, R. and Paul, F. and Hauser, A.E. and Niesner, R. and Infante-Duarte, C.
International Journal of Molecular Sciences 23 (3): 1538. 28 January 2022

From forensics to clinical research: expanding the variant calling pipeline for the precision ID mtDNA whole genome panel.
Cortes-Figueiredo, F. and Carvalho, F.S. and Fonseca, A.C. and Paul, F. and Ferro, J.M. and Schönherr, S. and Weissensteiner, H. and Morais, V.A.
International Journal of Molecular Sciences 22 (21): 12031. 6 November 2021

Sleep disorders reduce health-related quality of life in multiple sclerosis (Nottingham Health Profile data in patients with multiple sclerosis).
Veauthier, C. and Gaede, G. and Radbruch, H. and Wernecke, K.D. and Paul, F.
International Journal of Molecular Sciences 16 (7): 16514-16528. 21 July 2015

International Symposium on Biomedical Imaging (ISBI)

SynergyNet: a fusion framework for multiple sclerosis brain MRI segmentation with local refinement.
Vang, Y.S. and Cao, Y. and Chang, P.D. and Chow, D.S. and Brandt, A.U. and Paul, F. and Scheel, M. and Xie, X.
In: 2020 IEEE 17th International Symposium on Biomedical Imaging (ISBI), 3-7 Apr 2020, Iowa City, IA, USA. 22 May 2020

Investigative Ophthalmology & Visual Science

Comparison of standard versus wide-field composite images of the corneal subbasal layer by In vivo confocal microscopy.
Kheirkhah, A. and Muller, R. and Mikolajczak, J. and Ren, A. and Kadas, E.M. and Zimmermann, H. and Pruess, H. and Paul, F. and Brandt, A.U. and Hamrah, P.
Investigative Ophthalmology & Visual Science 56 (10): 5801-5807. 1 September 2015

Retinal segmentation to demonstrate hyperplasia in ataxia of charlevoix-saguenay: critique on study methodology and results.
Albrecht, P. and Balk, L. and Oberwahrenbrock, T. and Petzold, A. and Paul, F.
Investigative Ophthalmology & Visual Science 55 (8): 4728. 4 August 2014

Investigative Radiology

Different impact of gadopentetate and gadobutrol on inflammation-promoted retention and toxicity of gadolinium within the mouse brain.
Anderhalten, L. and Silva, R.V. and Morr, A. and Wang, S. and Smorodchenko, A. and Saatz, J. and Traub, H. and Mueller, S. and Boehm-Sturm, P. and Rodriguez-Sillke, Y. and Kunkel, D. and Hahndorf, J. and Paul, F. and Taupitz, M. and Sack, I. and Infante-Duarte, C.
Investigative Radiology 57 (10): 677-688. 1 October 2022

Increased retention of gadolinium in the inflamed brain after repeated administration of gadopentetate dimeglumine: a proof-of-concept study in mice combining ICP-MS and micro- and nano-SR-XRF.
Wang, S. and Hesse, B. and Roman, M. and Stier, D. and Castillo-Michel, H. and Cotte, M. and Suuronen, J.P. and Lagrange, A. and Radbruch, H. and Paul, F. and Taupitz, M. and Schellenberger, E. and Sack, I. and Infante-Duarte, C.
Investigative Radiology 54 (10): 617-626. October 2019

JAMA Neurology

Immunoglobulin A antibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with central nervous system demyelination.
Ayroza Galvão Ribeiro Gomes, A.B. and Kulsvehagen, L. and Lipps, P. and Cagol, A. and Cerdá-Fuertes, N. and Neziraj, T. and Flammer, J. and Lerner, J. and Lecourt, A.C. and de Oliveira S Siebenborn, N. and Cortese, R. and Schaedelin, S. and Andreoli Schoeps, V. and de Moura Brasil Matos, A. and Trombini Mendes, N. and Dos Reis Pereira, C. and Ribeiro Monteiro, M.L. and Dos Apóstolos-Pereira, S.L. and Schindler, P. and Chien, C. and Schwake, C. and Schneider, R. and Pakeerathan, T. and Aktas, O. and Fischer, U. and Mehling, M. and Derfuss, T. and Kappos, L. and Ayzenberg, I. and Ringelstein, M. and Paul, F. and Callegaro, D. and Kuhle, J. and Papadopoulou, A. and Granziera, C. and Pröbstel, A.K.
JAMA Neurology 80 (9): 989-995. September 2023

Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin oligodendrocyte glycoprotein antibody-associated disease.
Chen, J.J. and Huda, S. and Hacohen, Y. and Levy, M. and Lotan, I. and Wilf-Yarkoni, A. and Stiebel-Kalish, H. and Hellmann, M.A. and Sotirchos, E.S. and Henderson, A.D. and Pittock, S.J. and Bhatti, M.T. and Eggenberger, E.R. and Di Nome, M. and Kim, H.J. and Kim, S.H. and Saiz, A. and Paul, F. and Dale, R.C. and Ramanathan, S. and Palace, J. and Camera, V. and Leite, M.I. and Lam, B.L. and Bennett, J.L. and Mariotto, S. and Hodge, D. and Audoin, B. and Maillart, E. and Deschamps, R. and Pique, J. and Flanagan, E.P. and Marignier, R.
JAMA Neurology 79 (5): 518-525. 1 May 2022

Association of a marker of N-acetylglucosamine with progressive multiple sclerosis and neurodegeneration.
Brandt, A.U. and Sy, M. and Bellmann-Strobl, J. and Newton, B.L. and Pawling, J. and Zimmermann, H.G. and Yu, Z. and Chien, C. and Dörr, J. and Wuerfel, J.T. and Dennis, J.W. and Paul, F. and Demetriou, M.
JAMA Neurology 78 (7): 842-852. July 2021

Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis.
Sinnecker, T. and Clarke, M.A. and Meier, D. and Enzinger, C. and Calabrese, M. and De Stefano, N. and Pitiot, A. and Giorgio, A. and Schoonheim, M.M. and Paul, F. and Pawlak, M.A. and Schmidt, R. and Kappos, L. and Montalban, X. and Rovira, À. and Evangelou, N. and Wuerfel, J.
JAMA Neurology 76 (12): 1446-1456. December 2019

Association of intrathecal immunoglobulin G synthesis with disability worsening in multiple sclerosis.
Gasperi, C. and Salmen, A. and Antony, G. and Bayas, A. and Heesen, C. and Kümpfel, T. and Linker, R.A. and Paul, F. and Stangel, M. and Tackenberg, B. and Bergh, F.T. and Warnke, C. and Weber, F. and Wiendl, H. and Wildemann, B. and Zettl, U.K. and Ziemann, U. and Zipp, F. and Tumani, H. and Gold, R. and Hemmer, B.
JAMA Neurology 76 (7): 841-849. 29 April 2019

Association of retinal ganglion cell layer thickness with future disease activity in patients with clinically isolated syndrome.
Zimmermann, H.G. and Knier, B. and Oberwahrenbrock, T. and Behrens, J. and Pfuhl, C. and Aly, L. and Kaminski, M. and Hoshi, M.M. and Specovius, S. and Giess, R.M. and Scheel, M. and Mühlau, M. and Bellmann-Strobl, J. and Ruprecht, K. and Hemmer, B. and Korn, T. and Paul, F. and Brandt, A.U.
JAMA Neurology 75 (9): 1071-1079. September 2018

Anatomical wiring and functional networking changes in the visual system following optic neuritis.
Backner, Y. and Kuchling, J. and Massarwa, S. and Oberwahrenbrock, T. and Finke, C. and Bellmann-Strobl, J. and Ruprecht, K. and Brandt, A.U. and Zimmermann, H. and Raz, N. and Paul, F. and Levin, N.
JAMA Neurology 75 (3): 287-295. March 2018

Association of visual impairment in neuromyelitis optica spectrum disorder with visual network reorganization.
Finke, C. and Zimmermann, H. and Pache, F. and Oertel, F.C. and Chavarro, V.S. and Kramarenko, Y. and Bellmann-Strobl, J. and Ruprecht, K. and Brandt, A.U. and Paul, F.
JAMA Neurology 75 (3): 296-303. March 2018

Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies.
Finke, C. and Prüss, H. and Heine, J. and Reuter, S. and Kopp, U.A. and Wegner, F. and Then Bergh, F. and Koch, S. and Jansen, O. and Münte, T. and Deuschl, G. and Ruprecht, K. and Stöcker, W. and Wandinger, K.P. and Paul, F. and Bartsch, T.
JAMA Neurology 74 (1): 50-59. January 2017

Use of advanced magnetic resonance imaging techniques in neuromyelitis optica spectrum disorder.
Kremer, S. and Renard, F. and Achard, S. and Lana-Peixoto, M.A. and Palace, J. and Asgari, N. and Klawiter, E.C. and Tenembaum, S.N. and Banwell, B. and Greenberg, B.M. and Bennett, J.L. and Levy, M. and Villoslada, P. and Saiz, A. and Fujihara, K. and Chan, K.H. and Schippling, S. and Paul, F. and Kim, H.J. and de Seze, J. and Wuerfel, J.T.
JAMA Neurology 72 (7): 815-822. July 2015

JCI Insight

Distinctive waves of innate immune response in the retina in experimental autoimmune encephalomyelitis.
Cruz-Herranz, A. and Oertel, F.C. and Kim, K. and Cantó, E. and Timmons, G. and Sin, J.H. and Devereux, M. and Baker, N. and Michel, B. and Schubert, R.D. and Rani, L. and Cordano, C. and Baranzini, S.E. and Green, A.J.
JCI Insight 6 (11): e149228. 8 June 2021

Transient enlargement of brain ventricles during relapsing-remitting multiple sclerosis and experimental autoimmune encephalomyelitis.
Millward, J.M. and Delgado, P.R. and Smorodchenko, A. and Boehmert, L. and Periquito, J. and Reimann, H.M. and Prinz, C. and Els, A. and Scheel, M. and Bellmann-Strobl, J. and Waiczies, H. and Wuerfel, J. and Infante-Duarte, C. and Chien, C. and Kuchling, J. and Pohlmann, A. and Zipp, F. and Paul, F. and Niendorf, T. and Waiczies, S.
JCI Insight 5 (21): e140040. 5 November 2020

JMIR Human Factors

Proposal for post hoc quality control in instrumented motion analysis using markerless motion capture: development and usability study.
Röhling, H.M. and Althoff, P. and Arsenova, R. and Drebinger, D. and Gigengack, N. and Chorschew, A. and Kroneberg, D. and Rönnefarth, M. and Ellermeyer, T. and Rosenkranz, S.C. and Heesen, C. and Behnia, B. and Hirano, S. and Kuwabara, S. and Paul, F. and Brandt, A.U. and Schmitz-Hübsch, T.
JMIR Human Factors 9 (2): e26825. 1 April 2022

Journal fuer Neurologie Neurochirurgie und Psychiatrie

Kognitive Stoerungen bei Multipler Sklerose und anderen autoimmunen Erkrankungen des zentralen Nervensystems [Cognitive dysfunction in multiple sclerosis and other autoimmune disorders in central nervous system].
Paul, F.
Journal fuer Neurologie Neurochirurgie und Psychiatrie 18 (1): 4-10. 2017

Journal of Biological Chemistry

N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation.
Sy, M. and Brandt, A.U. and Lee, S.U. and Newton, B. L. and Pawling, J. and Golzar, A. and Rahman, A.A. and Yu, Z. and Cooper, G. and Scheel, M. and Paul, F. and Dennis, J.W. and Demetriou, M.
Journal of Biological Chemistry 295 (51): 17413-17424. 18 December 2020

Journal of Biomedical Optics

Optic nerve head three-dimensional shape analysis.
Yadav, S.K. and Kadas, E.M. and Motamedi, S. and Polthier, K. and Haußer, F. and Gawlik, K. and Paul, F. and Brandt, A.
Journal of Biomedical Optics 23 (10): 106004. October 2018

Journal of Cerebral Blood Flow and Metabolism

What went wrong? The flawed concept of cerebrospinal venous insufficiency.
Valdueza, J.M. and Doepp, F. and Schreiber, S.J. and van Oosten, B.W. and Schmierer, K. and Paul, F. and Wattjes, M.P.
Journal of Cerebral Blood Flow and Metabolism 33 (5): 657-668. May 2013

Journal of Clinical Investigation

iPSC-derived reactive astrocytes from patients with multiple-sclerosis protect cocultured neurons in inflammatory conditions.
Kerkering, J. and Muinjonov, B. and Rosiewicz, K.S. and Diecke, S. and Biese, C. and Schiweck, J. and Chien, C. and Zocholl, D. and Conrad, T. and Paul, F. and Alisch, M. and Siffrin, V.
Journal of Clinical Investigation 133 (13): e164637. 3 July 2023

Journal of Clinical Medicine

Impaired hand grip strength correlates with greater disability and symptom severity in post-COVID myalgic encephalomyelitis/chronic fatigue syndrome.
Paffrath, A. and Kim, L. and Kedor, C. and Stein, E. and Rust, R. and Freitag, H. and Hoppmann, U. and Hanitsch, L.G. and Bellmann-Strobl, J. and Wittke, K. and Scheibenbogen, C. and Sotzny, F.
Journal of Clinical Medicine 13 (7): 2153. 8 April 2024

Safety and discontinuation rate of dimethyl fumarate (Zadiva®) in patients with multiple sclerosis: an observational retrospective study.
Abolfazli, R. and Sahraian, M.A. and Tayebi, A. and Kafi, H. and Samadzadeh, S.
Journal of Clinical Medicine 12 (15): 4937. 27 July 2023

Frequency and predictors of relapses following SARS-CoV-2 vaccination in patients with multiple sclerosis: interim results from a longitudinal observational study.
Frahm, N. and Fneish, F. and Ellenberger, D. and Haas, J. and Löbermann, M. and Peters, M. and Pöhlau, D. and Röper, A.L. and Schilling, S. and Stahmann, A. and Temmes, H. and Paul, F. and Zettl, U.K.
Journal of Clinical Medicine 12 (11): 3640. 24 May 2023

Journal of Imaging

Intraretinal layer segmentation using cascaded compressed U-Nets.
Yadav, S.K. and Kafieh, R. and Zimmermann, H.G. and Kauer-Bonin, J. and Nouri-Mahdavi, K. and Mohammadzadeh, V. and Shi, L. and Kadas, E.M. and Paul, F. and Motamedi, S. and Brandt, A.U.
Journal of Imaging 8 (5): 139. 17 May 2022

Journal of Immunology

Cutting edge: Serum but not mucosal antibody responses are associated with pre-existing SARS-CoV-2 spike cross-reactive CD4(+) T cells following BNT162b2 vaccination in the elderly.
Meyer-Arndt, L. and Schwarz, T. and Loyal, L. and Henze, L. and Kruse, B. and Dingeldey, M. and Gürcan, K. and Uyar-Aydin, Z. and Müller, M.A. and Drosten, C. and Paul, F. and Sander, L.E. and Demuth, I. and Lauster, R. and Giesecke-Thiel, C. and Braun, J. and Corman, V.M. and Thiel, A.
Journal of Immunology 208 (5): 1001-1008. 1 March 2022

Journal of Magnetic Resonance Imaging

Higher-resolution MR elastography reveals early mechanical signatures of neuroinflammation in patients with clinically isolated syndrome.
Fehlner, A. and Behrens, J.R. and Streitberger, K.J. and Papazoglou, S. and Braun, J. and Bellmann-Strobl, J. and Ruprecht, K. and Paul, F. and Würfel, J. and Sack, I.
Journal of Magnetic Resonance Imaging 44 (1): 51-58. July 2016

Journal of Natural Products

Immunomodulatory effects of new phenanthrene derivatives from Dendrobium crumenatum.
Kongkatitham, V. and Dehlinger, A. and Wang, M. and Poldorn, P. and Weidinger, C. and Letizia, M. and Chaotham, C. and Otto, C. and Ruprecht, K. and Paul, F. and Rungrotmongkol, T. and Likhitwitayawuid, K. and Böttcher, C. and Sritularak, B.
Journal of Natural Products 86 (5): 1294-1306. 26 May 2023

Journal of Neural Transmission

Self-perception and determinants of color vision in Parkinson's disease.
Brandt, A.U. and Zimmermann, H.G. and Oberwahrenbrock, T. and Isensee, J. and Müller, T. and Paul, F.
Journal of Neural Transmission 125 (2): 145-152. February 2018

The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
Levin, J. and Maaß, S. and Schuberth, M. and Respondek, G. and Paul, F. and Mansmann, U. and Oertel, W.H. and Lorenzl, S. and Krismer, F. and Seppi, K. and Poewe, W. and Wenning, G. and Giese, A. and Boetzel, K. and Hoeglinger, G.
Journal of Neural Transmission 123 (4): 439-445. April 2016

Journal of Neuro-Ophthalmology

Retinal changes after acute and late optic neuritis in aquaporin-4 antibody seropositive NMOSD.
Oertel, F.C. and Zimmermann, H.G. and Motamedi, S. and Bereuter, C. and Asseyer, E.S. and Chien, C. and Marignier, R. and Cobo-Calvo, A. and Leocani, L. and Pisa, M. and Radaelli, M. and Villoslada, P. and Sanchez-Dalmau, B. and Martinez-Lapiscina, E.H. and Lana-Peixoto, M.A. and Fontenelle, M.A. and Aktas, O. and Ringelstein, M. and Albrecht, P. and Green, A.J. and Yeaman, M.R. and Smith, T.J. and Cook, L. and Paul, F. and Brandt, A.U.
Journal of Neuro-Ophthalmology 29 September 2023 (In Press)

Normative data and conversion equation for spectral-domain optical coherence tomography in an international healthy control cohort.
Kenney, R. and Liu, M. and Hasanaj, L. and Joseph, B. and Al-Hassan, A.A. and Balk, L. and Behbehani, R. and Brandt, A.U. and Calabresi, P.A. and Frohman, E.M. and Frohman, T. and Havla, J. and Hemmer, B. and Jiang, H. and Knier, B. and Korn, T. and Leocani, L. and Martínez-Lapiscina, E.H. and Papadopoulou, A. and Paul, F. and Petzold, A. and Pisa, M. and Villoslada, P. and Zimmermann, H. and Ishikawa, H. and Schuman, J.S. and Wollstein, G. and Chen, Y. and Saidha, S. and Thorpe, L.E. and Galetta, S.L. and Balcer, L.J.
Journal of Neuro-Ophthalmology 42 (4): 442-453. December 2022

The International Multiple Sclerosis Visual System Consortium: advancing visual system research in multiple sclerosis.
Balcer, L.J. and Balk, L.J. and Brandt, A.U. and Calabresi, P.A. and Martinez-Lapiscina, E.H. and Nolan, R.C. and Paul, F. and Petzold, A. and Saidha, S.
Journal of Neuro-Ophthalmology 38 (4): 494-501. December 2018

Journal of Neuroengineering and Rehabilitation

Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test.
Behrens, J. and Pfueller, C. and Mansow-Model, S. and Otte, K. and Paul, F. and Brandt, A.U.
Journal of Neuroengineering and Rehabilitation 11 : 89. 27 May 2014

Journal of Neuroimaging

MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease.
Carnero Contentti, E. and Okuda, D.T. and Rojas, J.I. and Chien, C. and Paul, F. and Alonso, R.
Journal of Neuroimaging 33 (5): 688-702. September 2023

Journal of Neuroimmune Pharmacology

Inflammatory cytokines associated with multiple sclerosis directly induce alterations of neuronal cytoarchitecture in human neurons.
Meyer-Arndt, L. and Kerkering, J. and Kuehl, T. and Gil Infante, A. and Paul, F. and Rosiewicz, K.S. and Siffrin, V. and Alisch, M.
Journal of Neuroimmune Pharmacology 18 (1-2): 145-159. June 2023

Safety and clinical outcomes of rituximab treatment in patients with multiple sclerosis and neuromyelitis optica: experience from a national online registry (GRAID).
Rommer, P.S. and Dörner, T. and Freivogel, K. and Haas, J. and Kieseier, B.C. and Kümpfel, T. and Paul, F. and Proft, F. and Schulze-Koops, H. and Schmidt, E. and Wiendl, H. and Ziemann, U. and Zettl, U.K.
Journal of Neuroimmune Pharmacology 11 (1): 1-8. March 2016

Journal of Neuroimmunology

Immune cell subpopulations and serum neurofilament light chain are associated with increased risk of disease worsening in multiple sclerosis.
Brune-Ingebretsen, S. and Høgestøl, E.A. and de Rosbo, N.K. and Berg-Hansen, P. and Brunborg, C. and Blennow, K. and Zetterberg, H. and Paul, F. and Uccelli, A. and Villoslada, P. and Harbo, H.F and Berge, T.
Journal of Neuroimmunology 382 : 578175. 15 September 2023

CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosis.
Fuchs, L. and Mausner-Fainberg, K. and Luban, A. and Asseyer, S.E. and Golan, M. and Benhamou, M. and Volovitz, I. and Regev, K. and Vigiser, I. and Piura, Y. and Kolb, H. and Paul, F. and Karni, A.
Journal of Neuroimmunology 371 : 577936. 15 October 2022

C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD.
Pache, F. and Ringelstein, M. and Aktas, O. and Kleiter, I. and Jarius, S. and Siebert, N. and Bellmann-Strobl, J. and Paul, F. and Ruprecht, K.
Journal of Neuroimmunology 360 : 577699. 15 November 2021

Binding patterns and functional properties of human antibodies to AQP4 and MOG on murine optic nerve and retina.
Faissner, S. and Graz, F. and Reinehr, S. and Petrikowski, L. and Haupeltshofer, S. and Ceylan, U. and Stute, G. and Winklmeier, S. and Pache, F. and Paul, F. and Ruprecht, K. and Meinl, E. and Dick, H.B. and Gold, R. and Kleiter, I. and Joachim, S.C.
Journal of Neuroimmunology 342 : 577194. 15 May 2020

Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: a peptide microarray-based case-control study.
Schlemm, L. and Giess, R.M. and Rasche, L. and Pfuhl, C. and Wakonig, K. and Behrens, J.R. and Scheibenbogen, C. and Bellmann-Strobl, J. and Paul, F. and Reimer, U. and Ruprecht, K.
Journal of Neuroimmunology 297 : 56-62. 15 August 2016

Autoantibodies to tetraspanins (CD9, CD81 and CD82) in demyelinating diseases.
Miyaji, K. and Paul, F. and Shahrizaila, N. and Umapathi, T. and Yuki, N.
Journal of Neuroimmunology 291 : 78-81. 15 February 2016

Association of serum Epstein-Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosis.
Pfuhl, C. and Oechtering, J. and Rasche, L. and Gieß, R.M. and Behrens, J.R. and Wakonig, K. and Freitag, E. and Pache, F.C. and Otto, C. and Hofmann, J. and Eberspächer, B. and Bellmann-Strobl, J. and Paul, F. and Ruprecht, K.
Journal of Neuroimmunology 285 : 156-160. 15 August 2015

Toxoplasma gondii seropositivity is negatively associated with multiple sclerosis.
Stascheit, F. and Paul, F. and Harms, L. and Rosche, B.
Journal of Neuroimmunology 285 : 119-124. 15 August 2015

Complement regulatory proteins (CD46, 55 and 59) expressed on Schwann cells: Immune targets in demyelinating neuropathies?
Miyaji, K. and Paul, F. and Shahrizaila, N. and Umapathi, T. and Yuki, N.
Journal of Neuroimmunology 276 (1-2): 172-174. November 2014

Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
Ruprecht, K. and Wunderlich, B. and Gieß, R. and Meyer, P. and Loebel, M. and Lenz, K. and Hofmann, J. and Rosche, B. and Wengert, O. and Paul, F. and Reimer, U. and Scheibenbogen, C.
Journal of Neuroimmunology 272 (1-2): 56-61. 15 July 2014

The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.
Fiebiger, S.M. and Bros, H. and Grobosch, T. and Janssen, A. and Chanvillard, C. and Paul, F. and Dörr, J. and Millward, J.M. and Infante-Duarte, C.
Journal of Neuroimmunology 262 (1-2): 66-71. 15 September 2013

Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation.
Hamann, I. and Dörr, J. and Glumm, R. and Chanvillard, C. and Janssen, A. and Millward, J.M. and Paul, F. and Ransohoff, R.M. and Infante-Duarte, C.
Journal of Neuroimmunology 254 (1-2): 165-169. 15 January 2013

Journal of Neuroinflammation

Bruton's tyrosine kinase-bearing B cells and microglia in neuromyelitis optica spectrum disorder.
Liu, Y. and Huang, Z. and Zhang, T.X. and Han, B. and Yang, G. and Jia, D. and Yang, L. and Liu, Q. and Lau, A.Y.L. and Paul, F. and Verkhratsky, A. and Shi, F.D. and Zhang, C.
Journal of Neuroinflammation 20 (1): 309. 21 December 2023

Optical coherence tomography angiography measurements in multiple sclerosis: a systematic review and meta-analysis.
Mohammadi, S. and Gouravani, M. and Salehi, M.A. and Arevalo, J.F. and Galetta, S.L. and Harandi, H. and Frohman, E.M. and Frohman, T.C. and Saidha, S. and Sattarnezhad, N. and Paul, F.
Journal of Neuroinflammation 20 (1): 85. 27 March 2023

Upregulated complement receptors correlate with Fc gamma receptor 3A-positive natural killer and natural killer-T cells in neuromyelitis optica spectrum disorder.
Nishiyama, S. and Wright, A.E. and Lotan, I. and Mikami, T. and Paul, F. and Aoki, M. and Levy, M.
Journal of Neuroinflammation 19 (1): 296. 12 December 2022

Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD.
Schroeder-Castagno, M. and Del Rio-Serrato, A. and Wilhelm, A. and Romero-Suárez, S. and Schindler, P. and Alvarez-González, C. and Duchow, A.S. and Bellmann-Strobl, J. and Ruprecht, K. and Hastermann, M. and Grütz, G. and Wildemann, B. and Jarius, S. and Schmitz-Hübsch, T. and Paul, F. and Infante-Duarte, C.
Journal of Neuroinflammation 19 (1): 239. 1 October 2022

CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage.
Hyun, J.W. and Kim, Y. and Kim, K.H. and Kim, S.H. and Olesen, M.N. and Asgari, N. and Siritho, S. and Paul, F. and Kim, H.J.
Journal of Neuroinflammation 19 (1): 86. 12 April 2022

Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
Jarius, S. and Pache, F. and Körtvelyessy, P. and Jelčić, I. and Stettner, M. and Franciotta, D. and Keller, E. and Neumann, B. and Ringelstein, M. and Senel, M. and Regeniter, A. and Kalantzis, R. and Willms, J.F. and Berthele, A. and Busch, M. and Capobianco, M. and Eisele, A. and Reichen, I. and Dersch, R. and Rauer, S. and Sandner, K. and Ayzenberg, I. and Gross, C.C. and Hegen, H. and Khalil, M. and Kleiter, I. and Lenhard, T. and Haas, J. and Aktas, O. and Angstwurm, K. and Kleinschnitz, C. and Lewerenz, J. and Tumani, H. and Paul, F. and Stangel, M. and Ruprecht, K. and Wildemann, B.
Journal of Neuroinflammation 19 (1): 19. 20 January 2022

Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Schindler, P. and Grittner, U. and Oechtering, J. and Leppert, D. and Siebert, N. and Duchow, A.S. and Oertel, F.C. and Asseyer, S. and Kuchling, J. and Zimmermann, H.G. and Brandt, A.U. and Benkert, P. and Reindl, M. and Jarius, S. and Paul, F. and Bellmann-Strobl, J. and Kuhle, J. and Ruprecht, K.
Journal of Neuroinflammation 18 (1): 105. 1 May 2021

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
Jarius, S. and Pellkofer, H. and Siebert, N. and Korporal-Kuhnke, M. and Hümmert, M.W. and Ringelstein, M. and Rommer, P.S. and Ayzenberg, I. and Ruprecht, K. and Klotz, L. and Asgari, N. and Zrzavy, T. and Höftberger, R. and Tobia, R. and Buttmann, M. and Fechner, K. and Schanda, K. and Weber, M. and Asseyer, S. and Haas, J. and Lechner, C. and Kleiter, I. and Aktas, O. and Trebst, C. and Rostasy, K. and Reindl, M. and Kümpfel, T. and Paul, F. and Wildemann, B.
Journal of Neuroinflammation 17 (1): 261. 3 September 2020

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients.
Jarius, S. and Lechner, C. and Wendel, E.M. and Baumann, M. and Breu, M. and Schimmel, M. and Karenfort, M. and Marina, A.D. and Merkenschlager, A. and Thiels, C. and Blaschek, A. and Salandin, M. and Leiz, S. and Leypoldt, F. and Pschibul, A. and Hackenberg, A. and Hahn, A. and Syrbe, S. and Strautmanis, J. and Häusler, M. and Krieg, P. and Eisenkölbl, A. and Stoffels, J. and Eckenweiler, M. and Ayzenberg, I. and Haas, J. and Höftberger, R. and Kleiter, I. and Korporal-Kuhnke, M. and Ringelstein, M. and Ruprecht, K. and Siebert, N. and Schanda, K. and Aktas, O. and Paul, F. and Reindl, M. and Wildemann, B. and Rostásy, K.
Journal of Neuroinflammation 17 (1): 262. 3 September 2020

Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study.
Oertel, F.C. and Outteryck, O. and Knier, B. and Zimmermann, H. and Borisow, N. and Bellmann-Strobl, J. and Blaschek, A. and Jarius, S. and Reindl, M. and Ruprecht, K. and Meinl, E. and Hohlfeld, R. and Paul, F. and Brandt, A.U. and Kümpfel, T. and Havla, J.
Journal of Neuroinflammation 16 (1): 154. 25 July 2019

Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.
Olesen, M.N. and Soelberg, K. and Debrabant, B. and Nilsson, A.C. and Lillevang, S.T. and Grauslund, J. and Brandslund, I. and Madsen, J.S. and Paul, F. and Smith, T.J. and Jarius, S. and Asgari, N.
Journal of Neuroinflammation 16 (1): 59. 11 March 2019

Myelinoclastic diffuse sclerosis (Schilder's disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures.
Jarius, S. and Haas, J. and Paul, F. and Wildemann, B.
Journal of Neuroinflammation 16 (1): 51. 28 February 2019

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.
Jarius, S. and Paul, F. and Aktas, O. and Asgari, N. and Dale, R.C. and de Seze, J. and Franciotta, D. and Fujihara, K. and Jacob, A. and Kim, H.J. and Kleiter, I. and Kümpfel, T. and Levy, M. and Palace, J. and Ruprecht, K. and Saiz, A. and Trebst, C. and Weinshenker, B.G. and Wildemann, B.
Journal of Neuroinflammation 15 (1): 134. 3 May 2018

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.
Jarius, S. and Ruprecht, K. and Stellmann, J.P. and Huss, A. and Ayzenberg, I. and Willing, A. and Trebst, C. and Pawlitzki, M. and Abdelhak, A. and Grüter, T. and Leypoldt, F. and Haas, J. and Kleiter, I. and Tumani, H. and Fechner, K. and Reindl, M. and Paul, F. and Wildemann, B.
Journal of Neuroinflammation 15 (1): 88. 19 March 2018

Baló's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures.
Jarius, S. and Würthwein, C. and Behrens, J.R. and Wanner, J. and Haas, J. and Paul, F. and Wildemann, B.
Journal of Neuroinflammation 15 (1): 22. 18 January 2018

Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS.
Ziemssen, T. and Tumani, H. and Sehr, T. and Thomas, K. and Paul, F. and Richter, N. and Samara, E. and Spiegelstein, O. and Sorani, E. and Bar-Ilan, O. and Mimrod, D. and Hayardeny, L.
Journal of Neuroinflammation 14 (1): 172. 31 August 2017

Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.
Jarius, S. and König, F.B. and Metz, I. and Ruprecht, K. and Paul, F. and Brück, W. and Wildemann, B.
Journal of Neuroinflammation 14 (1): 171. 29 August 2017

Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis.
Hahn, S. and Trendelenburg, G. and Scharf, M. and Denno, Y. and Brakopp, S. and Teegen, B. and Probst, C. and Wandinger, K.P. and Buttmann, M. and Haarmann, A. and Szabados, F. and Vom Dahl, M. and Kuempfel, T. and Eichhorn, P. and Gold, H. and Paul, F. and Jarius, S. and Melzer, N. and Stöcker, W. and Komorowski, L.
Journal of Neuroinflammation 14 (1): 123. 23 June 2017

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
Jarius, S. and Kleiter, I. and Ruprecht, K. and Asgari, N. and Pitarokoili, K. and Borisow, N. and Hümmert, M.W. and Trebst, C. and Pache, F. and Winkelmann, A. and Beume, L.A. and Ringelstein, M. and Stich, O. and Aktas, O. and Korporal-Kuhnke, M. and Schwarz, A. and Lukas, C. and Haas, J. and Fechner, K. and Buttmann, M. and Bellmann-Strobl, J. and Zimmermann, H. and Brandt, A.U. and Franciotta, D. and Schanda, K. and Paul, F. and Reindl, M. and Wildemann, B.
Journal of Neuroinflammation 13 (1): 281. 1 November 2016

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.
Pache, F. and Zimmermann, H. and Mikolajczak, J. and Schumacher, S. and Lacheta, A. and Oertel, F.C. and Bellmann-Strobl, J. and Jarius, S. and Wildemann, B. and Reindl, M. and Waldman, A. and Soelberg, K. and Asgari, N. and Ringelstein, M. and Aktas, O. and Gross, N. and Buttmann, Ma. and Ach, T. and Ruprecht, K. and Paul, F. and Brandt, A.U.
Journal of Neuroinflammation 13 (1): 282. 1 November 2016

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius, S. and Ruprecht, K. and Kleiter, I. and Borisow, N. and Asgari, N. and Pitarokoili, K. and Pache, F. and Stich, O. and Beume, L.A. and Hümmert, M.W. and Ringelstein, M. and Trebst, C. and Winkelmann, A. and Schwarz, A. and Buttmann, M. and Zimmermann, H. and Kuchling, J. and Franciotta, D. and Capobianco, M. and Siebert, E. and Lukas, C. and Korporal-Kuhnke, M. and Haas, J. and Fechner, K. and Brandt, A.U. and Schanda, K. and Aktas, O. and Paul, F. and Reindl, M. and Wildemann, B.
Journal of Neuroinflammation 13 (1): 280. 28 October 2016

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius, S. and Ruprecht, K. and Kleiter, I. and Borisow, N. and Asgari, N. and Pitarokoili, K. and Pache, F. and Stich, O. and Beume, L.A. and Hümmert, M.W. and Trebst, C. and Ringelstein, M. and Aktas, O. and Winkelmann, A. and Buttmann, M. and Schwarz, A. and Zimmermann, H. and Brandt, A.U. and Franciotta, D. and Capobianco, M. and Kuchling, J. and Haas, J. and Korporal-Kuhnke, M. and Lillevang, S.T. and Fechner, K. and Schanda, K. and Paul, F. and Wildemann, B. and Reindl, M.
Journal of Neuroinflammation 13 (1): 279. 26 September 2016

Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
Keller, A. and Leidinger, P. and Meese, E. and Haas, J. and Backes, C. and Rasche, L. and Behrens, J.R. and Pfuhl, C. and Wakonig, K. and Gieß, R.M. and Jarius, S. and Meder, B. and Bellmann-Strobl, J. and Paul, F. and Pache, F.C. and Ruprecht, K.
Journal of Neuroinflammation 12 (1): 196. 31 October 2015

Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.
Jarius, S. and Paul, F. and Fechner, K. and Ruprecht, K. and Kleiter, I. and Franciotta, D. and Ringelstein, M. and Pache, F. and Aktas, O. and Wildemann, B.
Journal of Neuroinflammation 11 (1): 129. 29 July 2014

Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study.
Jarius, S. and Kleffner, I. and Dörr, J.M. and Sastre-Garriga, J. and Illes, Z. and Eggenberger, E. and Chalk, C. and Ringelstein, M. and Aktas, O. and Montalban, X. and Fechner, K. and Stöcker, W. and Ringelstein, E.B. and Paul, F. and Wildemann, B.
Journal of Neuroinflammation 11 : 46. 8 March 2014

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.
Jarius, S. and Ruprecht, K. and Wildemann, B. and Kuempfel, T. and Ringelstein, M. and Geis, C. and Kleiter, I. and Kleinschnitz, C. and Berthele, A. and Brettschneider, J. and Hellwig, K. and Hemmer, B. and Linker, R.A. and Lauda, F. and Mayer, C.A. and Tumani, H. and Melms, A. and Trebst, C. and Stangel, M. and Marziniak, M. and Hoffmann, F. and Schippling, S. and Faiss, J.H. and Neuhaus, O. and Ettrich, B. and Zentner, C. and Guthke, K. and Hofstadt-van Oy, U. and Reuss, R. and Pellkofer, H. and Ziemann, U. and Kern, P. and Wandinger, K.P. and Bergh, F.T. and Boettcher, T. and Langel, S. and Liebetrau, M. and Rommer, P.S. and Niehaus, S. and Muench, C. and Winkelmann, A. and Zettl U, U.K. and Metz, I. and Veauthier, C. and Sieb, J.P. and Wilke, C. and Hartung, H.P. and Aktas, O. and Paul, F.
Journal of Neuroinflammation 9 : 14. 19 January 2012

Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance.
Jarius, S. and Franciotta, D. and Paul, F. and Ruprecht, K. and Bergamaschi, R. and Rommer, P.S. and Reuss, R. and Probst, C. and Kristoferitsch, W. and Wandinger, K.P. and Wildemann, B.
Journal of Neuroinflammation 7 : 52. 8 September 2010

Journal of Neurology

Improving the sensitivity of myelin oligodendrocyte glycoprotein-antibody testing: exclusive or predominant MOG-IgG3 seropositivity - a potential diagnostic pitfall in patients with MOG-EM/MOGAD.
Jarius, S. and Ringelstein, M. and Schanda, K. and Ruprecht, K. and Korporal-Kuhnke, M. and Viehöver, A. and Hümmert, M.W. and Schindler, P. and Endmayr, V. and Gastaldi, M. and Trebst, C. and Franciotta, D. and Aktas, O. and Höftberger, R. and Haas, J. and Komorowski, L. and Paul, F. and Reindl, M. and Wildemann, B.
Journal of Neurology 13 April 2024 (In Press)

Body mass, neuro-hormonal stress processing, and disease activity in lean to obese people with multiple sclerosis.
Meyer-Arndt, L. and Brasanac, J. and Gamradt, S. and Bellmann-Strobl, J. and Maurer, L. and Mai, K. and Steward, T. and Spranger, J. and Schmitz-Hübsch, T. and Paul, F. and Gold, S.M. and Weygandt, M.
Journal of Neurology 271 (4): 1584-1598. April 2024

Predicting disease severity in multiple sclerosis using multimodal data and machine learning.
Andorra, M. and Freire, A. and Zubizarreta, I. and de Rosbo, N.K. and Bos, S.D. and Rinas, M. and Høgestøl, E.A. and de Rodez Benavent, S.A. and Berge, T. and Brune-Ingebretse, S. and Ivaldi, F. and Cellerino, M. and Pardini, M. and Vila, G. and Pulido-Valdeolivas, I. and Martinez-Lapiscina, E.H. and Llufriu, S. and Saiz, A. and Blanco, Y. and Martinez-Heras, E. and Solana, E. and Bäcker-Koduah, P. and Behrens, J. and Kuchling, J. and Asseyer, S. and Scheel, M. and Chien, C. and Zimmermann, H. and Motamedi, S. and Kauer-Bonin, J. and Brandt, A. and Saez-Rodriguez, J. and Alexopoulos, L.G. and Paul, F. and Harbo, H.F. and Shams, H. and Oksenberg, J. and Uccelli, A. and Baeza-Yates, R. and Villoslada, P.
Journal of Neurology 271 (3): 1133-1149. March 2024

Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome.
Boesl, F. and Goereci, Y. and Gerhard, A. and Bremer, B. and Raeder, V. and Schweitzer, F. and Hoppmann, U. and Behrens, J. and Bellmann-Strobl, J. and Paul, F. and Wildemann, B. and Jarius, S. and Prüss, H. and Audebert, H.J. and Warnke, C. and Franke, C.
Journal of Neurology 271 (1): 59-70. January 2024

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
Kümpfel, T. and Giglhuber, K. and Aktas, O. and Ayzenberg, I. and Bellmann-Strobl, J. and Häußler, V. and Havla, J. and Hellwig, K. and Hümmert, M.W. and Jarius, S. and Kleiter, I. and Klotz, L. and Krumbholz, M. and Paul, F. and Ringelstein, M. and Ruprecht, K. and Senel, M. and Stellmann, J.P. and Bergh, F.T. and Trebst, C. and Tumani, H. and Warnke, C. and Wildemann, B. and Berthele, A.
Journal of Neurology 271 (1): 141-176. January 2024

Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.
Jarius, S. and Aktas, O. and Ayzenberg, I. and Bellmann-Strobl, J. and Berthele, A. and Giglhuber, K. and Häußler, V. and Havla, J. and Hellwig, K. and Hümmert, M.W. and Kleiter, I. and Klotz, L. and Krumbholz, M. and Kümpfel, T. and Paul, F. and Ringelstein, M. and Ruprecht, K. and Senel, M. and Stellmann, J.P. and Bergh, F.T. and Tumani, H. and Wildemann, B. and Trebst, C.
Journal of Neurology 270 (7): 3341-3368. July 2023

Treadmill training with virtual reality to enhance gait and cognitive function among people with multiple sclerosis: a randomized controlled trial.
Galperin, I. and Mirelman, A. and Schmitz-Hübsch, T. and Hsieh, K.L. and Regev, K. and Karni, A. and Brozgol, M. and Cornejo Thumm, P. and Lynch, S.G. and Paul, F. and Devos, H. and Sosnoff, J. and Hausdorff, J.M.
Journal of Neurology 270 (3): 1388-1401. March 2023

Treatment of MOG antibody associated disorders: results of an international survey.
Whittam, D.H. and Karthikeayan, V. and Gibbons, E. and Kneen, R. and Chandratre, S. and Ciccarelli, O. and Hacohen, Y. and de Seze, J. and Deiva, K. and Hintzen, R.Q. and Wildemann, B. and Jarius, S. and Kleiter, I. and Rostasy, K. and Huppke, P. and Hemmer, B. and Paul, F. and Aktas, O. and Pröbstel, A.K. and Arrambide, G. and Tintore, M. and Amato, M.P. and Nosadini, M. and Mancardi, M.M. and Capobianco, M. and Illes, Z. and Siva, A. and Altintas, A. and Akman-Demir, G. and Pandit, L. and Apiwattankul, M. and Hor, J.Y. and Viswanathan, S. and Qiu, W. and Kim, H.J. and Nakashima, I. and Fujihara, K. and Ramanathan, S. and Dale, R.C. and Boggild, M. and Broadley, S. and Lana-Peixoto, M.A. and Sato, D.K. and Tenembaum, S. and Cabre, P. and Wingerchuk, D.M. and Weinshenker, B.G. and Greenberg, B. and Matiello, M. and Klawiter, E.C. and Bennett, J.L. and Wallach, A.I. and Kister, I. and Banwell, B.L. and Traboulsee, A. and Pohl, D. and Palace, J. and Leite, M.I. and Levy, M. and Marignier, R. and Solomon, T. and Lim, M. and Huda, S. and Jacob, A.
Journal of Neurology 367 (12): 3565-3577. December 2020

Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS).
Johnen, A. and Bürkner, P.C. and Landmeyer, N.C. and Ambrosius, B. and Calabrese, P. and Motte, J. and Hessler, N. and Antony, G. and König, I.R. and Klotz, L. and Hoshi, M.M. and Aly, L. and Groppa, S. and Luessi, F. and Paul, F. and Tackenberg, B. and Bergh, F.T. and Kümpfel, T. and Tumani, H. and Stangel, M. and Weber, F. and Bayas, A. and Wildemann, B. and Heesen, C. and Zettl, U.K. and Zipp, F. and Hemmer, B. and Meuth, S.G. and Gold, R. and Wiendl, H. and Salmen, A.
Journal of Neurology 266 (2): 386-397. February 2019

Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension.
Albrecht, P. and Blasberg, C. and Ringelstein, M. and Mueller, A.K. and Finis, D. and Guthoff, R. and Kadas, E.M. and Lagreze, W. and Aktas, O. and Hartung, H.P. and Paul, F. and Brandt, A.U. and Methner, A.
Journal of Neurology 264 (7): 1370-1380. July 2017

Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome.
Huss, A.M. and Halbgebauer, S. and Öckl, P. and Trebst, C. and Spreer, A. and Borisow, N. and Harrer, A. and Brecht, I. and Balint, B. and Stich, O. and Schlegel, S. and Retzlaff, N. and Winkelmann, A. and Roesler, R. and Lauda, F. and Yildiz, O. and Voss, E. and Muche, R. and Rauer, S. and Bergh, F.T. and Otto, M. and Paul, F. and Wildemann, B. and Kraus, J. and Ruprecht, K. and Stangel, M. and Buttmann, M. and Zettl, U.K. and Tumani, H.
Journal of Neurology 263 (12): 2499-2504. December 2016

Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.
Ayzenberg, I. and Schöllhammer, J. and Hoepner, R. and Hellwig, K. and Ringelstein, M. and Aktas, O. and Kümpfel, T. and Krumbholz, M. and Trebst, C. and Paul, F. and Pache, F. and Obermann, M. and Zeltner, L. and Schwab, M. and Berthele, A. and Jarius, S. and Kleiter, I.
Journal of Neurology 263 (3): 575-582. March 2016

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.
Juryńczyk, M. and Weinshenker, B. and Akman-Demir, G. and Asgari, N. and Barnes, D. and Boggild, M. and Chaudhuri, A. and D'hooghe, M. and Evangelou, N. and Geraldes, R. and Illes, Z. and Jacob, A. and Kim, H.J. and Kleiter, I. and Levy, M. and Marignier, R. and McGuigan, C. and Murray, K. and Nakashima, I. and Pandit, L. and Paul, F. and Pittock, S. and Selmaj, K. and de Sèze, J. and Siva, A. and Tanasescu, R. and Vukusic, S. and Wingerchuk, D. and Wren, D. and Leite, I. and Palace, J.
Journal of Neurology 263 (1): 140-149. January 2016

Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency.
Doss, S. and Rinnenthal, J.L. and Schmitz-Hübsch, T. and Brandt, A.U. and Papazoglou, S. and Lux, S. and Maul, S. and Würfel, J. and Endres, M. and Klockgether, T. and Minnerop, M. and Paul, F.
Journal of Neurology 262 (8): 1927-1935. August 2015

Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75.
Krumbholz, M. and Hofstadt-van Oy, U. and Angstwurm, K. and Kleiter, I. and Jarius, S. and Paul, F. and Aktas, O. and Buchholz, G. and Kern, P. and Straube, A. and Kümpfel, T.
Journal of Neurology 262 (5): 1379-1384. May 2015

Detailing intra-lesional venous lumen shrinking in multiple sclerosis investigated by sFLAIR MRI at 7-T.
Mueller, K. and Kuchling, J. and Doerr, J. and Harms, L. and Ruprecht, K. and Niendorf, T. and Wuerfel, J. and Paul, F. and Sinnecker, T.
Journal of Neurology 261 (10): 2032-2036. October 2014

Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).
Trebst, C. and Jarius, S. and Berthele, A. and Paul, F. and Schippling, S. and Wildemann, B. and Borisow, N. and Kleiter, I. and Aktas, O. and Kümpfel, T.
Journal of Neurology 261 (1): 1-16. January 2014

Dynamics of saccade parameters in multiple sclerosis patients with fatigue.
Finke, C. and Pech, L.M. and Soemmer, C. and Schlichting, J. and Stricker, S. and Endres, M. and Ostendorf, F. and Ploner, C.J. and Brandt, A.U. and Paul, F.
Journal of Neurology 259 (12): 2656-2663. December 2012

Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?
Hackmack, K. and Weygandt, M. and Wuerfel, J. and Pfueller, C.F. and Bellmann-Strobl, J. and Paul, F. and Haynes, J.D.
Journal of Neurology 259 (10): 2151-2160. October 2012

Journal of Neurology Neurosurgery and Psychiatry

The T1-weighted/T2-weighted ratio as a biomarker of anti-NMDA receptor encephalitis.
Hartung, T.J. and Cooper, G. and Jünger, V. and Komnenić, D. and Ryan, L. and Heine, J. and Chien, C. and Paul, F. and Prüss, H. and Finke, C.
Journal of Neurology Neurosurgery and Psychiatry 95 (4): 366-373. 13 March 2024

Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder.
Aktas, O. and Hartung, H.P. and Smith, M.A. and Rees, W.A. and Fujihara, K. and Paul, F. and Marignier, R. and Bennett, J.L. and Kim, H.J. and Weinshenker, B.G. and Pittock, S.J. and Wingerchuk, D.M. and Cutter, G. and She, D. and Gunsior, M. and Cimbora, D. and Katz, E. and Cree, B.A.
Journal of Neurology Neurosurgery and Psychiatry 94 (9): 757-768. September 2023

Association of obesity with disease outcome in multiple sclerosis.
Lutfullin, I. and Eveslage, M. and Bittner, S. and Antony, G. and Flaskamp, M. and Luessi, F. and Salmen, A. and Gisevius, B. and Klotz, L. and Korsukewitz, C. and Berthele, A. and Groppa, S. and Then Bergh, F. and Wildemann, B. and Bayas, A. and Tumani, H. and Meuth, S.G. and Trebst, C. and Zettl, U.K. and Paul, F. and Heesen, C. and Kuempfel, T. and Gold, R. and Hemmer, B. and Zipp, F. and Wiendl, H. and Lünemann, J.D.
Journal of Neurology Neurosurgery and Psychiatry 94 (1): 57-61. January 2023

SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod.
Meyer-Arndt, L. and Braun, J. and Fauchere, F. and Vanshylla, K. and Loyal, L. and Henze, L. and Kruse, B. and Dingeldey, M. and Jürchott, K. and Mangold, M. and Maraj, A. and Braginets, A. and Böttcher, C. and Nitsche, A. and de la Rosa, K. and Ratswohl, C. and Sawitzki, B. and Holenya, P. and Reimer, U. and Sander, L.E. and Klein, F. and Paul, F. and Bellmann-Strobl, J. and Thiel, A. and Giesecke-Thiel, C.
Journal of Neurology Neurosurgery and Psychiatry 93 (9): 960-971. September 2022

Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders.
Lu, A. and Zimmermann, H.G. and Specovius, S. and Motamedi, S. and Chien, C. and Bereuter, C. and Lana-Peixoto, M.A. and Fontenelle, M.A. and Ashtari, F. and Kafieh, R. and Dehghani, A. and Pourazizi, M. and Pandit, L. and D'Cunha, A. and Kim, H.J. and Hyun, J.W. and Jung, S.K. and Leocani, L. and Pisa, M. and Radaelli, M. and Siritho, S. and May, E.F. and Tongco, C. and De Sèze, J. and Senger, T. and Palace, J. and Roca-Fernández, A. and Leite, M.I. and Sharma, S.M. and Stiebel-Kalish, H. and Asgari, N. and Soelberg, K.K. and Martinez-Lapiscina, E.H. and Havla, J. and Mao-Draayer, Y. and Rimler, Z. and Reid, A. and Marignier, R. and Cobo-Calvo, A. and Altintas, A. and Tanriverdi, U. and Yildirim, R. and Aktas, O. and Ringelstein, M. and Albrecht, P. and Tavares, I.M. and Bichuetti, D.B. and Jacob, A. and Huda, S. and Soto de Castillo, I. and Petzold, A. and Green, A.J. and Yeaman, M.R. and Smith, T.J. and Cook, L. and Paul, F. and Brandt, A.U. and Oertel, F.C.
Journal of Neurology Neurosurgery and Psychiatry 93 (2): 188-195. February 2022

Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany.
Liu, J. and Mori, M. and Zimmermann, H. and Brandt, A. and Havla, J. and Tanaka, S. and Sugimoto, K. and Oji, S. and Uzawa, A. and Asseyer, S. and Cooper, G. and Jarius, S. and Bellmann-Strobl, J. and Ruprecht, K. and Siebert, N. and Masuda, H. and Uchida, T. and Ohtani, R. and Nomura, K. and Meinl, E. and Kuempfel, T. and Paul, F. and Kuwabara, S.
Journal of Neurology Neurosurgery and Psychiatry 92 (4): 377-383. April 2021

Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis.
Abrahamyan, S. and Eberspächer, B. and Hoshi, M.M. and Aly, L. and Luessi, F. and Groppa, S. and Klotz, L. and Meuth, S.G. and Schroeder, C. and Grüter, T. and Tackenberg, B. and Paul, F. and Then-Bergh, F. and Kümpfel, T. and Weber, F. and Stangel, M. and Bayas, A. and Wildemann, B. and Heesen, C. and Zettl, U. and Warnke, C. and Antony, G. and Hessler, N. and Wiendl, H. and Bittner, S. and Hemmer, B. and Gold, R. and Salmen, A. and Ruprecht, K.
Journal of Neurology Neurosurgery and Psychiatry 91 (7): 681-686. July 2020

Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders.
Papadopoulou, A. and Oertel, F.C. and Gaetano, L. and Kuchling, J. and Zimmermann, H. and Chien, C. and Siebert, N. and Asseyer, S. and Bellmann-Strobl, J. and Ruprecht, K. and Chakravarty, M.M. and Scheel, M. and Magon, S. and Wuerfel, J. and Paul, F. and Brandt, A.U.
Journal of Neurology Neurosurgery and Psychiatry 90 (10): 1156-1164. October 2019

Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study.
Oertel, F.C. and Havla, J. and Roca-Fernández, A. and Lizak, N. and Zimmermann, H. and Motamedi, S. and Borisow, N. and White, O.B. and Bellmann-Strobl, J. and Albrecht, P. and Ruprecht, K. and Jarius, S. and Palace, J. and Leite, M.I. and Kuempfel, T. and Paul, F. and Brandt, A.U.
Journal of Neurology Neurosurgery and Psychiatry 89 (12): 1259-1265. December 2018

Beyond the limbic system: disruption and functional compensation of large-scale brain networks in patients with anti-LGI1 encephalitis.
Heine, J. and Prüss, H. and Kopp, U.A. and Wegner, F. and Then Bergh, F. and Münte, T. and Wandinger, K.P. and Paul, F. and Bartsch, T. and Finke, C.
Journal of Neurology Neurosurgery and Psychiatry 89 (11): 1191-1199. November 2018

Worldwide prevalence of neuromyelitis optica spectrum disorders.
Mori, M. and Kuwabara, S. and Paul, F.
Journal of Neurology Neurosurgery and Psychiatry 89 (6): 555-556. June 2018

Superficial white matter damage in anti-NMDA receptor encephalitis.
Phillips, O. R. and Joshi, S.H. and Narr, K.L. and Shattuck, D.W. and Singh, M. and Di Paola, M. and Ploner, C.J. and Prüss, H. and Paul, F. and Finke, C.
Journal of Neurology Neurosurgery and Psychiatry 89 (5): 518-525. May 2018

A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial).
Stürner, K.H. and Stellmann, J.P. and Dörr, J. and Paul, F. and Friede, T. and Schammler, S. and Reinhardt, S. and Gellissen, S. and Weissflog, G. and Faizy, T.D. and Werz, O. and Fleischer, S. and Vaas, L.A.I. and Herrmann, F. and Pless, O. and Martin, R. and Heesen, C.
Journal of Neurology Neurosurgery and Psychiatry 89 (4): 330-338. 15 March 2018

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response.
Stellmann, J.P. and Krumbholz, M. and Friede, T. and Gahlen, A. and Borisow, N. and Fischer, K. and Hellwig, K. and Pache, F. and Ruprecht, K. and Havla, J. and Kümpfel, T. and Aktas, O. and Hartung, H.P. and Ringelstein, M. and Geis, C. and Kleinschnitz, C. and Berthele, A. and Hemmer, B. and Angstwurm, K. and Young, K.L. and Schuster, S. and Stangel, M. and Lauda, F. and Tumani, H. and Mayer, C. and Zeltner, L. and Ziemann, U. and Linker, R.A. and Schwab, M. and Marziniak, M. and Then Bergh, F. and Hofstadt-van Oy, U. and Neuhaus, O. and Zettl, U. and Faiss, J. and Wildemann, B. and Paul, F. and Jarius, S. and Trebst, C. and Kleiter, I.
Journal of Neurology Neurosurgery and Psychiatry 88 (8): 639-647. August 2017

Diagnostic criteria for Susac syndrome.
Kleffner, I. and Dörr, J. and Ringelstein, M. and Gross, C.C. and Böckenfeld, Y. and Schwindt, W. and Sundermann, B. and Lohmann, H. and Wersching, H. and Promesberger, J. and von Königsmarck, N. and Alex, A. and Guthoff, R. and Frijns, C.J.M. and Kappelle, L.J. and Jarius, S. and Wildemann, B. and Aktas, O. and Paul, F. and Wiendl, H. and Duning, T.
Journal of Neurology Neurosurgery and Psychiatry 87 (12): 1287-1295. 25 December 2016

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
Waters, P. and Reindl, M. and Saiz, A. and Schanda, K. and Tuller, F. and Kral, V. and Nytrova, P. and Sobek, O. and Nielsen, H.H. and Barington, T. and Lillevang, S.T. and Illes, Z. and Rentzsch, K. and Berthele, A. and Berki, T. and Granieri, L. and Bertolotto, A. and Giometto, B. and Zuliani, L. and Hamann, D. and van Pelt, E.D. and Hintzen, R. and Höftberger, R. and Costa, C. and Comabella, M. and Montalban, X. and Tintoré, M. and Siva, A. and Altintas, A. and Deniz, G. and Woodhall, M. and Palace, J. and Paul, F. and Hartung, H.P. and Aktas, O. and Jarius, S. and Wildemann, B. and Vedeler, C. and Ruiz, A. and Leite, M.I. and Trillenberg, P. and Probst, M. and Saschenbrecker, S. and Vincent, A. and Marignier, R.
Journal of Neurology Neurosurgery and Psychiatry 87 (9): 1005-1015. September 2016

Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial.
Köpke, S. and Kern, S. and Ziemssen, T. and Berghoff, M. and Kleiter, I. and Marziniak, M. and Paul, F. and Vettorazzi, E. and Pöttgen, J. and Fischer, K. and Kasper, J. and Heesen, C.
Journal of Neurology Neurosurgery and Psychiatry 85 (4): 411-418. April 2014

Journal of Neurology, Neurosurgery, and Psychiatry

Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis.
Rosenkranz, S.C. and Gutmann, L. and Has Silemek, A.C. and Dorr, M. and Häußler, V. and Lüpke, M. and Mönch, A. and Reinhardt, S. and Kuhle, J. and Tilsley, P. and Heesen, C. and Friese, M.A. and Brandt, A. and Paul, F. and Zimmermann, H. and Stellmann, J.P.
Journal of Neurology, Neurosurgery, and Psychiatry 94 (11): 924-933. 12 October 2023

Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders.
Oertel, F.C. and Zimmermann, H.G. and Motamedi, S. and Chien, C. and Aktas, O. and Albrecht, P. and Ringelstein, M. and Dcunha, A. and Pandit, L. and Martinez-Lapiscina, E.H. and Sanchez-Dalmau, B. and Villoslada, P. and Palace, J. and Roca-Fernández, A. and Leite, M.I. and Sharma, S.M. and Leocani, L. and Pisa, M. and Radaelli, M. and Lana-Peixoto, M.A. and Fontenelle, M.A. and Havla, J. and Ashtari, F. and Kafieh, R. and Dehghani, A. and Pourazizi, M. and Marignier, R. and Cobo-Calvo, A. and Asgari, N. and Jacob, A. and Huda, S. and Mao-Draayer, Y. and Green, A.J. and Kenney, R. and Yeaman, M.R. and Smith, T.J. and Cook, L. and Brandt, A.U. and Paul, F. and Petzold, A.
Journal of Neurology, Neurosurgery, and Psychiatry 94 (7): 560-566. July 2023

Journal of Neuroscience Methods

Identification of the gliogenic state of human neural stem cells to optimize in vitro astrocyte differentiation.
Alisch, M. and Kerkering, J. and Crowley, T. and Rosiewicz, K. and Paul, F. and Siffrin, V.
Journal of Neuroscience Methods 361 : 109284. 1 September 2021

Journal of Neurotrauma

Studying axonal outgrowth and regeneration of the corticospinal tract in organotypic slice cultures.
Pohland, M. and Glumm, R. and Stoenica, L. and Höltje, M. and Kiwit, J. and Ahnert-Hilger, G. and Strauss, U. and Bräuer, A.U. and Paul, F. and Glumm, J.
Journal of Neurotrauma 32 (19): 1465-1477. 1 October 2015

Journal of Translational Medicine

Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).
Haffke, M. and Freitag, H. and Rudolf, G. and Seifert, M. and Doehner, W. and Scherbakov, N. and Hanitsch, L. and Wittke, K. and Bauer, S. and Konietschke, F. and Paul, F. and Bellmann-Strobl, J. and Kedor, C. and Scheibenbogen, C. and Sotzny, F.
Journal of Translational Medicine 20 (1): 138. 22 March 2022

An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Wirth, K.J. and Scheibenbogen, C. and Paul, F.
Journal of Translational Medicine 19 (1): 471. 22 November 2021

Journal of Visualized Experiments

Magnetic resonance imaging of multiple sclerosis at 7.0 Tesla.
Waiczies, S. and Els, A. and Kuchling, J. and Markenroth Bloch, K. and Pankowska, A. and Waiczies, H. and Herrmann, C. and Chien, C. and Finke, C. and Paul, F. and Niendorf, T.
Journal of Visualized Experiments (168): e62142. 19 February 2021

Journal of the Neurological Sciences

Identification and treatment of the visual processing asymmetry in MS patients with optic neuritis: The Pulfrich phenomenon.
Sobhanian, M.J. and Agarwal, R. and Meltzer, E. and Kildebeck, E. and Frohman, B.S. and Frohman, A.N. and Galetta, S.L. and Saidha, S. and White, O. and Villoslada, P. and Paul, F. and Petzold, A. and Rennaker, R.L. and Martinez-Lapiscina, E.H. and Balcer, L.J. and Kardon, R. and Frohman, E.M. and Frohman, T.C.
Journal of the Neurological Sciences 387 : 60-69. 15 April 2018

Alzheimer's disease: elevated pigment epithelium-derived factor in the cerebrospinal fluid is mostly of systemic origin.
Lang, V. and Zille, M. and Infante-Duarte, C. and Jarius, S. and Jahn, H. and Paul, F. and Ruprecht, K. and Pina, A.L.
Journal of the Neurological Sciences 375 : 123-128. 15 April 2017

Retinal imaging and axonal degeneration in later onset multiple sclerosis.
Huhn, K. and Laemmer, R. and Zimmermann, H. and Lämmer, A. and Waschbisch, A. and Utz, K. and Gieß, R.M. and Paul, F. and Linker, R.A. and Lee, D.H.
Journal of the Neurological Sciences 370 : 1-6. 15 November 2016

Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry.
Jarius, S. and Franciotta, D. and Paul, F. and Bergamaschi, R. and Rommer, P.S. and Ruprecht, K. and Ringelstein, M. and Aktas, O. and Kristoferitsch, W. and Wildemann, B.
Journal of the Neurological Sciences 320 (1-2): 32-37. 15 September 2012

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
Jarius, S. and Paul, F. and Franciotta, D. and Ruprecht, K. and Ringelstein, M. and Bergamaschi, R. and Rommer, P. and Kleiter, I. and Stich, O. and Reuss, R. and Rauer, S. and Zettl, U.K. and Wandinger, K.P. and Melms, A. and Aktas, O. and Kristoferitsch, W. and Wildemann, B.
Journal of the Neurological Sciences 306 (1-2): 82-90. 15 July 2011

Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis.
Jarius, S. and Frederikson, J. and Waters, P. and Paul, F. and Akman-Demir, G. and Marignier, R. and Franciotta, D. and Ruprecht, K. and Kuenz, B. and Rommer, P. and Kristoferitsch, W. and Wildemann, B. and Vincent, A.
Journal of the Neurological Sciences 298 (1-2): 158-162. 15 November 2010

Klinische Monatsblaetter fuer Augenheilkunde

Optische Kohärenztomografie bei Erkrankungen des zentralen Nervensystems [Optical coherence tomography in disorders of the central nervous system].
Papadopoulou, A. and Oertel, F.C. and Zimmermann, H. and Zeitz, O. and Brandt, A.U. and Paul, F.
Klinische Monatsblaetter fuer Augenheilkunde 235 (11): 1242-1258. 20 November 2018

Klinische Monatsblatter fur Augenheilkunde

Neuroophthalmologische Präsentation der Retrobulbärneuritis im Rahmen der Myelin-Oligodendrozyten-Glykoprotein-Antikörper-assoziierten Erkrankung [Neuro-ophthalmological presentation of optic neuritis in myelin oligodendrocyte glycoprotein antibody-associated disease].
Lin, T.Y. and Asseyer, S. and Buenrostro, G.S. and Feldmann, K. and Hamann, S. and Paul, F. and Zimmermann, H.G.
Klinische Monatsblatter fur Augenheilkunde 239 (11): 1305-1314. 21 November 2022

Diagnostik der Neuromyelitis-optica-Spektrum-Erkrankung (NMOSD) und der MOG-Antikörper-assoziierten Erkrankung (MOGAD) [Diagnosis of neuromyelitis optica spectrum disorder (NMOSD) and MOG Antibody-associated disease (MOGAD)].
Mewes, D. and Kuchling, J. and Schindler, P. and Khalil, A.A.A. and Jarius, S. and Paul, F. and Chien, C.
Klinische Monatsblatter fur Augenheilkunde 239 (11): 1315-1324. November 2022

Klinische Neurophysiologie

Optische Kohaerenztomografie in der Neurologie: Methodik und Anwendung in Forschung und Klinik [Optical coherence tomography in neurology: method and application in research and clinical routine].
Zimmermann, H.G. and Brandt, A.U. and Paul, F.
Klinische Neurophysiologie 48 (4): 211-225. December 2017

Lancet

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.
Cree, B.A.C. and Bennett, J.L. and Kim, H.J. and Weinshenker, B.G. and Pittock, S.J. and Wingerchuk, D.M. and Fujihara, K. and Paul, F. and Cutter, G.R. and Marignier, R. and Green, A.J. and Aktas, O. and Hartung, H.P. and Lublin, F.D. and Drappa, J. and Barron, G. and Madani, S. and Ratchford, J.N. and She, D. and Cimbora, D. and Katz, E.
Lancet 394 (10206): 1352-1363. 12 October 2019

Chronic cerebrospinal venous insufficiency in multiple sclerosis: the final curtain.
Paul, F. and Wattjes, M.P.
Lancet 383 (9912): 106-108. 11 January 2014

Lancet Digital Health

Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trial.
Gold, S.M. and Friede, T. and Meyer, B. and Moss-Morris, R. and Hudson, J. and Asseyer, S. and Bellmann-Strobl, J. and Leisdon, A. and Ißels, L. and Ritter, K. and Schymainski, D. and Pomeroy, H. and Lynch, S.G. and Cozart, J.S. and Thelen, J. and Román, C.A.F. and Cadden, M. and Guty, E. and Lau, S. and Pöttgen, J. and Ramien, C. and Seddiq-Zai, S. and Kloidt, A.M. and Wieditz, J. and Penner, I.K. and Paul, F. and Sicotte, N.L. and Bruce, J.M. and Arnett, P.A. and Heesen, C.
Lancet Digital Health 5 (10): e668-e678. October 2023

Lancet Neurology

Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.
Banwell, B. and Bennett, J.L. and Marignier, R. and Kim, H.J. and Brilot, F. and Flanagan, E.P. and Ramanathan, S. and Waters, P. and Tenembaum, S. and Graves, J.S. and Chitnis, T. and Brandt, A.U. and Hemingway, C. and Neuteboom, R. and Pandit, L. and Reindl, M. and Saiz, A. and Sato, D.K. and Rostasy, K. and Paul, F. and Pittock, S.J. and Fujihara, K. and Palace, J.
Lancet Neurology 22 (3): 268-282. March 2023

Diagnosis and classification of optic neuritis.
Petzold, A. and Fraser, C.L. and Abegg, M. and Alroughani, R. and Alshowaeir, D. and Alvarenga, R. and Andris, C. and Asgari, N. and Barnett, Y. and Battistella, R. and Behbehani, R. and Berger, T. and Bikbov, M.M. and Biotti, D. and Biousse, V. and Boschi, A. and Brazdil, M. and Brezhnev, A. and Calabresi, P.A. and Cordonnier, M. and Costello, F. and Cruz, F.M. and Cunha, L.P. and Daoudi, S. and Deschamps, R. and de Seze, J. and Diem, R. and Etemadifar, M. and Flores-Rivera, J. and Fonseca, P. and Frederiksen, J. and Frohman, E. and Frohman, T. and Tilikete, C.F. and Fujihara, K. and Gálvez, A. and Gouider, R. and Gracia, F. and Grigoriadis, N. and Guajardo, J.M. and Habek, M. and Hawlina, M. and Martínez-Lapiscina, E.H. and Hooker, J. and Hor, J.Y. and Howlett, W. and Huang-Link, Y. and Idrissova, Z. and Illes, Z. and Jancic, J. and Jindahra, P. and Karussis, D. and Kerty, E. and Kim, H.J. and Lagrèze, W. and Leocani, L. and Levin, N. and Liskova, P. and Liu, Y. and Maiga, Y. and Marignier, R. and McGuigan, C. and Meira, D. and Merle, H. and Monteiro, M.L.R. and Moodley, A. and Moura, F. and Muñoz, S. and Mustafa, S. and Nakashima, I. and Noval, S. and Oehninger, C. and Ogun, O. and Omoti, A. and Pandit, L. and Paul, F. and Rebolleda, G. and Reddel, S. and Rejdak, K. and Rejdak, R. and Rodriguez-Morales, A.J. and Rougier, M.B. and Sa, M.J. and Sanchez-Dalmau, B. and Saylor, D. and Shatriah, I. and Siva, A. and Stiebel-Kalish, H. and Szatmary, G. and Ta, L. and Tenembaum, S. and Tran, H. and Trufanov, Y. and van Pesch, V. and Wang, A.G. and Wattjes, M.P. and Willoughby, E. and Zakaria, M. and Zvornicanin, J. and Balcer, L. and Plant, G.T.
Lancet Neurology 21 (12): 1120-1134. December 2022

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial.
Foley, J.F. and Defer, G. and Ryerson, L.Z. and Cohen, J.A. and Arnold, D.L. and Butzkueven, H. and Cutter, G. and Giovannoni, G. and Killestein, J. and Wiendl, H. and Smirnakis, K. and Xiao, S. and Kong, G. and Kuhelj, R. and Campbell, N.
Lancet Neurology 21 (7): 608-619. July 2022

Myelin-oligodendrocyte glycoprotein antibody-associated disease.
Marignier, R. and Hacohen, Y. and Cobo-Calvo, A. and Pröbstel, A.K. and Aktas, O. and Alexopoulos, H. and Amato, M.P. and Asgari, N. and Banwell, B. and Bennett, J. and Brilot, F. and Capobianco, M. and Chitnis, T. and Ciccarelli, O. and Deiva, K. and De Sèze, J. and Fujihara, K. and Jacob, A. and Kim, H.J. and Kleiter, I. and Lassmann, H. and Leite, M.I. and Linington, C. and Meinl, E. and Palace, J. and Paul, F. and Petzold, A. and Pittock, S. and Reindl, M. and Sato, D.K. and Selmaj, K. and Siva, A. and Stankoff, B. and Tintore, M. and Traboulsee, A. and Waters, P. and Waubant, E. and Weinshenker, B. and Derfuss, T. and Vukusic, S. and Hemmer, B.
Lancet Neurology 20 (9): 762-772. September 2021

Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial.
Levin, J. and Maaß, S. and Schuberth, M. and Giese, A. and Oertel, W.H. and Poewe, W. and Trenkwalder, C. and Wenning, G.K. and Mansmann, U. and Südmeyer, M. and Eggert, K. and Mollenhauer, B. and Lipp, A. and Löhle, M. and Classen, J. and Münchau, A. and Kassubek, J. and Gandor, F. and Berg, D. and Egert-Schwender, S. and Eberhardt, C. and Paul, F. and Bötzel, K. and Ertl-Wagner, B. and Huppertz, H.J. and Ricard, I. and Höglinger, G.U.
Lancet Neurology 18 (8): 724-735. August 2019

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders.
Ciccarelli, O. and Cohen, J.A. and Reingold, S.C. and Weinshenker, B.G.
Lancet Neurology 18 (2): 185-197. February 2019

Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis.
Petzold, A. and Balcer, L.J. and Calabresi, P.A. and Costello, F. and Frohman, T.C. and Frohman, E.M. and Martinez-Lapiscina, E.H. and Green, A.J. and Kardon, R. and Outteryck, O. and Paul, F. and Schippling, S. and Vermersch, P. and Villoslada, P. and Balk, L.J.
Lancet Neurology 16 (10): 797-812. October 2017

What is the future of proof of concept studies in multiple sclerosis?
Paul, F.
Lancet Neurology 15 (11): 1107-1109. October 2016

Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
Martinez-Lapiscina, E.H. and Arnow, S. and Wilson, J.A. and Saidha, S. and Preiningerova, J.L. and Oberwahrenbrock, T. and Brandt, A.U. and Pablo, L.E. and Guerrieri, S. and Gonzalez, I. and Outteryck, O. and Mueller, A.K. and Albrecht, P. and Chan, W. and Lukas, S. and Balk, L.J. and Fraser, C. and Frederiksen, J.L. and Resto, J. and Frohman, T. and Cordano, C. and Zubizarreta, I. and Andorra, M. and Sanchez-Dalmau, B. and Saiz, A. and Bermel, R. and Klistorner, A. and Petzold, A. and Schippling, S. and Costello, F. and Aktas, O. and Vermersch, P. and Oreja-Guevara, C. and Comi, G. and Leocani, L. and Garcia-Martin, E. and Paul, F. and Havrdova, E. and Frohman, E. and Balcer, L.J. and Green, A.J. and Calabresi, P.A. and Villoslada, P.
Lancet Neurology 15 (6): 574-584. May 2016

Lancet Psychiatry

Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study.
Peer, M. and Prüss, H. and Ben-Dayan, I. and Paul, F. and Arzy, S. and Finke, C.
Lancet Psychiatry 4 (10): 768-774. October 2017

Life

The worm-specific immune response in multiple sclerosis patients receiving controlled Trichuris suis ova immunotherapy.
Yordanova, I.A. and Ebner, F. and Schulz, A.R. and Steinfelder, S. and Rosche, B. and Bolze, A. and Paul, F. and Mei, H.E. and Hartmann, S.
Life 11 (2): 101. 29 January 2021

Magnetic Resonance Materials in Physics Biology and Medicine

Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study.
Schumacher, S. and Pache, F. and Bellmann-Strobl, J. and Behrens, J. and Dusek, P. and Harms, L. and Ruprecht, K. and Nytrova, P. and Chawla, S. and Niendorf, T. and Kister, I. and Paul, F. and Ge, Y. and Wuerfel, J. and Sinnecker, T.
Magnetic Resonance Materials in Physics Biology and Medicine 29 (3): 535-541. June 2016

Magnetic Resonance in Medicine

Simultaneous T(2) and T(2)* mapping of multiple sclerosis lesions with radial RARE-EPI.
Herrmann, C. and Els, A. and Boehmert, L. and Periquito, J. and Eigentler, T.W. and Millward, J. and Waiczies, S. and Kuchling, J. and Paul, F. and Niendorf, T.
Magnetic Resonance in Medicine 86 (3): 1383-1402. September 2021

Molecular Neurodegeneration

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.
Lee, D.H. and Heidecke, H. and Schröder, A. and Paul, F. and Wachter, R. and Hoffmann, R. and Ellrichmann, G. and Dragun, D. and Waschbisch, A. and Stegbauer, J. and Klotz, P. and Gold, R. and Dechend, R. and Müller, D.N. and Saft, C. and Linker, R.A.
Molecular Neurodegeneration 9 (1): 49. 15 November 2014

Movement Disorders

Development of SARA(home), a new video-based tool for the assessment of ataxia at home.
Grobe-Einsler, M. and Taheri Amin, A. and Faber, J. and Schaprian, T. and Jacobi, H. and Schmitz-Hübsch, T. and Diallo, A. and Tezenas du Montcel, S. and Klockgether, T.
Movement Disorders 36 (5): 1242-1246. May 2021

Brain iron and metabolic abnormalities in C19orf12 mutation carriers: a 7.0 tesla MRI study in mitochondrial membrane protein-associated neurodegeneration.
Dusek, P. and Mekle, R. and Skowronska, M. and Acosta-Cabronero, J. and Huelnhagen, T. and Robinson, S.D. and Schubert, F. and Deschauer, M. and Els, A. and Ittermann, B. and Schottmann, G. and Madai, V.I. and Paul, F. and Klopstock, T. and Kmiec, T. and Niendorf, T. and Wuerfel, J. and Schneider, S.A.
Movement Disorders 35 (1): 142-150. January 2020

Photoreceptor layer thinning in idiopathic Parkinson's disease.
Roth, N.M. and Saidha, S. and Zimmermann, H. and Brandt, A.U. and Isensee, J. and Benkhellouf-Rutkowska, A. and Dornauer, M. and Kühn, A.A. and Mueller, T. and Calabresi, P.A. and Paul, F.
Movement Disorders 29 (9): 1163-1170. August 2014

Reply to: Photoreceptor layer thinning in Parkinsonian syndromes.
Brandt, A.U. and Paul, F. and Saidha, S.
Movement Disorders 29 (9): 1222-1223. August 2014

Movement Disorders Clinical Practice

Functionally relevant maculopathy and optic atrophy in spinocerebellar ataxia type 1.
Oertel, F.C. and Zeitz, O. and Rönnefarth, M. and Bereuter, C. and Motamedi, S. and Zimmermann, H.G. and Kuchling, J. and Grosch, A.S. and Doss, S. and Browne, A. and Paul, F. and Schmitz-Hübsch, T. and Brandt, A.U.
Movement Disorders Clinical Practice 7 (5): 502-508. July 2020

Ranking of dystonia severity by pairwise video comparison.
Ellermeyer, T. and Otte, K. and Heinrich, F. and Mansow-Model, S. and Kayser, B. and Lipp, A. and Seidel, A. and Krause, P. and Lauritsch, K. and Gusho, E. and Paul, F. and Kühn, A.A. and Brandt, A.U. and Schmitz-Hübsch, T.
Movement Disorders Clinical Practice 3 (6): 587-595. November 2016

7‐Tesla magnetic resonance imaging for brain iron quantification in homozygous and heterozygous PANK2 mutation carriers.
Dusek, P. and Tovar Martinez, E.M. and Madai, V.I. and Jech, R. and Sobesky, J. and Paul, F. and Niendorf, T. and Wuerfel, J. and Schneider, S.A.
Movement Disorders Clinical Practice 1 (4): 329-335. December 2014

Multiple Sclerosis

Time to diagnosis in multiple sclerosis: epidemiological data from the German Multiple Sclerosis Registry.
Blaschke, S.J. and Ellenberger, D. and Flachenecker, P. and Hellwig, K. and Paul, F. and Pöhlau, D. and Kleinschnitz, C. and Rommer, P.S. and Rueger, M.A. and Zettl, U.K. and Stahmann, A. and Warnke, C.
Multiple Sclerosis 28 (6): 865-871. May 2021

Correlation of self-assessed fatigue and alertness in multiple sclerosis.
Weinges-Evers, N. and Brandt, A.U. and Bock, M. and Pfueller, C.F. and Doerr, J. and Bellmann-Strobl, J. and Scherer, P. and Urbanek, C. and Boers, C. and Ohlraun, S. and Zipp, F. and Paul, F.
Multiple Sclerosis 16 (9): 1134-1140. September 2010

Time domain and spectral domain optical coherence tomography in multiple sclerosis: a comparative cross-sectional study.
Bock, M. and Brandt, A.U. and Doerr, J. and Pfueller, C.F. and Ohlraun, S. and Zipp, F. and Paul, F.
Multiple Sclerosis 16 (7): 893-896. July 2010

Attention Network Test reveals alerting network dysfunction in multiple sclerosis.
Urbanek, C. and Weinges-Evers, N. and Bellmann-Strobl, J. and Bock, M. and Doerr, J. and Hahn, E. and Neuhaus, A.H. and Opgen-Rhein, C. and Ta, T.M. and Herges, K. and Pfueller, C.F. and Radbruch, H. and Wernecke, K.D. and Ohlraun, S. and Zipp, F. and Dettling, M. and Paul, F.
Multiple Sclerosis 16 (1): 93-99. January 2010

Multiple Sclerosis International

Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography.
Oberwahrenbrock, T. and Schippling, S. and Ringelstein, M. and Kaufhold, F. and Zimmermann, H. and Keser, N. and Young, K.L. and Harmel, J. and Hartung, H.P. and Martin, R. and Paul, F. and Aktas, O. and Brandt, A.U.
Multiple Sclerosis International 2012 : 530305. 25 July 2012

Imaging the visual pathway in neuromyelitis optica.
Pfueller, C.F. and Paul, F.
Multiple Sclerosis International 2011 : 869814. 16 March 2011

Multiple Sclerosis Journal

Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: pathological and clinical aspects.
Samadzadeh, S. and Olesen, M.N. and Wirenfeldt, M. and Möller, S. and Misu, T. and Soelberg, K. and Frederiksen, J.L. and Heegaard, S. and Mariotto, S. and Fujihara, K. and Ruprecht, K. and Andersen, T.L. and Marignier, R. and Lillevang, S.T. and Flanagan, E.P. and Pittock, S.J. and Kim, H.J. and Bennett, J.L. and Paul, F. and Sorensen, G.L. and Weinshenker, B.G. and Lassmann, H. and Asgari, N.
Multiple Sclerosis Journal 29 (14): 1721-1735. 14 December 2023

Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.
Carnero Contentti, E. and Lopez, P.A. and Tkachuk, V. and Vrech, C. and Zarate, M.A. and Correale, J. and Deri, N. and Luetic, G. and Marrodan, M. and Pagani Cassara, F. and Tavolini, D. and Ysrraelit, M.C. and Balbuena, M.E. and Hryb, J. and Chiganer, E. and Leguizamon, F. and Knorre, E. and Zanga, G. and Pestchanker, C. and Barboza, A. and Nadur, D. and Cristiano, E. and Patrucco, L. and Alonso, R. and Alonso Serena, M. and Paul, F. and Rojas, J.I.
Multiple Sclerosis Journal 29 (10): 1240-1249. September 2023

Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease.
Lotan, I. and Chen, J.J. and Hacohen, Y. and Abdel-Mannan, O. and Mariotto, S. and Huda, S. and Gibbons, E. and Wilf-Yarkoni, A. and Hellmann, M.A. and Stiebel-Kalish, H. and Pittock, S.J. and Flanagan, E.P. and Molazadeh, N. and Anderson, M. and Salky, R. and Romanow, G. and Schindler, P. and Duchow, A.S. and Paul, F. and Levy, M.
Multiple Sclerosis Journal 29 (9): 1080-1089. August 2023

Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum.
Weinshenker, B.G. and Wingerchuk, D.M. and Green, A.J. and Bennett, J.L. and Kim, H.J. and Pittock, S.J. and Fujihara, K. and Paul, F. and Cutter, G. and Marignier, R. and Aktas, O. and Hartung, H.P. and She, D. and Smith, M. and Rees, W. and Patterson, K. and Cimbora, D. and Katz, E. and Cree, B.A.
Multiple Sclerosis Journal 29 (8): 945-955. July 2023

Cognition in patients with neuromyelitis optica spectrum disorders: a prospective multicentre study of 217 patients (CogniNMO-Study).
Hümmert, M.W. and Stern, C. and Paul, F. and Duchow, A. and Bellmann-Strobl, J. and Ayzenberg, I. and Schwake, C. and Kleiter, I. and Hellwig, K. and Jarius, S. and Wildemann, B. and Senel, M. and Berthele, A. and Giglhuber, K. and Luessi, F. and Grothe, M. and Klotz, L. and Schülke, R. and Gingele, S. and Faiss, J.H. and Walter, A. and Warnke, C. and Then Bergh, F. and Aktas, O. and Ringelstein, M. and Stellmann, J.P. and Häußler, V. and Havla, J. and Pellkofer, H. and Kümpfel, T. and Kopp, B. and Trebst, C.
Multiple Sclerosis Journal 29 (7): 819-831. June 2023

Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis.
Meaton, I. and Altokhis, A. and Allen, C.M. and Clarke, M.A. and Sinnecker, T. and Meier, D. and Enzinger, C. and Calabrese, M. and De Stefano, N. and Pitiot, A. and Giorgio, A. and Schoonheim, M.M. and Paul, F. and Pawlak, M.A. and Schmidt, R. and Granziera, C. and Kappos, L. and Montalban, X. and Rovira, À. and Wuerfel, Jens and Evangelou, N.
Multiple Sclerosis Journal 28 (14): 2212-2220. December 2022

Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis.
Brune, S. and Høgestøl, E.A. and de Rodez Benavent, S.A. and Berg-Hansen, P. and Beyer, M.K. and Leikfoss, I.S. and Bos, S.D. and Sowa, P. and Brunborg, C. and Andorra, M. and Pulido Valdeolivas, I. and Asseyer, S. and Brandt, A. and Chien, C. and Scheel, M. and Blennow, K. and Zetterberg, H. and Kerlero de Rosbo, N. and Paul, F. and Uccelli, A. and Villoslada, P. and Berge, T. and Harbo, H.F.
Multiple Sclerosis Journal 28 (12): 1859-1870. October 2022

Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders.
Ayadi, N. and Oertel, F.C. and Asseyer, S. and Rust, R. and Duchow, A. and Kuchling, J. and Bellmann-Strobl, J. and Ruprecht, K. and Klistorner, A. and Brandt, A.U. and Paul, F. and Zimmermann, H.G.
Multiple Sclerosis Journal 28 (5): 757-767. April 2022

Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation.
Cooper, G. and Chien, C. and Zimmermann, H. and Bellmann-Strobl, J. and Ruprecht, K. and Kuchling, J. and Asseyer, S. and Brandt, A.U. and Scheel, M. and Finke, C. and Paul, F.
Multiple Sclerosis Journal 27 (14): 2180-2190. December 2021

Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD.
Cree, B.A.C. and Bennett, J.L. and Kim, H.J. and Weinshenker, B.G. and Pittock, S.J. and Wingerchuk, D. and Fujihara, K. and Paul, F. and Cutter, G.R. and Marignier, R. and Green, A.J. and Aktas, O. and Hartung, H.P. and Williams, I.M. and Drappa, J. and She, D. and Cimbora, D. and Rees, W. and Ratchford, J.N. and Katz, E.
Multiple Sclerosis Journal 27 (13): 2052-2061. 1 November 2021

Functional connectivity alterations of striato-cortical circuits in multiple sclerosis.
Jaeger, S. and Paul, F. and Finke, C.
Multiple Sclerosis Journal 27 (9): 1469-1470. 1 August 2021

Spinal cord and brain MRI should be routinely performed during follow-up in patients with NMOSD - commentary.
Paul, F.
Multiple Sclerosis Journal 27 (1): 16-18. 1 January 2021

Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity.
Chien, C. and Scheel, M. and Schmitz-Hübsch, T. and Borisow, N. and Ruprecht, K. and Bellmann-Strobl, J. and Paul, F. and Brandt, A.U.
Multiple Sclerosis Journal 25 (14): 1926-1936. December 2019

Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis.
Graetz, C. and Gröger, A. and Luessi, F. and Salmen, A. and Zöller, D. and Schultz, J. and Siller, N. and Fleischer, V. and Bellenberg, B. and Berthele, A. and Biberacher, V. and Havla, J. and Hecker, M. and Hohlfeld, R. and Infante-Duarte, C. and Kirschke, J.S. and Kümpfel, T. and Linker, R. and Paul, F. and Pfeuffer, S. and Sämann, P. and Toenges, G. and Weber, F. and Zettl, U.K. and Jahn-Eimermacher, A. and Antony, G. and Groppa, S. and Wiendl, H. and Hemmer, B. and Mühlau, M. and Lukas, C. and Gold, R. and Lill, C.M. and Zipp, F.
Multiple Sclerosis Journal 25 (5): 661-668. 1 April 2019

Multiple sclerosis-related fatigue: altered resting-state functional connectivity of the ventral striatum and dorsolateral prefrontal cortex.
Jaeger, S. and Paul, F. and Scheel, M. and Brandt, A. and Heine, J. and Pach, D. and Witt, C.M. and Bellmann-Strobl, J. and Finke, C.
Multiple Sclerosis Journal 25 (4): 554-564. April 2019

Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders.
Mealy, M.A. and Kim, S.H. and Schmidt, F. and López, R. and Jimenez Arango, J.A. and Paul, F. and Wingerchuk, D.M. and Greenberg, B.M. and Kim, H.Jin. and Levy, M.
Multiple Sclerosis Journal 24 (13): 1737-1742. 1 November 2018

Brain activity, regional gray matter loss, and decision-making in multiple sclerosis.
Weygandt, M. and Wakonig, K. and Behrens, J. and Meyer-Arndt, L. and Söder, E. and Brandt, A.U. and Bellmann-Strobl, J. and Ruprecht, K. and Gold, S.M. and Haynes, J.D. and Paul, F.
Multiple Sclerosis Journal 24 (9): 1163-1173. 1 August 2018

A population-based prospective study of optic neuritis.
Soelberg, K. and Jarius, S. and Skejoe, H.P.B. and Engberg, H. and Mehlsen, J.J. and Nilsson, A.C. and Madsen, J.S. and Reindl, M. and Wildemann, B. and Grauslund, J. and Kyvik, K.O. and Smith, T.J. and Lillevang, S.T. and Paul, F. and Weinshenker, B.G. and Asgari, N.
Multiple Sclerosis Journal 23 (14): 1893-1901. 1 December 2017

Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density.
Mikolajczak, J. and Zimmermann, H. and Kheirkhah, A. and Kadas, E.M. and Oberwahrenbrock, T. and Muller, R. and Ren, A. and Kuchling, J. and Dietze, H. and Prüss, H. and Paul, F. and Hamrah, P. and Brandt, A.U.
Multiple Sclerosis Journal 23 (14): 1847-1853. 1 December 2017

Influence of female sex and fertile age on neuromyelitis optica spectrum disorders.
Borisow, N. and Kleiter, I. and Gahlen, A. and Fischer, K. and Wernecke, K.D. and Pache, F. and Ruprecht, K. and Havla, J. and Krumbholz, M. and Kümpfel, T. and Aktas, O. and Ringelstein, M. and Geis, C. and Kleinschnitz, C. and Berthele, A. and Hemmer, B. and Angstwurm, K. and Weissert, R. and Stellmann, J.P. and Schuster, S. and Stangel, M. and Lauda, F. and Tumani, H. and Mayer, C. and Zeltner, L. and Ziemann, U. and Linker, R.A. and Schwab, M. and Marziniak, M. and Then Bergh, F. and Hofstadt-van Oy, U. and Neuhaus, O. and Winkelmann, A. and Marouf, W. and Rückriem, L. and Faiss, J. and Wildemann, B. and Paul, F. and Jarius, S. and Trebst, C. and Hellwig, K.
Multiple Sclerosis Journal 23 (8): 1092-1103. July 2017

Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.
Schlemm, L. and Chien, C. and Bellmann-Strobl, J. and Dörr, J. and Wuerfel, J. and Brandt, A.U. and Paul, F. and Scheel, M.
Multiple Sclerosis Journal 23 (7): 963-972. June 2017

Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression.
Hasselmann, H. and Bellmann-Strobl, J. and Ricken, R. and Oberwahrenbrock, T. and Rose, M. and Otte, C. and Adli, M. and Paul, F. and Brandt, A.U. and Finke, C. and Gold, S.M.
Multiple Sclerosis Journal 22 (11): 1476-1484. October 2016

Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Jarius, S. and Metz, I. and König, F.B. and Ruprecht, K. and Reindl, M. and Paul, F. and Brück, W. and Wildemann, B.
Multiple Sclerosis Journal 22 (12): 1541-1549. October 2016

Validity of visual perceptive computing for static posturography in patients with multiple sclerosis.
Behrens, J.R. and Mertens, S. and Krüger, T. and Grobelny, A. and Otte, K. and Mansow-Model, S. and Gusho, E. and Paul, F. and Brandt, A.U. and Schmitz-Hübsch, T.
Multiple Sclerosis Journal 22 (12): 1596-1606. October 2016

Placebo-controlled study in neuromyelitis optica : ethical and design considerations.
Cree, B.A.C. and Bennett, J.L. and Sheehan, M. and Cohen, J. and Hartung, H.P. and Aktas, O. and Kim, H.J. and Paul, F. and Pittock, S. and Weinshenker, B. and Wingerchuk, D. and Fujihara, K. and Cutter, G. and Patra, K. and Flor, A. and Barron, G. and Madani, S. and Ratchford, J.N. and Katz, E.
Multiple Sclerosis Journal 22 (7): 862-872. June 2016

Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica.
Hertwig, L. and Pache, F. and Romero-Suarez, S. and Stuerner, K.H. and Borisow, N. and Behrens, J. and Bellmann-Strobl, J. and Seeger, B. and Asselborn, N. and Ruprecht, K. and Millward, J.M. and Infante-Duarte, C. and Paul, F.
Multiple Sclerosis Journal 22 (2): 160-173. February 2016

Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue.
Finke, C. and Schlichting, J. and Papazoglou, S. and Scheel, M. and Freing, A. and Soemmer, C. and Pech, L.M. and Pajkert, A. and Pfueller, C.J. and Wuerfel, J.T. and Ploner, C. and Paul, F. and Brandt, A.U.
Multiple Sclerosis Journal 21 (7): 925-934. June 2015

Demographic and clinical features of neuromyelitis optica: A review.
Pandit, L. and Asgari, N. and Apiwattanakul, M. and Palace, J. and Paul, F. and Leite, M.I. and Kleiter, I. and Chitnis, T.
Multiple Sclerosis Journal 21 (7): 845-853. June 2015

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.
Bennett, J.L. and de Seze, J. and Lana-Peixoto, M. and Palace, J. and Waldman, A. and Schippling, S. and Tenembaum, S. and Banwell, B. and Greenberg, B. and Levy, M. and Fujihara, K. and Chan, K.H. and Kim, H.J. and Asgari, N. and Sato, D.K. and Saiz, A. and Wuerfel, J. and Zimmermann, H. and Green, A. and Villoslada, P. and Paul, F.
Multiple Sclerosis Journal 21 (6): 678-688. May 2015

Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria.
Schippling, S. and Balk, L. and Costello, F. and Albrecht, P. and Balcer, L. and Calabresi, P. and Frederiksen, J. and Frohman, E. and Green, A. and Klistorner, A. and Outteryck, O. and Paul, F. and Plant, G. and Traber, G. and Vermersch, P. and Villoslada, P. and Wolf, S. and Petzold, A.
Multiple Sclerosis Journal 21 (2): 163-170. February 2015

Signaling networks in MS: a systems-based approach to developing new pharmacological therapies.
Kotelnikova, E. and Bernardo-Faura, M. and Silberberg, G. and Kiani, N.A. and Messinis, D. and Melas, I.N. and Artigas, L. and Schwartz, E. and Mazo, I. and Masso, M. and Alexopoulos, L.G. and Mas, J.M. and Olsson, T. and Tegner, J. and Martin, R. and Zamora, A. and Paul, F. and Saez-Rodriguez, J. and Villoslada, P.
Multiple Sclerosis Journal 21 (2): 138-146. February 2015

Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.
Kuchling, J. and Ramien, C. and Bozin, I. and Dörr, J. and Harms, L. and Rosche, B. and Niendorf, T. and Paul, F. and Sinnecker, T. and Wuerfel, J.
Multiple Sclerosis Journal 20 (14): 1866-1871. December 2014

Retinal nerve fibre layer thickness correlates with brain white matter damage in multiple sclerosis: a combined optical coherence tomography and diffusion tensor imaging study.
Scheel, M. and Finke, C. and Oberwahrenbrock, T. and Freing, A. and Pech, L.M. and Schlichting, J. and Sömmer, C. and Wuerfel, J. and Paul, F. and Brandt, A.U.
Multiple Sclerosis Journal 20 (14): 1904-1907. December 2014

Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
Kremer, L. and Mealy, M. and Jacob, A. and Nakashima, I. and Cabre, P. and Bigi, S. and Paul, F. and Jarius, S. and Aktas, O. and Elsone, L. and Mutch, K. and Levy, M. and Takai, Y. and Collongues, N. and Banwell, B. and Fujihara, K. and de Seze, J.
Multiple Sclerosis Journal 20 (7): 843-847. June 2014

Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Ringelstein, M. and Metz, I. and Ruprecht, K. and Koch, A. and Rappold, J. and Ingwersen, J. and Mathys, C. and Jarius, S. and Brück, W. and Hartung, H.P. and Paul, F. and Aktas, O.
Multiple Sclerosis Journal 20 (7): 882-888. June 2014

Visual evoked potentials in neuromyelitis optica and its spectrum disorders.
Ringelstein, M. and Kleiter, I. and Ayzenberg, I. and Borisow, N. and Paul, F. and Ruprecht, K. and Kraemer, M. and Cohn, E. and Wildemann, B. and Jarius, S. and Hartung, H.P. and Aktas, O. and Albrecht, P.
Multiple Sclerosis Journal 20 (5): 617-620. April 2014

Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing.
Keller, A. and Leidinger, P. and Steinmeyer, F. and Stähler, C. and Franke, A. and Hemmrich-Stanisak, G. and Kappel, A. and Wright, I. and Dörr, J. and Paul, F. and Diem, R. and Tocariu-Krick, B. and Meder, B. and Backes, C. and Meese, E. and Ruprecht, K.
Multiple Sclerosis Journal 20 (3): 295-303. March 2014

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
Collongues, N. and Marignier, R. and Jacob, A. and Leite, M. and Siva, A. and Paul, F. and Zephir, H. and Akman-Demir, G. and Elsone, L. and Jarius, S. and Papeix, C. and Mutch, K. and Saip, S. and Wildemann, B. and Kitley, J. and Karabudak, R. and Aktas, O. and Kuscu, D. and Altintas, A. and Palace, J. and Confavreux, C. and De Seze, J.
Multiple Sclerosis Journal 20 (8): 1086-1094. 2014

Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome.
Oberwahrenbrock, T. and Ringelstein, M. and Jentschke, S. and Deuschle, K. and Klumbies, K. and Bellmann-Strobl, J. and Harmel, J. and Ruprecht, K. and Schippling, S. and Hartung, H.P. and Aktas, O. and Brandt, A.U. and Paul, F.
Multiple Sclerosis Journal 19 (14): 1887-1895. December 2013

Are there Epstein-Barr virus seronegative patients with multiple sclerosis?
Deuschle, K. and Hofmann, J. and Otto, C. and Bellmann-Strobl, J. and Scherner, O. and Klumbies, K. and Schneider, E. and Broddack, J. and Paul, F. and Ruprecht, K.
Multiple Sclerosis Journal 19 (9): 1242-1243. August 2013

Breastfeeding is associated with lower risk for multiple sclerosis.
Conradi, S. and Malzahn, U. and Paul, F. and Quill, S. and Harms, L. and Then Bergh, F. and Ditzenbach, A. and Georgi, T. and Heuschmann, P. and Rosche, B.
Multiple Sclerosis Journal 19 (5): 553-558. April 2013

Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations.
Zimmermann, H. and Freing, A. and Kaufhold, F. and Gaede, G. and Bohn, E. and Bock, M. and Oberwahrenbrock, T. and Young, K.L. and Dörr, J. and Wuerfel, J.T. and Schippling, S. and Paul, F. and Brandt, A.U.
Multiple Sclerosis Journal 19 (4): 443-450. April 2013

'Obstructive sleep apnea is associated with fatigue in multiple sclerosis' by Kaminska et al.
Veauthier, C. and Blau, A. and Paul, F.
Multiple Sclerosis Journal 19 (3): 372-373. March 2013

Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study.
Sinnecker, T. and Bozin, I. and Dörr, J. and Pfueller, C.F. and Harms, L. and Niendorf, T. and Brandt, A.U. and Paul, F. and Wuerfel, J.
Multiple Sclerosis Journal 19 (3): 316-325. March 2013

Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis.
Wuerfel, J. and Sinnecker, T. and Ringelstein, E.B. and Jarius, S. and Schwindt, W. and Niendorf, T. and Paul, F. and Kleffner, I. and Doerr, J.
Multiple Sclerosis Journal 18 (11): 1592-1599. November 2012

Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature.
Jarius, S. and Paul, F. and Franciotta, D. and de Seze, J. and Muench, C. and Salvetti, M. and Ruprecht, K. and Liebetrau, M. and Wandinger, K. and Akman-Demir, G. and Melms, A. and Kristoferitsch, W. and Wildemann, B.
Multiple Sclerosis Journal 18 (8): 1135-1143. August 2012

Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist?
Veauthier, C. and Paul, F.
Multiple Sclerosis Journal 18 (2): 248-249. February 2012

Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
Jarius, S. and Jacobi, C. and de Seze, J. and Zephir, H. and Paul, F. and Franciotta, D. and Rommer, P. and Mader, S. and Kleiter, I. and Reindl, M. and Akman-Demir, G. and Seifert-Held, T. and Kristoferitsch, W. and Melms, A. and Wandinger, K.P. and Wildemann, B.
Multiple Sclerosis Journal 17 (9): 1067-1073. September 2011

Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study.
Veauthier, C. and Radbruch, H. and Gaede, G. and Pfueller, C. and Doerr, J. and Bellmann-Strobl, J. and Wernecke, K.D. and Zipp, F. and Paul, F. and Sieb, J.
Multiple Sclerosis Journal 17 (5): 613-622. May 2011

Multiple Sclerosis Journal Experimental Translational and Clinical

Superficial white matter integrity in neuromyelitis optica spectrum disorder and multiple sclerosis.
Komnenić, D. and Phillips, O.R. and Joshi, S.H. and Chien, C. and Schmitz-Hübsch, T. and Asseyer, S. and Paul, F. and Finke, C.
Multiple Sclerosis Journal Experimental Translational and Clinical 10 (1): 20552173231226107. 2024

Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: a study from the RelevarEM registry.
Carnero Contentti, E. and Lopez, P.A. and Pettinicchi, J.P. and Criniti, J. and Pappolla, A. and Miguez, J. and Cristiano, E. and Patrucco, L. and Liwacki, S. and Tkachuk, V. and Balbuena, M.E. and Vrech, C. and Deri, N. and Correale, J. and Marrodan, M. and Ysrraelit, M.C. and Leguizamon, F. and Luetic, G. and Menichini, M.L. and Tavolini, D. and Mainella, C. and Zanga, G. and Burgos, M. and Hryb, J. and Barboza, A. and Lazaro, L. and Alonso, R. and Fernández Liguori, N. and Nadur, D. and Alonso Serena, M. and Caride, A. and Paul, F. and Rojas, J.I.
Multiple Sclerosis Journal Experimental Translational and Clinical 9 (4): 20552173231205444. 17 October 2023

Functional connectome fingerprinting and stability in multiple sclerosis.
Mantwill, M. and Asseyer, S. and Chien, C. and Kuchling, J. and Schmitz-Hübsch, T. and Brandt, A.U. and Haynes, J.D. and Paul, F. and Finke, C.
Multiple Sclerosis Journal Experimental Translational and Clinical 9 (3): 20552173231195879. 25 August 2023

Prediction of high and low disease activity in early MS patients using multiple kernel learning identifies importance of lateral ventricle intensity.
Chien, C. and Seiler, M. and Eitel, F. and Schmitz-Hübsch, T. and Paul, F. and Ritter, K.
Multiple Sclerosis Journal Experimental Translational and Clinical 8 (3): 20552173221109770. 1 July 2022

Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: data from a nationwide registry in Argentina.
Contentti, E.C. and Lopez, P.A. and Pettinicchi, J.P. and Criniti, J. and Pappolla, A. and Miguez, J. and Patrucco, L. and Carnero Contentti, E. and Liwacki, S. and Tkachuk, V. and Balbuena, M.E. and Vrech, C. and Deri, N. and Correale, J. and Marrodan, M. and Ysrraelit, M.C. and Leguizamon, F. and Luetic, G. and Menichini, M.L. and Tavolini, D. and Mainella, C. and Zanga, G. and Burgos, M. and Hryb, J. and Barboza, A. and Lazaro, L. and Alonso, R. and Liguori, N.F. and Nadur, D. and Chercoff, A. and Alonso Serena, M. and Caride, A. and Paul, F. and Rojas, J.I.
Multiple Sclerosis Journal Experimental Translational and Clinical 7 (3): 20552173211032334. 1 July 2021

AQP4-IgG autoimmunity in Japan and Germany: differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders.
Asseyer, S. and Masuda, H. and Mori, M. and Bellmann-Strobl, J. and Ruprecht, K. and Siebert, N. and Cooper, G. and Chien, C. and Duchow, A. and Schließeit, J. and Liu, J. and Sugimoto, K. and Uzawa, A. and Ohtani, R. and Paul, F. and Brandt, A.U. and Kuwabara, S. and Zimmermann, H.G.
Multiple Sclerosis Journal Experimental Translational and Clinical 7 (2): 205521732110068. 1 April 2021

A novel investigation method for axonal damage in neuromyelitis optica spectrum disorder: In vivo corneal confocal microscopy.
Altıntaş, A. and Yildiz-Tas, A. and Yilmaz, S. and Bayraktutar, B.N. and Comert, M.C. and Zimmermann, H. and Brandt, A.U. and Paul, F. and Sahin, A.
Multiple Sclerosis Journal Experimental Translational and Clinical 7 (1): 2055217321998060. 1 January 2021

Evaluation of the 'ring sign' and the 'core sign' as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis.
Blindenbacher, N. and Brunner, E. and Asseyer, S. and Scheel, M. and Siebert, N. and Rasche, L. and Bellmann-Strobl, J. and Brandt, A. and Ruprecht, K. and Meier, D. and Wuerfel, J. and Paul, F. and Sinnecker, T.
Multiple Sclerosis Journal Experimental Translational and Clinical 6 (1): 2055217320915480. 30 March 2020

High-dose vitamin D supplementation in multiple sclerosis - results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial.
Dörr, J. and Koduah, P. and Wernecke, K.D. and Becker, E. and Hoffmann, F. and Faiss, J. and Brockmeier, B. and Hoffmann, O. and Anvari, K. and Wuerfel, J. and Piper, S.K. and Bellmann-Strobl, J. and Brandt, A.U. and Paul, F.
Multiple Sclerosis Journal Experimental Translational and Clinical 6 (1): 2055217320903474. 24 January 2020

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study.
Balk, L.J. and Coric, D. and Knier, B. and Zimmermann, H.G. and Behbehani, R. and Alroughani, R. and Martinez-Lapiscina, E.H. and Brandt, A.U. and Sánchez-Dalmau, B. and Vidal-Jordana, A. and Albrecht, P. and Koska, V. and Havla, J. and Pisa, M. and Nolan, R.C. and Leocani, L. and Paul, F. and Aktas, O. and Montalban, X. and Balcer, L.J. and Villoslada, P. and Outteryck, O. and Korn, T. and Petzold, A.
Multiple Sclerosis Journal Experimental Translational and Clinical 5 (3): 2055217319871582. 1 July 2019

Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders.
Asseyer, S. and Schmidt, F. and Chien, C. and Scheel, M. and Ruprecht, K. and Bellmann-Strobl, J. and Brandt, A.U. and Paul, F.
Multiple Sclerosis Journal Experimental Translational and Clinical 4 (3): 2055217318796684. 1 July 2018

Multiple Sclerosis and Related Disorders

Discrimination of multiple sclerosis using OCT images from two different centers.
Khodabandeh, Z. and Rabbani, H. and Ashtari, F. and Zimmermann, H.G. and Motamedi, S. and Brandt, A.U. and Paul, F. and Kafieh, R.
Multiple Sclerosis and Related Disorders 77 : 104846. September 2023

Serum glial fibrillary acidic protein correlates with retinal structural damage in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Lin, T.Y. and Schindler, P. and Grittner, U. and Oertel, F.C. and Lu, A. and Motamedi, S. and Yadav, S.K. and Duchow, A.S. and Jarius, S. and Kuhle, J. and Benkert, P. and Brandt, A.U. and Bellmann-Strobl, J. and Schmitz-Hübsch, T. and Paul, F. and Ruprecht, K. and Zimmermann, H.G.
Multiple Sclerosis and Related Disorders 67 : 104100. November 2022

Fragmentation, circadian amplitude, and fractal pattern of daily-living physical activity in people with multiple sclerosis: is there relevant information beyond the total amount of physical activity?
Salomon, A. and Galperin, I. and Buzaglo, D. and Mirelman, A. and Regev, K. and Karni, A. and Schmitz-Hübsch, T. and Paul, F. and Devos, H. and Sosnoff, J.J. and Tamir, R. and Shimoni, N. and Hausdorff, J.M.
Multiple Sclerosis and Related Disorders 68 : 104108. 2 September 2022

OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS.
Chen, J.J. and Sotirchos, E.S. and Henderson, A.D. and Vasileiou, E.S. and Flanagan, E.P. and Bhatti, M.T. and Jamali, S. and Eggenberger, E.R. and Dinome, M. and Frohman, L.P. and Arnold, A.C. and Bonelli, L. and Seleme, N. and Mejia-Vergara, A.J. and Moss, H.E. and Padungkiatsagul, T. and Stiebel-Kalish, H. and Lotan, I. and Hellmann, M.A. and Hodge, D. and Oertel, F.C. and Paul, F. and Saidha, S. and Calabresi, P.A. and Pittock, S.J.
Multiple Sclerosis and Related Disorders 58 : 103525. February 2022

Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: evaluation of 794 attacks from a nationwide registry in Argentina.
Carnero Contentti, E. and Lopez, P.A. and Pettinicchi, J.P. and Criniti, J. and Pappolla, A. and Miguez, J. and Patrucco, L. and Cristiano, E. and Liwacki, S. and Tkachuk, V. and Balbuena, M.E. and Vrech, C. and Deri, N. and Correale, J. and Marrodan, M. and Ysrraelit, M.C. and Leguizamon, F. and Luetic, G. and Menichini, M.L. and Tavolini, D. and Mainella, C. and Zanga, G. and Burgos, M. and Hryb, J. and Barboza, A. and Lazaro, L. and Alonso, R. and Fernández Liguori, N. and Nadur, D. and Chercoff, A. and Alonso Serena, M. and Caride, A. and Paul, F. and Rojas, J.I.
Multiple Sclerosis and Related Disorders 58 : 103466. February 2022

AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
Marignier, R. and Pittock, S.J. and Paul, F. and Kim, H.J. and Bennett, J. L. and Weinshenker, B.G. and Wingerchuk, D.M. and Green, A.J. and Fujihara, K. and Cutter, G. and Aktas, O. and Hartung, H.P. and Drappa, J. and Ratchford, J.N. and She, D. and Smith, M. and Rees, W. and Cimbora, D. and Katz, E. and Cree, B.A.C.
Multiple Sclerosis and Related Disorders 57 : 103356. January 2022

Characteristics of secondary progressive multiple sclerosis: disease activity and provision of care in Germany - a registry-based/multicentric cohort study.
Frahm, N. and Ellenberger, D. and Fneish, F. and Christoph, K. and Warnke, C. and Zettl, U.K. and Paul, F. and Rauser, B. and Stahmann, A. and Vogelmann, V. and Flachenecker, P.
Multiple Sclerosis and Related Disorders 56 : 103281. November 2021

The Asian and African/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residence.
Soares-dos-Reis, R. and Tsz-Ching, J.L. and Kim, S.H. and Jacob, A. and Whittam, D. and Berthelot, E. and Paul, F. and Nakashima, I. and Tye, J.S.N. and De Seze, J. and Jitprapaikulsan, J. and Tan, K. and Yang, L. and Elsone, L. and Leite, M.I. and Mealy, M.A. and Levy, M. and Fan, M. and Siebert, N. and Asgari, N. and Cabre, P. and Siritho, S. and Pittock, S.J. and Wing-Ho, S.C. and Senger, T. and Yeo, T. and Takai, Y. and Pandit, L. and Kim, H.J. and Palace, J.
Multiple Sclerosis and Related Disorders 53 : 103080. August 2021

Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration.
Ellenberger, D. and Flachenecker, P. and Haas, J. and Hellwig, K. and Paul, F. and Stahmann, A. and Warnke, C. and Zettl, U.K. and Rommer, P.S.
Multiple Sclerosis and Related Disorders 46 : 102485. November 2020

Ventral posterior nucleus volume is associated with neuropathic pain intensity in neuromyelitis optica spectrum disorders.
Asseyer, S. and Kuchling, J. and Gaetano, L. and Komnenić, D. and Siebert, N. and Chien, C. and Scheel, M. and Oertel, F.C. and Ruprecht, K. and Bellmann-Strobl, J. and Finke, C. and Chakravarty, M.M. and Magon, S. and Wuerfel, J. and Paul, F. and Papadopoulou, A. and Brandt, A.U.
Multiple Sclerosis and Related Disorders 46 : 102579. November 2020

Visual system damage and network maladaptation are associated with cognitive performance in neuromyelitis optica spectrum disorders.
Chavarro, V.S. and Bellmann-Strobl, J. and Zimmermann, H.G. and Scheel, M. and Chien, C. and Oertel, F.C. and Weygandt, M. and Ruprecht, K. and Paul, F. and Finke, C. and Brandt, A.U.
Multiple Sclerosis and Related Disorders 45 : 102406. October 2020

Treatment of MOG-IgG-associated disorder with rituximab: an international study of 121 patients.
Whittam, D.H. and Cobo-Calvo, A. and Lopez-Chiriboga, A.S. and Pardo, S. and Gornall, M. and Cicconi, S. and Brandt, A. and Berek, K. and Berger, T. and Jelcic, I. and Gombolay, G. and Oliveira, L.M. and Callegaro, D. and Kaneko, K. and Misu, T. and Capobianco, M. and Gibbons, E. and Karthikeayan, V. and Brochet, B. and Audoin, B. and Mathey, G. and Laplaud, D. and Thouvenot, E. and Cohen, M. and Tourbah, A. and Maillart, E. and Ciron, J. and Deschamps, R. and Biotti, D. and Rostasy, K. and Neuteboom, R. and Hemingway, C. and Forsyth, R. and Matiello, M. and Webb, S. and Hunt, D. and Murray, K. and Hacohen, Y. and Lim, M. and Leite, M.I. and Palace, J. and Solomon, T. and Lutterotti, A. and Fujihara, K. and Nakashima, I. and Bennett, J.L. and Pandit, L. and Chitnis, T. and Weinshenker, B.G. and Wildemann, B. and Sato, D.K. and Kim, S.H. and Huda, S. and Kim, H.J. and Reindl, M. and Levy, M. and Jarius, S. and Tenembaum, S. and Paul, F. and Pittock, S. and Marignier, R. and Jacob, A.
Multiple Sclerosis and Related Disorders 44 : 102251. September 2020

Longitudinal ultra-high field MRI of brain lesions in neuromyelitis optica spectrum disorders.
Chawla, S. and Ge, Y. and Wuerfel, J. and Asadollahi, S. and Mohan, S. and Paul, F. and Sinnecker, T. and Kister, I.
Multiple Sclerosis and Related Disorders 42 : 102066. July 2020

Diagnostic procedures in suspected attacks in patients with neuromyelitis optica spectrum disorders: results of an international survey.
D'Souza, M. and Papadopoulou, A. and Levy, M. and Jacob, A. and Yeaman, M.R. and Kümpfel, T. and Marignier, R. and Paul, F. and Brandt, A.U.
Multiple Sclerosis and Related Disorders 41 : 102027. June 2020

Prodromal headache in MOG-antibody positive optic neuritis.
Asseyer, S. and Hamblin, J. and Messina, S. and Mariano, R. and Siebert, N. and Everett, R. and Küker, W. and Bellmann-Strobl, J. and Ruprecht, K. and Jarius, S. and Leite, M.I. and Brandt, A. and Paul, F. and Palace, J.
Multiple Sclerosis and Related Disorders 40 : 101965. May 2020

Neural mechanisms of perceptual decision-making and their link to neuropsychiatric symptoms in multiple sclerosis.
Weygandt, M. and Behrens, J. and Brasanac, J. and Söder, E. and Meyer-Arndt, L. and Wakonig, K. and Ritter, K. and Brandt, A.U. and Bellmann-Strobl, J. and Gold, S.M. and Haynes, J.D. and Paul, F.
Multiple Sclerosis and Related Disorders 33 : 139-145. August 2019

Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.
Mealy, M.A. and Mossburg, S.E. and Kim, S.H. and Messina, S. and Borisow, N. and Lopez-Gonzalez, R. and Ospina, J.P. and Scheel, M. and Yeshokumar, A.K. and Awad, A. and Leite, M.I. and Arango, J.A.J. and Paul, F. and Palace, J. and Kim, H.J. and Levy, M.
Multiple Sclerosis and Related Disorders 28 : 64-68. February 2019

MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder.
Narayan, R. and Simpson, A. and Fritsche, K. and Salama, S. and Pardo, S. and Mealy, M. and Paul, F. and Levy, M.
Multiple Sclerosis and Related Disorders 25 : 66-72. October 2018

Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder.
Mealy, M.A. and Cook, L.J. and Pache, F. and Velez, D.L. and Borisow, N. and Becker, D. and Jimenez Arango, J.A. and Paul, F. and Levy, M.
Multiple Sclerosis and Related Disorders 23 : 78-82. July 2018

Frequent retinal ganglion cell damage after acute optic neuritis.
Brandt, A.U. and Specovius, S. and Oberwahrenbrock, T. and Zimmermann, H.G. and Paul, F. and Costello, F.
Multiple Sclerosis and Related Disorders 22 : 141-147. May 2018

Magnetic resonance imaging findings at the first episode of acute optic neuritis.
Soelberg, K. and Skejoe, H.P.B. and Grauslund, J. and Smith, T.J. and Lillevang, S.T. and Jarius, S. and Wildemann, B. and Paul, F. and Asgari, N.
Multiple Sclerosis and Related Disorders 20 : 30-36. February 2018

What should a person with relapsing-remitting multiple sclerosis know? - Focus group and survey data of a risk knowledge questionnaire (RIKNO 2.0).
Heesen, C. and Pöttgen, J. and Rahn, A.C. and Liethmann, K. and Kasper, J. and Vahter, L. and Drulovic, J. and Van Nunen, A. and Wilkie, D. and Beckmann, Y. and Paul, F. and Köpke, S. and Giordano, A. and Solari, A.
Multiple Sclerosis and Related Disorders 18 : 186-195. November 2017

Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: a multicenter cohort study.
Kessler, R.A. and Mealy, M.A. and Jimenez-Arango, J.A. and Quan, C. and Paul, F. and López, R. and Hopkins, S. and Levy, M.
Multiple Sclerosis and Related Disorders 17 : 198-201. October 2017

Severe structural and functional visual system damage leads to profound loss of Vision-related quality of life in patients with neuromyelitis optica spectrum disorders.
Schmidt, F. and Zimmermann, H. and Mikolajczak, J. and Oertel, F.C. and Pache, F. and Weinhold, M. and Schinzel, J. and Bellmann-Strobl, J. and Ruprecht, K. and Paul, F. and Brandt, A.U.
Multiple Sclerosis and Related Disorders 11 : 45-50. January 2017

Nanomedicine: Nanotechnology, Biology and Medicine

Inflammation-induced brain endothelial activation leads to uptake of electrostatically stabilized iron oxide nanoparticles via sulfated glycosaminoglycans.
Berndt, D. and Millward, J.M. and Schnorr, J. and Taupitz, M. and Stangl, V. and Paul, F. and Wagner, S. and Wuerfel, J.T. and Sack, I. and Ludwig, A. and Infante-Duarte, C.
Nanomedicine: Nanotechnology, Biology and Medicine 13 (4): 1411-1421. May 2017

Nature Communications

Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases.
Wang, M. and Dehlinger, A. and Fernández Zapata, C. and Golan, M. and Gallaccio, G. and Sander, L.E. and Schlickeiser, S. and Kunkel, D. and Schmitz-Hübsch, T. and Sawitzki, B. and Karni, A. and Braun, J. and Loyal, L. and Thiel, A. and Bellmann-Strobl, J. and Paul, F. and Meyer-Arndt, L. and Boettcher, C.
Nature Communications 14 (1): 7728. 25 November 2023

Differential compartmentalization of myeloid cell phenotypes and responses towards the CNS in Alzheimer's disease.
Fernández Zapata, C. and Giacomello, G. and Spruth, E.J. and Middeldorp, J. and Gallaccio, G. and Dehlinger, A. and Dames, C. and Leman, J.K.H. and van Dijk, R.E. and Meisel, A. and Schlickeiser, S. and Kunkel, D. and Hol, E.M. and Paul, F. and Parr, M.K. and Priller, J. and Böttcher, C.
Nature Communications 13 (1): 7210. 23 November 2022

A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.
Kedor, C. and Freitag, H. and Meyer-Arndt, L. and Wittke, K. and Hanitsch, L.G. and Zoller, T. and Steinbeis, F. and Haffke, M. and Rudolf, G. and Heidecker, B. and Bobbert, T. and Spranger, J. and Volk, H.D. and Skurk, C. and Konietschke, F. and Paul, F. and Behrends, U. and Bellmann-Strobl, J. and Scheibenbogen, C.
Nature Communications 13 (1): 5104. 30 August 2022

Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica.
Agasing, A.M. and Wu, Q. and Khatri, B. and Borisow, N. and Ruprecht, K. and Brandt, A.U. and Gawde, S. and Kumar, G. and Quinn, J.L. and Ko, R.M. and Mao-Draayer, Y. and Lessard, C.J. and Paul, F. and Axtell, R.C.
Nature Communications 11 (1): 2856. 5 June 2020

Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation.
Starossom, S.C. and Campo Garcia, J. and Woelfle, T. and Romero-Suarez, S. and Olah, M. and Watanabe, F. and Cao, L. and Yeste, A. and Tukker, J.J. and Quintana, F.J. and Imitola, J. and Witzel, F. and Schmitz, D. and Morkel, M. and Paul, F. and Infante-Duarte, C. and Khoury, S.J.
Nature Communications 10 (1): 217. 15 January 2019

Nature Reviews Disease Primers

Neuromyelitis optica.
Jarius, S. and Paul, F. and Weinshenker, B.G. and Levy, M. and Kim, H.J. and Wildemann, B.
Nature Reviews Disease Primers 6 (1): 85. 22 October 2020

Nature Reviews Neurology

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.
Geraldes, R. and Ciccarelli, O. and Barkhof, F. and De Stefano, N. and Enzinger, C. and Filippi, M. and Hofer, M. and Paul, F. and Preziosa, P. and Rovira, A. and DeLuca, G.C. and Kappos, L. and Yousry, T. and Fazekas, F. and Frederiksen, J. and Gasperini, C. and Sastre-Garriga, J. and Evangelou, N. and Palace, J.
Nature Reviews Neurology 14 (4): 199-213. April 2018

Fatigue as a symptom or comorbidity of neurological diseases.
Penner, I.K. and Paul, F.
Nature Reviews Neurology 13 (11): 662-675. November 2017

The investigation of acute optic neuritis: a review and proposed protocol.
Petzold, A. and Wattjes, M.P. and Costello, F. and Flores-Rivera, J. and Fraser, C.L. and Fujihara, K. and Leavitt, J. and Marignier, R. and Paul, F. and Schippling, S. and Sindic, C. and Villoslada, P. and Weinshenker, B. and Plant, G.T.
Nature Reviews Neurology 10 (8): 447-458. August 2014

Characteristics of Susac syndrome: a review of all reported cases.
Dörr, J. and Krautwald, S. and Wildemann, B. and Jarius, S. and Ringelstein, M. and Duning, T. and Aktas, O. and Ringelstein, E.B. and Paul, F. and Kleffner, I.
Nature Reviews Neurology 9 (6): 307-316. June 2013

Nature and Science of Sleep

The first night effect in multiple sclerosis patients undergoing home-based polysomnography.
Veauthier, C. and Piper, S.K. and Gaede, G. and Penzel, T. and Paul, F.
Nature and Science of Sleep 10 : 337-344. 23 October 2018

Nervenarzt

Autoimmunenzephalitis - ein Update [Autoimmune encephalitis - an update].
Heine, J. and Duchow, A. and Rust, R. and Paul, F. and Prüß, H. and Finke, C.
Nervenarzt 94 (6): 525-537. June 2023

Differenzialdiagnostik autoimmun-entzündlicher Rückenmarkserkrankungen [Differential diagnostics of autoimmune inflammatory spinal cord diseases].
Oertel, F.C. and Scheel, M. and Chien, C. and Bischof, A. and Finke, C. and Paul, F.
Nervenarzt 92 (4): 293-306. April 2021

Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose : aktueller Stand und Empfehlungen in Deutschland [Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : current status and recommendations in Germany].
Bittner, S. and Engel, S. and Lange, C. and Weber, M.S. and Haghikia, A. and Luessi, F. and Korn, T. and Klotz, L. and Bayas, A. and Paul, F. and Heesen, C. and Stangel, M. and Wildemann, B. and Bergh, F.T. and Tackenberg, B. and Trebst, C. and Warnke, C. and Linker, R. and Kerschensteiner, M. and Zettl, U. and Tumani, H. and Brück, W. and Meuth, S.G. and Kümpfel, T. and Hemmer, B. and Wiendl, H. and Gold, R. and Zipp, F.
Nervenarzt 90 (12): 1245-1253. December 2019

MOG-Enzephalomyelitis: Internationale Empfehlungen zu Diagnose und Antikörpertestung [MOG encephalomyelitis: international recommendations on diagnosis and antibody testing].
Jarius, S. and Paul, F. and Aktas, O. and Asgari, N. and Dale, R.C. and de Seze, J. and Franciotta, D. and Fujihara, K. and Jacob, A. and Kim, H.J. and Kleiter, I. and Kümpfel, T. and Levy, M. and Palace, J. and Ruprecht, K. and Saiz, A. and Trebst, C. and Weinshenker, B.G. and Wildemann, B.
Nervenarzt 89 (12): 1388-1399. December 2018

Neuromyelitis-optica-Spektrum-Erkrankung und Schwangerschaft [Neuromyelitis optica spectrum disorder and pregnancy].
Borisow, N. and Hellwig, K. and Paul, F.
Nervenarzt 89 (6): 666-673. June 2018

Optische Kohaerenztomographie bei Neuromyelitis optica-Spektrum-Erkrankungen [Optical coherence tomography in neuromyelitis optica spectrum disorders].
Oertel, F.C. and Zimmermann, H. and Brandt, A.U. and Paul, F.
Nervenarzt 88 (12): 1411-1420. December 2017

Therapie der Fatigue bei Multipler Sklerose: Ein Behandlungsalgorithmus [Therapy of fatigue in multiple sclerosis : a treatment algorithm].
Veauthier, C. and Paul, F.
Nervenarzt 87 (12): 1310-1321. December 2016

Monitoring von Blutparametern unter verlaufsmodifizierender MS-Therapie : Substanzspezifische Relevanz und aktuelle Handlungsempfehlungen [Monitoring of blood parameters under course-modified MS therapy : substance-specific relevance and current recommendations for action].
Klotz, L. and Berthele, A. and Brück, W. and Chan, A. and Flachenecker, P. and Gold, R. and Haghikia, A. and Hellwig, K. and Hemmer, B. and Hohlfeld, R. and Korn, T. and Kümpfel, T. and Lang, M. and Limmroth, V. and Linker, R.A. and Meier, U. and Meuth, S.G. and Paul, F. and Salmen, A. and Stangel, M. and Tackenberg, B. and Tumani, H. and Warnke, C. and Weber, M.S. and Ziemssen, T. and Zipp, F. and Wiendl, H.
Nervenarzt 87 (6): 645-659. June 2016

Current immunotherapy of multiple sclerosis [Aktuelle Immuntherapie der Multiplen Sklerose].
Paul, F. and Ruprecht, K.
Nervenarzt 86 (8): 1031-1044. August 2015

Ultrahochfeld-MRT im Kontext neurologischer Erkrankungen [Ultrahigh field MRI in context of neurological diseases].
Kuchling, J. and Sinnecker, T. and Bozin, I. and Dörr, J. and Madai, V.I. and Sobesky, J. and Niendorf, T. and Paul, F. and Wuerfel, J.
Nervenarzt 85 (4): 445-458. April 2014

Diagnostik und Verlaufsbeurteilung der Multiplen Sklerose: Stellenwert der optischen Kohaerenztomographie [Diagnosis and monitoring of multiple sclerosis: the value of optical coherence tomography].
Bock, M. and Paul, F. and Dörr, J.
Nervenarzt 84 (4): 483-492. April 2013

Neuromyelitis optica.
Wildemann, B. and Jarius, S. and Paul, F.
Nervenarzt 84 (4): 436-441. April 2013

Therapieoptionen bei immunvermittelten Enzephalomyelitiden [Therapeutic options for autoimmune encephalomyelitis].
Borisow, N. and Prüss, H. and Paul, F.
Nervenarzt 84 (4): 461-465. April 2013

Vitamin D und Multiple Sklerose: Der Stellenwert fuer das Erkrankungsrisiko und die Behandlung [Vitamin D and multiple sclerosis: the role for risk of disease and treatment].
Döring, A. and Paul, F. and Dörr, J.
Nervenarzt 84 (2): 173-189. February 2013

Susac-Syndrom: Eine interdisziplinaere Herausforderung [Susac syndrome: an interdisciplinary challenge].
Doerr, J. and Jarius, S. and Wildemann, B. and Ringelstein, E.B. and Schwindt, W. and Deppe, M. and Wandinger, K.P. and Promesberger, J. and Paul, F. and Kleffner, I.
Nervenarzt 82 (10): 1250-1263. October 2011

Diagnostik und Therapie der Neuromyelitis optica: Konsensusempfehlungen der Neuromyelitis optica Studiengruppe [Diagnosis and treatment of neuromyelitis optica: Consensus recommendations of the Neuromyelitis Optica Study Group].
Trebst, C. and Berthele, A. and Jarius, S. and Kuempfel, T. and Schippling, S. and Wildemann, B. and Wilke, C.
Nervenarzt 82 (6): 768-777. June 2011

Flupirtine add-on to IFN β-1b in RRMS.
Paul, F. and Doerr, J.M.
Nervenarzt 81 (Suppl 1): 28-29. October 2010

Nervenheilkunde

Multiple Sklerose - klinisch relevante Themen.
Paul, F.
Nervenheilkunde 30 (7): 461-462. 2011

Optische Kohaerenztomografie in der Multiplen Sklerose.
Woelbert, M. and Brandt, A.U. and Paul, F. and Schippling, S.
Nervenheilkunde 30 (7): 493-497. 2011

NeuroImage

Conduction delays in the visual pathways of progressive multiple sclerosis patients covary with brain structure.
Berman, S. and Backner, Y. and Krupnik, R. and Paul, F. and Petrou, P. and Karussis, D. and Levin, N. and Mezer, A.A.
NeuroImage 221 : 117204. 1 November 2020

Power estimation for non-standardized multisite studies.
Keshavan, A. and Paul, F. and Beyer, M.K. and Zhu, A.H. and Papinutto, N. and Shinohara, R.T. and Stern, W. and Amann, M. and Bakshi, R. and Bischof, A. and Carriero, A. and Comabella, M. and Crane, J.C. and D'Alfonso, S. and Demaerel, P. and Dubois, B. and Filippi, M. and Fleischer, V. and Fontaine, B. and Gaetano, L. and Goris, A. and Graetz, C. and Gröger, A. and Groppa, S. and Hafler, D.A. and Harbo, H.F. and Hemmer, B. and Jordan, K. and Kappos, L. and Kirkish, G. and Llufriu, S. and Magon, S. and Martinelli-Boneschi, F. and McCauley, J. and Montalban, X. and Muhlau, M. and Pelletier, D. and Pattany, P.M. and Pericak-Vance, M. and Rebeix, I. and Rocca, M. and Rovira, A. and Schlaeger, R. and Saiz, A. and Sprenger, T. and Stecco, A. and Uitdehaag, B.M.J. and Villoslada, P. and Wattjes, M.P. and Weiner, H. and Wuerfel, J. and Zimmer, C. and Zipp, F. and Hauser, S. and Oksenberg, J.R. and Henry, R.G.
NeuroImage 134 : 281-294. 1 July 2016

Multi-scale classification of disease using structural MRI and wavelet transform.
Hackmack, K. and Paul, F. and Weygandt, M. and Allefeld, C. and Haynes, J.D.
NeuroImage 62 (1): 48-58. 1 August 2012

MR-elastography reveals degradation of tissue integrity in multiple sclerosis.
Wuerfel, J. and Paul, F. and Beierbach, B. and Hamhaber, U. and Klatt, D. and Papazoglou, S. and Zipp, F. and Martus, P. and Braun, J. and Sack, I.
NeuroImage 49 (3): 2520-2525. 1 February 2010

NeuroImage: Clinical

Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: a longitudinal multicenter study.
Rise, H.H. and Brune, S. and Chien, C. and Berge, T. and Bos, S.D. and Andorrà, M. and Valdeolivas, I.P. and Beyer, M.K. and Sowa, P. and Scheel, M. and Brandt, A.U. and Asseyer, S. and Blennow, K. and Pedersen, M.L. and Zetterberg, H. and de Schotten, M.T. and Cellerino, M. and Uccelli, A. and Paul, F. and Villoslada, P. and Harbo, H.F. and Westlye, L.T. and Høgestøl, E.A.
NeuroImage: Clinical 35 : 103099. 28 June 2022

Functional connectivity dynamics reflect disability and multi-domain clinical impairment in patients with relapsing-remitting multiple sclerosis.
Romanello, A. and Krohn, S. and von Schwanenflug, N. and Chien, C. and Bellmann-Strobl, J. and Ruprecht, K. and Paul, F. and Finke, C.
NeuroImage: Clinical 36 : 103203. 2022

Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: a longitudinal study.
Papadopoulou, A. and Oertel, F.C. and Chien, C. and Kuchling, J. and Zimmermann, H.G. and Siebert, N. and Motamedi, S. and D'Souza, M. and Asseyer, S. and Bellmann-Strobl, J. and Ruprecht, K. and Chakravarty, M.M. and Scheel, M. and Magon, S. and Wuerfel, J. and Paul, F. and Brandt, A.U.
NeuroImage: Clinical 30 : 102608. 4 March 2021

Transdiagnostic hippocampal damage patterns in neuroimmunological disorders.
Heine, J. and Prüß, H. and Scheel, M. and Brandt, A.U. and Gold, S.M. and Bartsch, T. and Paul, F. and Finke, C.
NeuroImage: Clinical 28 : 102515. 2020

Uncovering convolutional neural network decisions for diagnosing multiple sclerosis on conventional MRI using layer-wise relevance propagation.
Eitel, F. and Soehler, E. and Bellmann-Strobl, J. and Brandt, A.U. and Ruprecht, K. and Giess, R.M. and Kuchling, J. and Asseyer, S. and Weygandt, M. and Haynes, J.D. and Scheel, M. and Paul, F. and Ritter, K.
NeuroImage: Clinical 24 : 102003. 6 September 2019

Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.
Kuchling, J. and Backner, Y. and Oertel, F.C. and Raz, N. and Bellmann-Strobl, J. and Ruprecht, K. and Paul, F. and Levin, N. and Brandt, A.U. and Scheel, M.
NeuroImage: Clinical 19 : 538-550. 8 May 2018

Cerebral magnetic resonance elastography in supranuclear palsy and idiopathic Parkinson's disease.
Lipp, A. and Trbojevic, R. and Paul, F. and Fehlner, A. and Hirsch, S. and Scheel, M. and Noack, C. and Braun, J. and Sack, I.
NeuroImage: Clinical 3 : 381-387. 20 September 2013

Magnetic resonance elastography reveals altered brain viscoelasticity in experimental autoimmune encephalomyelitis.
Riek, K. and Millward, J.M. and Hamann, I. and Mueller, S. and Pfueller, C.F. and Paul, F. and Braun, J. and Infante-Duarte, C. and Sack, I.
NeuroImage: Clinical 1 (1): 81-90. 12 November 2012

Neurobiology of Stress

Blunted neural and psychological stress processing predicts future grey matter atrophy in multiple sclerosis.
Meyer-Arndt, L. and Hetzer, S. and Asseyer, S. and Bellmann-Strobl, J. and Scheel, M. and Stellmann, J.Pa. and Heesen, C. and Engel, A.K. and Brandt, A.U. and Haynes, J.D. and Paul, F. and Gold, S.M. and Weygandt, M.
Neurobiology of Stress 13 : 100244. November 2020

Neurochemistry International

Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses.
Sellner, J. and Cepok, S. and Kalluri, S.R. and Nestler, A. and Kleiter, I. and Kuempfel, T. and Linker, R. and Melms, A. and Menge, T. and Tumani, H. and Paul, F. and Hemmer, B. and Berthele, A.
Neurochemistry International 57 (6): 662-667. November 2010

Neurodegenerative Disease Management

Effect of nabiximols on goal attainment scale scores in patients with treatment-resistant multiple sclerosis spasticity.
Paul, F. and Silván, C.V.
Neurodegenerative Disease Management 11 (2): 143-153. 1 March 2021

Satralizumab in the treatment of neuromyelitis optica spectrum disorder.
Duchow, A. and Bellmann-Strobl, J.
Neurodegenerative Disease Management 11 (1): 49-59. February 2021

Neurology

The role of optical coherence tomography criteria and machine learning in multiple sclerosis and optic neuritis diagnosis.
Kenney, R.C. and Liu, M. and Hasanaj, L. and Joseph, B. and Al-Hassan, A.A. and Balk, L.J. and Behbehani, R. and Brandt, A. and Calabresi, P.A. and Frohman, E. and Frohman, T.C. and Havla, J. and Hemmer, B. and Jiang, H. and Knier, B. and Korn, T. and Leocani, L. and Martinez-Lapiscina, E.H. and Papadopoulou, A. and Paul, F. and Petzold, A. and Pisa, M. and Villoslada, P. and Zimmermann, H. and Thorpe, L.E. and Ishikawa, H. and Schuman, J.S. and Wollstein, G. and Chen, Y. and Saidha, S. and Galetta, S. and Balcer, L.J.
Neurology 99 (11): e1100-e1112. 13 September 2022

Costs and health-related quality of life in patients with NMO spectrum disorders and MOG-antibody-associated disease: CHANCE(NMO) study.
Hümmert, M.W. and Schöppe, L.M. and Bellmann-Strobl, J. and Siebert, N. and Paul, F. and Duchow, A. and Pellkofer, H. and Kümpfel, T. and Havla, J. and Jarius, S. and Wildemann, B. and Berthele, A. and Bergh, F.T. and Pawlitzki, M. and Klotz, L. and Kleiter, I. and Stangel, M. and Gingele, S. and Weber, M.S. and Faiss, J.H. and Pul, R. and Walter, A. and Zettl, U. and Senel, M. and Stellmann, J.P. and Häußler, V. and Hellwig, K. and Ayzenberg, I. and Aktas, O. and Ringelstein, M. and Schreiber-Katz, O. and Trebst, C.
Neurology 98 (11): e1184-e1196. 15 March 2022

APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies.
Aytulun, A. and Cruz-Herranz, A. and Aktas, O. and Balcer, L.J. and Balk, L. and Barboni, P. and Blanco, A.A. and Calabresi, P.A. and Costello, F. and Sanchez-Dalmau, B. and DeBuc, D.C. and Feltgen, N. and Finger, R.P. and Frederiksen, J.L. and Frohman, E. and Frohman, T. and Garway-Heath, D. and Gabilondo, I. and Graves, J.S. and Green, A.J. and Hartung, H.P. and Havla, J. and Holz, F.G. and Imitola, J. and Kenney, R. and Klistorner, A. and Knier, B. and Korn, T. and Kolbe, S. and Krämer, J. and Lagrèze, W.A. and Leocani, L. and Maier, O. and Martínez-Lapiscina, E.H. and Meuth, S. and Outteryck, O. and Paul, F. and Petzold, A. and Pihl-Jensen, G. and Preiningerova, J.L. and Rebolleda, G. and Ringelstein, M. and Saidha, S. and Schippling, S. and Schuman, J.S. and Sergott, R.C. and Toosy, A. and Villoslada, P. and Wolf, S. and Yeh, E.A. and Yu-Wai-Man, P. and Zimmermann, H.G. and Brandt, A.U. and Albrecht, P.
Neurology 97 (2): 68-79. 13 July 2021

Wisdom of the expert crowd prediction of response for 3 neurology randomized trials.
Atanasov, P. and Diamantaras, A. and MacPherson, A. and Vinarov, E. and Benjamin, D.M. and Shrier, I. and Paul, F. and Dirnagl, U. and Kimmelman, J.
Neurology 95 (5): e488-e498. 4 August 2020

Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.
Ringelstein, M. and Harmel, J. and Zimmermann, H. and Brandt, A.U. and Paul, F. and Haarmann, A. and Buttmann, M. and Hümmert, M.W. and Trebst, C. and Schroeder, C. and Ayzenberg, I. and Kleiter, I. and Hellwig, K. and Havla, J. and Kümpfel, T. and Jarius, S. and Wildemann, B. and Rommer, P. and Weber, M.S. and Pellkofer, H. and Röpke, L. and Geis, C. and Retzlaff, N. and Zettl, U. and Deppe, M. and Klotz, L. and Young, K. and Stellmann, J.P. and Kaste, M. and Kermer, P. and Marouf, W. and Lauda, F. and Tumani, H. and Graf, J. and Klistorner, A. and Hartung, H.P. and Aktas, O. and Albrecht, P.
Neurology 94 (4): e407-e418. 28 January 2020

Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
Pfuhl, C. and Grittner, U. and Gieß, R.M. and Scheel, M. and Behrens, J.R. and Rasche, L. and Pache, F.C. and Wenzel, R. and Brandt, A.U. and Bellmann-Strobl, J. and Paul, F. and Ruprecht, K. and Oechtering, J.
Neurology 93 (15): e1439-e1451. 8 October 2019

Damage of the lateral geniculate nucleus in MS: assessing the missing node of the visual pathway.
Papadopoulou, A. and Gaetano, L. and Pfister, A. and Altermatt, A. and Tsagkas, C. and Morency, F. and Brandt, A.U. and Hardmeier, M. and Chakravarty, M.M. and Descoteaux, M. and Kappos, L. and Sprenger, T. and Magon, S.
Neurology 92 (19): e2240-e2249. 7 May 2019

Racial differences in neuromyelitis optica spectrum disorder.
Kim, S.H. and Mealy, M.A. and Levy, M. and Schmidt, F. and Ruprecht, K. and Paul, F. and Ringelstein, M. and Aktas, O. and Hartung, H.P. and Asgari, N. and Tsz-Ching, J.L. and Siritho, S. and Prayoonwiwat, N. and Shin, H.J. and Hyun, J.W. and Han, M. and Leite, M.I. and Palace, J. and Kim, H.J.
Neurology 91 (22): e2089-e2099. 27 November 2018

Venoplasty in MS: therapeutic intervention without any evidence.
Paul, F. and Wattjes, M.P.
Neurology 91 (18): 815-816. 30 October 2018

High risk of postpartum relapses in neuromyelitis optica spectrum disorder.
Klawiter, E.C. and Bove, R. and Elsone, L. and Alvarez, E. and Borisow, N. and Cortez, M. and Mateen, F. and Mealy, M.A. and Sorum, J. and Mutch, K. and Tobyne, S.M. and Ruprecht, K. and Buckle, G. and Levy, M. and Wingerchuk, D. and Paul, F. and Cross, A.H. and Jacobs, A. and Chitnis, T. and Weinshenker, B.
Neurology 89 (22): 2238-2244. 28 November 2017

The APOSTEL recommendations for reporting quantitative optical coherence tomography studies.
Cruz-Herranz, A. and Balk, L.J. and Oberwahrenbrock, T. and Saidha, S. and Martinez-Lapiscina, E.H. and Lagreze, W.A. and Schuman, J.S. and Villoslada, P. and Calabresi, P. and Balcer, L. and Petzold, A. and Green, A.J. and Paul, F. and Brandt, A.U. and Albrecht, P.
Neurology 86 (24): 2303-2309. 14 June 2016

Iridodonesis as a cause of recurrent vertigo.
Kunte, H. and Paul, F. and Pache, F. and Doerr, J. and Bellmann-Strobl, J. and Harms, L. and Kronenberg, G.
Neurology 85 (15): 1353. 13 October 2015

Retinal pathology in Susac syndrome detected by spectral-domain optical coherence tomography.
Ringelstein, M. and Albrecht, P. and Kleffner, I. and Bühn, B. and Harmel, J. and Müller, A.K. and Finis, D. and Guthoff, R. and Bergholz, R. and Duning, T. and Krämer, M. and Paul, F. and Brandt, A. and Oberwahrenbrock, T. and Mikolajczak, J. and Wildemann, B. and Jarius, S. and Hartung, H.P. and Aktas, O. and Dörr, J.
Neurology 85 (7): 610-618. 18 August 2015

Retinal pathology in idiopathic moyamoya angiopathy detected by optical coherence tomography.
Albrecht, P. and Blasberg, C. and Lukas, S. and Ringelstein, M. and Müller, A.K. and Harmel, J. and Kadas, E.M. and Finis, D. and Guthoff, R. and Aktas, O. and Hartung, H.P. and Paul, F. and Brandt, A.U. and Berlit, P. and Methner, A. and Kraemer, M.
Neurology 85 (6): 521-527. 11 August 2015

Pushing the boundaries of neuromyelitis optica: Does antibody make the disease?
Kister, I. and Paul, F.
Neurology 85 (2): 118-119. 14 July 2015

MRI characteristics of neuromyelitis optica spectrum disorder: An international update.
Kim, H.J. and Paul, F. and Lana-Peixoto, M.A. and Tenembaum, S. and Asgari, N. and Palace, J. and Klawiter, E.C. and Sato, D.K. and de Seze, J. and Wuerfel, J. and Banwell, B.L. and Villoslada, P. and Saiz, A. and Fujihara, K. and Kim, S.H.
Neurology 84 (11): 1165-1173. 17 March 2015

Dynamic formation of macular microcysts independent of vitreous traction changes.
Brandt, A.U. and Oberwahrenbrock, T. and Kadas, E.M. and Lagrèze, W.A. and Paul, F.
Neurology 83 (1): 73-77. 1 July 2014

T-cell homeostasis in pediatric multiple sclerosis: old cells in young patients.
Balint, B. and Haas, J. and Schwarz, A. and Jarius, S. and Fürwentsches, A. and Engelhardt, K. and Bussmann, C. and Ebinger, F. and Fritzsching, B. and Paul, F. and Seidel, U. and Vlaho, S. and Huppke, P. and Gärtner, J. and Wildemann, B.
Neurology 81 (9): 784-792. 27 August 2013

Bilateral vertebral artery dissection, agenesis of both ICAs, and connective tissue aberrations.
Lill, C.M. and Guenther-Kunkel, K. and Hoch, H. and Paul, F. and Grond-Ginsbach, C. and Hausser, I. and Zipp, F.
Neurology 80 (15): 1442-1443. 9 April 2013

Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.
Sinnecker, T. and Doerr, J. and Pfueller, C.F. and Harms, L. and Ruprecht, K. and Jarius, S. and Brueck, W. and Niendorf, T. and Wuerfel, J. and Paul, F.
Neurology 79 (7): 708-714. 14 August 2012

Venous drainage in multiple sclerosis: A combined MRI and ultrasound study.
Doepp, F. and Wuerfel, J.T. and Pfueller, C.F. and Valdueza, J.M. and Petersen, D. and Paul, F. and Schreiber, S.J.
Neurology 77 (19): 1745-1751. 8 November 2011

Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis.
Bellmann-Strobl, J. and Wuerfel, J. and Aktas, O. and Doerr, J. and Wernecke, K.D. and Zipp, F. and Paul, F.
Neurology 73 (20): 1624-1627. 17 November 2009

Neurology Neuroimmunology & Neuroinflammation

Clinical characterization and ancillary tests in Susac syndrome: a systematic review.
Wilf-Yarkoni, A. and Zmira, O. and Tolkovsky, A. and Pflantzer, B. and Gofrit, S.G. and Kleffner, I. and Paul, F. and Dörr, J.
Neurology Neuroimmunology & Neuroinflammation 11 (3): e200209. May 2024

The OSCAR-MP consensus criteria for quality assessment of retinal optical coherence tomography angiography.
Wicklein, R. and Yam, C. and Noll, C. and Aly, L. and Banze, N. and Romahn, E.F. and Wolf, E. and Hemmer, B. and Oertel, F.C. and Zimmermann, H. and Albrecht, P. and Ringelstein, M. and Baumann, C. and Feucht, N. and Penkava, J. and Havla, J. and Gernert, J.A. and Mardin, C. and Vasileiou, E.S. and Van Der Walt, A. and Al-Louzi, O. and Cabello, S. and Vidal-Jordana, A. and Krämer, J. and Wiendl, H. and Preiningerova, J.L. and Ciccarelli, O. and Garcia-Martin, E. and Kana, V. and Calabresi, P.A. and Paul, F. and Saidha, S. and Petzold, A. and Toosy, A.T. and Knier, B.
Neurology Neuroimmunology & Neuroinflammation 10 (6): e200169. November 2023

International delphi consensus on the management of AQP4-IgG+ NMOSD: recommendations for eculizumab, inebilizumab, and satralizumab.
Paul, F. and Marignier, R. and Palace, J. and Arrambide, G. and Asgari, N. and Bennett, J.L. and Cree, B.A.C. and De Sèze, J. and Fujihara, K. and Kim, H.J. and Hornby, R. and Huda, S. and Kissani, N. and Kleiter, I. and Kuwabara, S. and Lana-Peixoto, M. and Law, L. and Leite, M.I. and Pandit, L. and Pittock, S.J. and Quan, C. and Ramanathan, S. and Rotstein, D. and Saiz, A. and Sato, D.K. and Vaknin-Dembinsky, A.
Neurology Neuroimmunology & Neuroinflammation 10 (4): e200124. July 2023

Visually evoked potential as prognostic biomarker for neuroaxonal damage in multiple sclerosis from a multicenter longitudinal cohort.
Oertel, F.C. and Krämer, J. and Motamedi, S. and Keihani, A. and Zimmermann, H.G. and Dimitriou, N.G. and Condor-Montes, S. and Bereuter, C. and Cordano, C. and Abdelhak, A. and Trip, A. and Aktas, O. and Meuth, S.G. and Wiendl, H. and Ruprecht, K. and Bellmann-Strobl, J. and Paul, F. and Petzold, A. and Brandt, A.U. and Albrecht, P. and Green, A.J.
Neurology Neuroimmunology & Neuroinflammation 10 (3): e200092. May 2023

Effects of the COVID-19 pandemic on patients with NMO spectrum disorders and MOG-antibody-associated diseases: COPANMO(G)-Study.
Hümmert, M.W. and Bütow, F. and Tkachenko, D. and Ayzenberg, I. and Pakeerathan, T. and Hellwig, K. and Klotz, L. and Häußler, V. and Stellmann, J.P. and Warnke, C. and Goereci, Y. and Etgen, T. and Luessi, F. and Bronzlik, P. and Gingele, S. and Lauenstein, A.S. and Kleiter, I. and Rommer, P.S. and Paul, F. and Bellmann-Strobl, J. and Duchow, A. and Then Bergh, F. and Pul, R. and Walter, A. and Pellkofer, H. and Kümpfel, T. and Pompsch, M. and Kraemer, M. and Albrecht, P. and Aktas, O. and Ringelstein, M. and Senel, M. and Giglhuber, K. and Berthele, A. and Jarius, S. and Wildemann, B. and Trebst, C.
Neurology Neuroimmunology & Neuroinflammation 10 (2): e200082. March 2023

N2 year in review.
Dalmau, J. and Dalakas, M.C. and Kolson, D.L. and Paul, F. and Sánchez-Valle, R. and Zamvil, S.S.
Neurology Neuroimmunology & Neuroinflammation 10 (1): e200076. January 2023

Choroid plexus volume in multiple sclerosis vs neuromyelitis optica spectrum disorder: a retrospective, cross-sectional analysis.
Müller, J. and Sinnecker, T. and Wendebourg, M.J. and Schläger, R. and Kuhle, J. and Schädelin, S. and Benkert, P. and Derfuss, T. and Cattin, P. and Jud, C. and Spiess, F. and Amann, M. and Lincke, T. and Barakovic, M. and Cagol, A. and Tsagkas, C. and Parmar, K. and Pröbstel, A.K. and Reimann, S. and Asseyer, S. and Duchow, A. and Brandt, A. and Ruprecht, K. and Hadjikhani, N. and Fukumoto, S. and Watanabe, M. and Masaki, K. and Matsushita, T. and Isobe, N. and Kira, J.I. and Kappos, L. and Würfel, J. and Granziera, C. and Paul, F. and Yaldizli, Ö.
Neurology Neuroimmunology & Neuroinflammation 9 (3): e1147. May 2022

Efficacy and safety of masitinib in progressive forms of multiple sclerosis: a randomized, phase 3, clinical trial.
Vermersch, P. and Brieva-Ruiz, L. and Fox, R.J. and Paul, F. and Ramio-Torrenta, L. and Schwab, M. and Moussy, A. and Mansfield, C. and Hermine, O. and Maciejowski, M.
Neurology Neuroimmunology & Neuroinflammation 9 (3): e1148. May 2022

Leveraging visual outcome measures to advance therapy development in neuroimmunologic disorders.
Graves, J.S. and Oertel, F.C. and Van der Walt, A. and Collorone, S. and Sotirchos, E.S. and Pihl-Jensen, G. and Albrecht, P. and Yeh, E.A. and Saidha, S. and Frederiksen, J. and Newsome, S.D. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 9 (2): e1126. March 2022

Interleukin-6 receptor blockade in treatment-refractory MOG-IgG-associated disease and neuromyelitis optica spectrum disorders.
Ringelstein, M. and Ayzenberg, I. and Lindenblatt, G. and Fischer, K. and Gahlen, A. and Novi, G. and Hayward-Könnecke, H. and Schippling, S. and Rommer, P.S. and Kornek, B. and Zrzavy, T. and Biotti, D. and Ciron, J. and Audoin, B. and Berthele, A. and Giglhuber, K. and Zephir, H. and Kümpfel, T. and Berger, R. and Röther, J. and Häußler, V. and Stellmann, J.P. and Whittam, D. and Jacob, A. and Kraemer, M. and Gueguen, A. and Deschamps, R. and Bayas, A. and Hümmert, M.W. and Trebst, C. and Haarmann, A. and Jarius, S. and Wildemann, B. and Grothe, M. and Siebert, N. and Ruprecht, K. and Paul, F. and Collongues, N. and Marignier, R. and Levy, M. and Karenfort, M. and Deppe, M. and Albrecht, P. and Hellwig, K. and Gold, R. and Hartung, H.P. and Meuth, S.G. and Kleiter, I. and Aktas, O.
Neurology Neuroimmunology & Neuroinflammation 9 (1): e1100. January 2022

Retinal optical coherence tomography in neuromyelitis optica.
Oertel, F.C. and Specovius, S. and Zimmermann, H.G. and Chien, C. and Motamedi, S. and Bereuter, C. and Cook, L. and Lana Peixoto, M.A. and Fontanelle, M.A. and Kim, H.J. and Hyun, J.W. and Palace, J. and Roca-Fernandez, A. and Leite, M.I. and Sharma, S. and Ashtari, F. and Kafieh, R. and Dehghani, A. and Pourazizi, M. and Pandit, L. and D'Cunha, A. and Aktas, O. and Ringelstein, M. and Albrecht, P. and May, E. and Tongco, C. and Leocani, L. and Pisa, M. and Radaelli, M. and Martinez-Lapiscina, E.H. and Stiebel-Kalish, H. and Siritho, S. and de Seze, J. and Senger, T. and Havla, J. and Marignier, R. and Cobo-Calvo, A. and Bichuetti, D. and Tavares, I.M. and Asgari, N. and Soelberg, K. and Altintas, A. and Yildirim, R. and Tanriverdi, U. and Jacob, A. and Huda, S. and Rimler, Z. and Reid, A. and Mao-Draayer, Y. and Soto de Castillo, I. and Petzold, A. and Green, A.J. and Yeaman, M.R. and Smith, T. and Brandt, A.U. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 8 (6): e1068. November 2021

Increased serum neurofilament light and thin ganglion cell-inner plexiform layer are additive risk factors for disease activity in early multiple sclerosis.
Lin, T.Y. and Vitkova, V. and Asseyer, S. and Martorell Serra, I. and Motamedi, S. and Chien, C. and Ditzhaus, M. and Papadopoulou, A. and Benkert, P. and Kuhle, J. and Bellmann-Strobl, J. and Ruprecht, K. and Paul, F. and Brandt, A.U. and Zimmermann, H.G.
Neurology Neuroimmunology & Neuroinflammation 8 (5): e1051. September 2021

Disability outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
Marignier, R. and Bennett, J.L. and Kim, H.J. and Weinshenker, B.G. and Pittock, S.J. and Wingerchuk, D. and Fujihara, K. and Paul, F. and Cutter, G.R. and Green, A.J. and Aktas, O. and Hartung, H.P. and Lublin, F.D. and Williams, I.M. and Drappa, J. and She, D. and Cimbora, D. and Rees, W. and Smith, M. and Ratchford, J.N. and Katz, E. and Cree, B.A.C.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e978. May 2021

Epigallocatechin gallate in progressive MS: a randomized, placebo-controlled trial.
Rust, R. and Chien, C. and Scheel, M. and Brandt, A.U. and Dörr, J. and Wuerfel, J. and Klumbies, K. and Zimmermann, H. and Lorenz, M. and Wernecke, K.D. and Bellmann-Strobl, J. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e964. May 2021

Epigallocatechin gallate in relapsing-remitting multiple sclerosis: a randomized, placebo-controlled trial.
Bellmann-Strobl, J. and Paul, F. and Wuerfel, J. and Dörr, J. and Infante-Duarte, C. and Heidrich, E. and Körtgen, B. and Brandt, A. and Pfüller, C. and Radbruch, H. and Rust, R. and Siffrin, V. and Aktas, O. and Heesen, C. and Faiss, J. and Hoffmann, F. and Lorenz, M. and Zimmermann, B. and Groppa, S. and Wernecke, K.D. and Zipp, F.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e981. May 2021

Pain, depression, and quality of life in neuromyelitis optica spectrum disorder: a cross-sectional study of 166 AQP4 antibody-seropositive patients.
Ayzenberg, I. and Richter, D. and Henke, E. and Asseyer, S. and Paul, F. and Trebst, C. and Hümmert, M.W. and Havla, J. and Kümpfel, T. and Ringelstein, M. and Aktas, O. and Wildemann, B. and Jarius, S. and Häußler, V. and Stellmann, J.P. and Senel, M. and Klotz, L. and Pellkofer, H.L. and Weber, M.S. and Pawlitzki, M. and Rommer, P.S. and Berthele, A. and Wernecke, K.D. and Hellwig, K. and Gold, R. and Kleiter, I.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e985. May 2021

N2 year in review.
Dalmau, J. and Dalakas, M.C. and Kolson, D.L. and Paul, F. and Zamvil, S.S.
Neurology Neuroimmunology & Neuroinflammation 8 (1): e925. January 2021

Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders.
Motamedi, S. and Oertel, F.C. and Yadav, S.K. and Kadas, E.M. and Weise, M. and Havla, J. and Ringelstein, M. and Aktas, O. and Albrecht, P. and Ruprecht, K. and Bellmann-Strobl, J. and Zimmermann, H.G. and Paul, F. and Brandt, A.U.
Neurology Neuroimmunology & Neuroinflammation 7 (5): e805. September 2020

Genetic determinants of the humoral immune response in MS.
Gasperi, C. and Andlauer, T.F.M. and Keating, A. and Knier, B. and Klein, A. and Pernpeintner, V. and Lichtner, P. and Gold, R. and Zipp, F. and Then Bergh, F. and Stangel, M. and Tumani, H. and Wildemann, B. and Wiendl, H. and Bayas, A. and Kümpfel, T. and Zettl, U.K. and Linker, R.A. and Ziemann, U. and Knop, M. and Warnke, C. and Friese, M.A. and Paul, F. and Tackenberg, B. and Berthele, A. and Hemmer, B.
Neurology Neuroimmunology & Neuroinflammation 7 (5): e827. September 2020

Is APOE ε4 associated with cognitive performance in early MS?
Engel, S. and Graetz, C. and Salmen, A. and Muthuraman, M. and Toenges, G. and Ambrosius, B. and Bayas, A. and Berthele, A. and Heesen, C. and Klotz, L. and Kümpfel, T. and Linker, R.A. and Meuth, S.G. and Paul, F. and Stangel, M. and Tackenberg, B. and Then Bergh, F. and Tumani, H. and Weber, F. and Wildemann, B. and Zettl, U.K. and Antony, G. and Bittner, S. and Groppa, S. and Hemmer, B. and Wiendl, H. and Gold, R. and Zipp, F. and Lill, C.M. and Luessi, F.
Neurology Neuroimmunology & Neuroinflammation 7 (4): e728. July 2020

Cortical topological network changes following optic neuritis.
Backner, Y. and Ben-Shalom, I. and Kuchling, J. and Siebert, N. and Scheel, M. and Ruprecht, K. and Brandt, A. and Paul, F. and Levin, N.
Neurology Neuroimmunology & Neuroinflammation 7 (3): e687. May 2020

Impact of treatment on cellular immunophenotype in MS: a cross-sectional study.
Cellerino, M. and Ivaldi, F. and Pardini, M. and Rotta, G. and Vila, G. and Bäcker-Koduah, P. and Berge, T. and Laroni, A. and Lapucci, C. and Novi, G. and Boffa, G. and Sbragia, E. and Palmeri, S. and Asseyer, S. and Høgestøl, E. and Campi, C. and Piana, M. and Inglese, M. and Paul, F. and Harbo, H.F. and Villoslada, P. and Kerlero de Rosbo, N. and Uccelli, A.
Neurology Neuroimmunology & Neuroinflammation 7 (3): e693. May 2020

N2 year in review.
Dalmau, J. and Dalakas, M.C. and Kolson, D.L. and Paul, F. and Zamvil, S.S.
Neurology Neuroimmunology & Neuroinflammation 7 (1): e644. January 2020

Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD.
Cook, L.J. and Rose, J.W. and Alvey, J.S. and Jolley, A.M. and Kuhn, R. and Marron, B. and Pederson, M. and Enriquez, R. and Yearley, J. and McKechnie, S. and Han, M.H. and Tomczak, A.J. and Levy, M. and Mealy, M.A. and Coleman, J. and Bennett, J.L. and Johnson, R. and Barnes-Garcia, M. and Traboulsee, A.L. and Carruthers, R.L. and Lee, L.E. and Schubert, J.J. and McMullen, K. and Kister, I. and Rimler, Z. and Reid, A. and Sicotte, N.L. and Planchon, S.M. and Cohen, J.A. and Ivancic, D. and Sedlak, J.L. and Sand, I.K. and Repovic, P. and Amezcua, L. and Pruitt, A. and Amundson, E. and Chitnis, T. and Mullin, D.S. and Klawiter, E.C. and Russo, A.W. and Riley, C.S. and Onomichi, K.B. and Levine, L. and Nelson, K.E. and Nealon, N.M. and Engel, C. and Kruse-Hoyer, M. and Marcille, M. and Tornes, L. and Rumpf, A. and Greer, A. and Kenneally Behne, M. and Rodriguez, R.R. and Behne, D.W. and Blackway, D.W. and Coords, B. and Blaschke, T.F. and Sheard, J. and Smith, T.J. and Behne, J.M. and Yeaman, M.R.
Neurology Neuroimmunology & Neuroinflammation 6 (5): e583. September 2019

Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
Stiebel-Kalish, H. and Hellmann, M.A. and Mimouni, M. and Paul, F. and Bialer, O. and Bach, M. and Lotan, I.
Neurology Neuroimmunology & Neuroinflammation 6 (4): e572. July 2019

Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica.
Pasquier, B. and Borisow, N. and Rasche, L. and Bellmann-Strobl, J. and Ruprecht, K. and Niendorf, T. and Derfuss, T.J. and Wuerfel, J. and Paul, F. and Sinnecker, T.
Neurology Neuroimmunology & Neuroinflammation 6 (3): e541. May 2019

Gadolinium in human brain sections and colocalization with other elements.
El-Khatib, A.H. and Radbruch, H. and Trog, S. and Neumann, B. and Paul, F. and Koch, A. and Linscheid, M.W. and Jakubowski, N. and Schellenberger, E.
Neurology Neuroimmunology & Neuroinflammation 6 (1): e515. January 2019

N2 year in review and message from the editor to our reviewers.
Dalmau, J. and Kolson, D.L. and Paul, F. and Zamvil, S.S.
Neurology Neuroimmunology & Neuroinflammation 6 (1): e525. January 2019

Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions.
Kleiter, I. and Gahlen, A. and Borisow, N. and Fischer, K. and Wernecke, K.D. and Hellwig, K. and Pache, F. and Ruprecht, K. and Havla, J. and Kümpfel, T. and Aktas, O. and Hartung, H.P. and Ringelstein, M. and Geis, C. and Kleinschnitz, C. and Berthele, A. and Hemmer, B. and Angstwurm, K. and Stellmann, J.P. and Schuster, S. and Stangel, M. and Lauda, F. and Tumani, H. and Mayer, C. and Krumbholz, M. and Zeltner, L. and Ziemann, U. and Linker, R. and Schwab, M. and Marziniak, M. and Then Bergh, F. and Hofstadt-van Oy, U. and Neuhaus, O. and Zettl, U.K. and Faiss, J. and Wildemann, B. and Paul, F. and Jarius, S. and Trebst, C.
Neurology Neuroimmunology & Neuroinflammation 5 (6): e504. November 2018

Temporal visual resolution and disease severity in MS.
Ayadi, N. and Dörr, J. and Motamedi, S. and Gawlik, K. and Bellmann-Strobl, J. and Mikolajczak, J. and Brandt, A.U. and Zimmermann, H. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 5 (5): e492. 1 September 2018

VZV-associated acute retinal necrosis in a patient with MS treated with natalizumab.
Pawlitzki, M. and Teuber, J. and Campe, C. and Wagner, M. and Schuart, C. and Paul, F. and Bittner, D.
Neurology Neuroimmunology & Neuroinflammation 5 (5): e475. 1 September 2018

Multicenter reliability of semiautomatic retinal layer segmentation using OCT.
Oberwahrenbrock, T. and Traber, G.L. and Lukas, S. and Gabilondo, I. and Nolan, R. and Songster, C. and Balk, L. and Petzold, A. and Paul, F. and Villoslada, P. and Brandt, A.U. and Green, A.J. and Schippling, S.
Neurology Neuroimmunology & Neuroinflammation 5 (3): e449. 1 May 2018

Treatment choices and neuropsychological symptoms of a large cohort of early MS.
von Bismarck, O. and Dankowski, T. and Ambrosius, B. and Hessler, N. and Antony, Gi. and Ziegler, A. and Hoshi, M.M. and Aly, L. and Luessi, F. and Groppa, S. and Klotz, L. and Meuth, S.G. and Tackenberg, B. and Stoppe, M. and Then Bergh, F. and Tumani, H. and Kümpfel, T. and Stangel, M. and Heesen, C. and Wildemann, B. and Paul, F. and Bayas, A. and Warnke, C. and Weber, F. and Linker, R.A. and Ziemann, U. and Zettl, U.K. and Zipp, F. and Wiendl, H. and Hemmer, B. and Gold, R. and Salmen, A.
Neurology Neuroimmunology & Neuroinflammation 5 (3): e446. 1 May 2018

Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue.
Gaede, G. and Tiede, M. and Lorenz, I. and Brandt, A.U. and Pfueller, C. and Dörr, J. and Bellmann-Strobl, J. and Piper, S.K. and Roth, Y. and Zangen, A. and Schippling, S. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 5 (1): e423. 1 January 2018

Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder.
Asgari, N. and Flanagan, E.P. and Fujihara, K. and Kim, H.J. and Skejoe, H.P. and Wuerfel, J. and Kuroda, H. and Kim, S.H. and Maillart, E. and Marignier, R. and Pittock, S.J. and Paul, F. and Weinshenker, B.G.
Neurology Neuroimmunology & Neuroinflammation 4 (4): e343. July 2017

Olfactory dysfunction in patients with primary progressive MS.
Schmidt, F.A. and Maas, M.B. and Geran, R. and Schmidt, C. and Kunte, H. and Ruprecht, K. and Paul, F. and Göktas, Ö. and Harms, L.
Neurology Neuroimmunology & Neuroinflammation 4 (4): e369. July 2017

Contribution of blood vessels to retinal nerve fiber layer thickness in NMOSD.
Oertel, F.C. and Zimmermann, H. and Mikolajczak, J. and Weinhold, M. and Kadas, E.M. and Oberwahrenbrock, T. and Pache, F. and Bellmann-Strobl, J. and Ruprecht, K. and Paul, F. and Brandt, A.U.
Neurology Neuroimmunology & Neuroinflammation 4 (3): e338. May 2017

Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study.
Bove, R. and Elsone, L. and Alvarez, E. and Borisow, N. and Cortez, M.M. and Mateen, F.J. and Mealy, M.A. and Mutch, K. and Tobyne, S. and Ruprecht, K. and Buckle, G. and Levy, M. and Wingerchuk, D.M. and Paul, F. and Cross, A.H. and Weinshenker, B. and Jacob, A. and Klawiter, E.C. and Chitnis, T.
Neurology Neuroimmunology & Neuroinflammation 4 (3): e339. May 2017

Microstructural visual system changes in AQP4-antibody-seropositive NMOSD.
Oertel, F.C. and Kuchling, J. and Zimmermann, H. and Chien, C. and Schmidt, F. and Knier, B. and Bellmann-Strobl, J. and Korn, T. and Scheel, M. and Klistorner, A. and Ruprecht, K. and Paul, F. and Brandt, A.U.
Neurology Neuroimmunology & Neuroinflammation 4 (3): e334. May 2017

Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.
Chavarro, V.S. and Mealy, M.A. and Simpson, A. and Lacheta, A. and Pache, F. and Ruprecht, K. and Gold, S.M. and Paul, F. and Brandt, A.U. and Levy, M.
Neurology Neuroimmunology & Neuroinflammation 3 (6): e286. December 2016

Aquaporin-4 IgG autoimmune syndrome and immunoreactivity associated with thyroid cancer.
Soelberg, K. and Larsen, S.R. and Moerch, M.T. and Thomassen, M. and Brusgaard, K. and Paul, F. and Smith, T.J. and Godballe, C. and Grauslund, J. and Lillevang, S.T. and Asgari, N.
Neurology Neuroimmunology & Neuroinflammation 3 (4): e252. August 2016

MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T.
Sinnecker, T. and Schumacher, S. and Mueller, K. and Pache, F. and Dusek, P. and Harms, L. and Ruprecht, K. and Nytrova, P. and Chawla, S. and Niendorf, T. and Kister, I. and Paul, F. and Ge, Y. and Wuerfel, J.
Neurology Neuroimmunology & Neuroinflammation 3 (4): e259. August 2016

Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD.
Finke, C. and Heine, J. and Pache, F. and Lacheta, A. and Borisow, N. and Kuchling, J. and Bellmann-Strobl, J. and Ruprecht, K. and Brandt, A.U. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 3 (3): e229. June 2016

Widespread inflammation in CLIPPERS syndrome indicated by autopsy and ultra-high-field 7T MRI.
Blaabjerg, M. and Ruprecht, K. and Sinnecker, T. and Kondziella, D. and Niendorf, T. and Kerrn-Jespersen, B.M. and Lindelof, M. and Lassmann, H. and Kristensen, B.W. and Paul, F. and Illes, Z.
Neurology Neuroimmunology & Neuroinflammation 3 (3): e226. June 2016

Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis.
Metz, I. and Beißbarth, T. and Ellenberger, D. and Pache, F. and Stork, L. and Ringelstein, M. and Aktas, O. and Jarius, S. and Wildemann, B. and Dihazi, H. and Friede, T. and Brück, W. and Ruprecht, K. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 3 (2): e204. April 2016

Visual dysfunction, but not retinal thinning, following anti-NMDA receptor encephalitis.
Brandt, A.U. and Oberwahrenbrock, T. and Mikolajczak, J. and Zimmermann, H. and Prüss, H. and Paul, F. and Finke, C.
Neurology Neuroimmunology & Neuroinflammation 3 (2): e198. April 2016

7T MRI in natalizumab-associated PML and ongoing MS disease activity: a case study.
Sinnecker, T. and Othman, J. and Kühl, M. and Mekle, R. and Selbig, I. and Niendorf, T. and Kunkel, A. and Wienecke, P. and Kern, P. and Paul, F. and Faiss, J. and Wuerfel, J.
Neurology Neuroimmunology & Neuroinflammation 2 (6): e171. December 2015

Effects of diazoxide in multiple sclerosis: a randomized, double-blind phase 2 clinical trial.
Villoslada, P. and Rovira, A. and Montalban, X. and Arroyo, R. and Paul, F. and Meca-Lallana, V. and Ramo, C. and Fernandez, O. and Saiz, A. and Garcia-Merino, A. and Ramió-Torrentà, L. and Casanova, B. and Oreja-Guevara, C. and Muñoz, D. and Martinez-Rodriguez, J.E. and Lensch, E. and Prieto, J.M. and Meuth, S.G. and Nuñez, X. and Campás, C. and Pugliese, M.
Neurology Neuroimmunology & Neuroinflammation 2 (5): e147. October 2015

Update on biomarkers in neuromyelitis optica.
Melamed, E. and Levy, M. and Waters, P.J. and Sato, D.K. and Bennett, J.L. and John, G.R. and Hooper, D.C. and Saiz, A. and Bar-Or, A. and Kim, H.J. and Pandit, L. and Leite, M.I. and Asgari, N. and Kissani, N. and Hintzen, R. and Marignier, R. and Jarius, S. and Marcelletti, J. and Smith, T.J. and Yeaman, M.R. and Han, M.H.
Neurology Neuroimmunology & Neuroinflammation 2 (4): e134. 23 July 2015

Does Nrf2 help nerves to survive?
Ruprecht, K. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 2 (3): e105. June 2015

Neurology and Therapy

A response to: Letter to the editor regarding "Network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder".
Wingerchuk, D.M. and Zhang, I. and Kielhorn, A. and Royston, M. and Levy, M. and Fujihara, K. and Nakashima, I. and Tanvir, I. and Paul, F. and Pittock, S.J.
Neurology and Therapy 2 July 2022

Network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder.
Wingerchuk, D.M. and Zhang, I. and Kielhorn, A. and Royston, M. and Levy, M. and Fujihara, K. and Nakashima, I. and Tanvir, I. and Paul, F. and Pittock, S.J.
Neurology and Therapy 11 (1): 123-135. March 2022

Therapy switches in fingolimod-treated patients with multiple sclerosis: long-term experience from the German MS Registry.
Frahm, N. and Fneish, F. and Ellenberger, D. and Flachenecker, P. and Paul, F. and Warnke, C. and Kleinschnitz, C. and Parciak, T. and Krefting, D. and Hellwig, K. and Haas, J. and Rommer, P.S. and Stahmann, A. and Zettl, U.K.
Neurology and Therapy 11 (1): 319–336. March 2022

Neuropathology and Applied Neurobiology

Brain iron accumulation in Wilson disease: a post-mortem 7 Tesla MRI - histopathological study.
Dusek, P. and Bahn, E. and Litwin, T. and Jabłonka-Salach, K. and Łuciuk, A. and Huelnhagen, T. and Madai, V.I. and Dieringer, M.A. and Bulska, E. and Knauth, M. and Niendorf, T. and Sobesky, J. and Paul, F. and Schneider, S.A. and Czlonkowska, A. and Brück, W. and Wegner, C. and Wuerfel, J.
Neuropathology and Applied Neurobiology 43 (6): 514-532. October 2017

Neuropsychiatric Disease and Treatment

Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity.
Veauthier, C. and Gaede, G. and Radbruch, H. and Sieb, J.P. and Wernecke, K.D. and Paul, F.
Neuropsychiatric Disease and Treatment 11 : 2323-2329. 9 September 2015

Neuropsychobiology

Effects of deep repetitive transcranial magnetic stimulation on brain-derived neurotrophic factor serum concentration in healthy volunteers.
Gaede, G. and Hellweg, R. and Zimmermann, H. and Brandt, A.U. and Dörr, J. and Bellmann-Strobl, J. and Zangen, A. and Paul, F. and Pfueller, C.F.
Neuropsychobiology 69 (2): 112-119. April 2014

Neuroscience

Imaging of autoimmune encephalitis - relevance for clinical practice and hippocampal function.
Heine, J. and Prüss, H. and Bartsch, T. and Ploner, C.J. and Paul, F. and Finke, C.
Neuroscience 309 : 68-83. 19 November 2015

Neurotherapeutics

Fingolimod therapy in multiple sclerosis leads to the enrichment of a subpopulation of aged NK cells.
Schwichtenberg, S.C. and Wisgalla, A. and Schroeder-Castagno, M. and Alvarez-González, C. and Schlickeiser, S. and Siebert, N. and Bellmann-Strobl, J. and Wernecke, K.D. and Paul, F. and Dörr, J. and Infante-Duarte, C.
Neurotherapeutics 18 (3): 1783-1797. July 2021

Ophthalmologe

Untersuchung des Farbsehens bei akuter einseitiger Neuritis nervi optici mittels eines webbasierten Farbsehtests [Investigation of color vision in acute unilateral optic neuritis using a web-based color vision test].
Kuchenbecker, J. and Blum, M. and Paul, F.
Ophthalmologe 113 (3): 223-229. March 2016

Oxidative Medicine and Cellular Longevity

Preventing axonal sodium overload or mitochondrial calcium uptake protects axonal mitochondria from oxidative stress-induced alterations.
Ulshöfer, R. and Bros, H. and Hauser, A.E. and Niesner, R.A. and Paul, F. and Malla, B. and Infante-Duarte, C.
Oxidative Medicine and Cellular Longevity 2022 : 6125711. 24 May 2022

PLoS Computational Biology

Multiscale networks in multiple sclerosis.
Kennedy, K.E. and Kerlero de Rosbo, N. and Uccelli, A. and Cellerino, M. and Ivaldi, F. and Contini, P. and De Palma, R. and Harbo, H.F. and Berge, T. and Bos, S.D. and Høgestøl, E.A. and Brune-Ingebretsen, S. and de Rodez Benavent, S.A. and Paul, F. and Brandt, A.U. and Bäcker-Koduah, P. and Behrens, J. and Kuchling, J. and Asseyer, S. and Scheel, M. and Chien, C. and Zimmermann, H. and Motamedi, S. and Kauer-Bonin, J. and Saez-Rodriguez, J. and Rinas, M. and Alexopoulos, L.G. and Andorra, M. and Llufriu, S. and Saiz, A. and Blanco, Y. and Martinez-Heras, E. and Solana, E. and Pulido-Valdeolivas, I. and Martinez-Lapiscina, E.H. and Garcia-Ojalvo, J. and Villoslada, P.
PLoS Computational Biology 20 (2): e1010980. February 2024

DeepWAS: multivariate genotype-phenotype associations by directly integrating regulatory information using deep learning.
Arloth, J. and Eraslan, G. and Andlauer, T.F.M. and Martins, J. and Iurato, S. and Kühnel, B. and Waldenberger, M. and Frank, J. and Gold, R. and Hemmer, B. and Luessi, F. and Nischwitz, S. and Paul, F. and Wiendl, H. and Gieger, C. and Heilmann-Heimbach, S. and Kacprowski, T. and Laudes, M. and Meitinger, T. and Peters, A. and Rawal, R. and Strauch, K. and Lucae, S. and Müller-Myhsok, B. and Rietschel, M. and Theis, F.J. and Binder, E.B. and Mueller, N.S.
PLoS Computational Biology 16 (2): e1007616. 3 February 2020

Dynamics and heterogeneity of brain damage in multiple sclerosis.
Kotelnikova, E. and Kiani, N.A. and Abad, E. and Martinez-Lapiscina, E.H. and Andorra, M. and Zubizarreta, I. and Pulido-Valdeolivas, I. and Pertsovskaya, I. and Alexopoulos, L.G. and Olsson, T. and Martin, R. and Paul, F. and Tegnér, J. and Garcia-Ojalvo, J. and Villoslada, P.
PLoS Computational Biology 13 (10): e1005757. 26 October 2017

PLoS ONE

Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.
Wilf-Yarkoni, A. and Feldmann, K. and Rubarth, K. and Dorsch, E.M. and Rust, R. and Urman, I. and Hellmann, M.A. and Friedman, Y. and Lotan, I. and Bialer, O. and Buenrostro, G.S. and Zimmermann, H.G. and Leutloff, C. and Schmitz-Hübsch, T. and Paul, F. and Asseyer, S. and Stiebel-Kalish, H.
PLoS ONE 18 (12): e0288366. 7 December 2023

Diagnostic efficacy of the magnetic resonance T1w/T2w ratio for the middle cerebellar peduncle in multiple system atrophy and spinocerebellar ataxia: a preliminary study.
Wang, J. and Sugiyama, A. and Yokota, H. and Hirano, S. and Cooper, G. and Mukai, H. and Ohira, K. and Koide, K. and Ito, S. and Finke, C. and Brandt, A.U. and Paul, F. and Kuwabara, S.
PLoS ONE 17 (4): e0267024. 15 April 2022

Longitudinal study of multiple sclerosis lesions using ultra-high field (7T) multiparametric MR imaging.
Chawla, S. and Kister, I. and Sinnecker, T. and Wuerfel, J. and Brisset, J.C. and Paul, F. and Ge, Y.
PLoS ONE 13 (9): e0202918. 13 September 2018

Objective assessment of a relative afferent pupillary defect by B-mode ultrasound.
Schmidt, F.A. and Connolly, F. and Maas, M.B. and Grittner, U. and Harms, L. and Brandt, A. and Paul, F. and Schreiber, S. and Ruprecht, K.
PLoS ONE 13 (8): e0202774. 27 August 2018

Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.
Grobelny, A. and Behrens, J.R. and Mertens, S. and Otte, K. and Mansow-Model, S. and Krüger, T. and Gusho, E. and Bellmann-Strobl, J. and Paul, F. and Brandt, A.U. and Schmitz-Hübsch, T.
PLoS ONE 12 (12): e0189281. 15 December 2017

B-mode ultrasound assessment of pupillary function: feasibility, reliability and normal values.
Schmidt, F. and Ruprecht, K. and Connolly, F. and Maas, M.B. and Paul, F. and Hoffmann, J. and Harms, L. and Schreiber, S.J.
PLoS ONE 12 (12): e0189016. 6 December 2017

Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.
Gieß, R.M. and Pfuhl, C. and Behrens, J.R. and Rasche, L. and Freitag, E. and Khalighy, N. and Otto, C. and Wuerfel, J. and Brandt, A.U. and Hofmann, J. and Eberspächer, B. and Bellmann-Strobl, J. and Paul, F. and Ruprecht, K.
PLoS ONE 12 (4): e0175279. 7 April 2017

Accuracy and reliability of the kinect version 2 for clinical measurement of motor function.
Otte, K. and Kayser, B. and Mansow-Model, S. and Verrel, J. and Paul, F. and Brandt, A.U. and Schmitz-Hübsch, T.
PLoS ONE 11 (11): e0166532. 18 November 2016

Afferent visual pathway affection in patients with PMP22 deletion-related hereditary neuropathy with liability to pressure palsies.
Brandt, A.U. and Meinert-Bohn, E. and Rinnenthal, J. and Zimmermann, H. and Mikolajczak, J. and Oberwahrenbrock, T. and Papazoglou, S. and Pfüller, C.F. and Schinzel, J. and Tackenberg, B. and Paul, F. and Hahn, K. and Bellmann-Strobl, J.
PLoS ONE 11 (10): e0164617. 17 October 2016

Analysis of lymphocytic DNA damage in early multiple sclerosis by automated γ-H2AX and 53BP1 foci detection: A case control study.
Rasche, L. and Heiserich, L. and Behrens, J.R. and Lenz, K. and Pfuhl, C. and Wakonig, K. and Gieß, R.M. and Freitag, E. and Eberle, C. and Wuerfel, J. and Doerr, J. and Bauer, P. and Bellmann-Strobl, J. and Paul, F. and Roggenbuck, D. and Ruprecht, K.
PLoS ONE 11 (1): e0147968. 28 January 2016

Reliability of intra-retinal layer thickness estimates.
Oberwahrenbrock, T. and Weinhold, M. and Mikolajczak, J. and Zimmermann, H. and Paul, F. and Beckers, I. and Brandt, A.U.
PLoS ONE 10 (9): e0137316. 8 September 2015

Magnetic resonance phase alterations in multiple sclerosis patients with short and long disease duration.
Bozin, I. and Ge, Y. and Kuchling, J. and Dusek, P. and Chawla, S. and Harms, L. and Ruprecht, K. and Niendorf, T. and Paul, F. and Kister, I. and Sinnecker, T. and Wuerfel, J.
PLoS ONE 10 (7): e0128386. 17 July 2015

Treatment of chronic experimental autoimmune encephalomyelitis with epigallocatechin-3-gallate and glatiramer acetate alters expression of heme-oxygenase-1.
Janssen, A. and Fiebiger, S. and Bros, H. and Hertwig, L. and Romero-Suarez, S. and Hamann, I. and Chanvillard, C. and Bellmann-Strobl, J. and Paul, F. and Millward, J.M. and Infante-Duarte, C.
PLoS ONE 10 (6): e0130251. 26 June 2015

Multimodal retinal vessel analysis in CADASIL patients.
Alten, F. and Motte, J. and Ewering, C. and Osada, N. and Clemens, C.R. and Kadas, E.M. and Eter, N. and Paul, F. and Marziniak, M.
PLoS ONE 9 (11): e112311. 5 November 2014

Vessel labeling in combined confocal scanning laser ophthalmoscopy and optical coherence tomography Images : criteria for blood vessel discrimination.
Motte, J. and Alten, F. and Ewering, C. and Osada, N. and Kadas, E.M. and Brandt, A.U. and Oberwahrenbrock, T. and Clemens, C.R. and Eter, N. and Paul, F. and Marziniak, M.
PLoS ONE 9 (9): e102034. 9 September 2014

Pregnancy in multiple sclerosis: a questionnaire study.
Borisow, N. and Paul, F. and Ohlraun, S. and Pach, D. and Fischer, F. and Dörr, J.
PLoS ONE 9 (6): e99106. 5 June 2014

Enlargement of cerebral ventricles as an early indicator of encephalomyelitis.
Lepore, S. and Waiczies, H. and Hentschel, J. and Ji, Y. and Skodowski, J. and Pohlmann, A. and Millward, J.M. and Paul, F. and Wuerfel, J. and Niendorf, T. and Waiczies, S.
PLoS ONE 8 (8): e72841. 22 August 2013

Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.
Derkow, K. and Bauer, J.M.J. and Hecker, M. and Paap, B.K. and Thamilarasan, M. and Koczan, D. and Schott, E. and Deuschle, K. and Bellmann-Strobl, J. and Paul, F. and Zettl, U.K. and Ruprecht, K. and Lehnardt, S.
PLoS ONE 8 (8): e70626. 12 August 2013

Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis.
Kaufhold, F. and Zimmermann, H. and Schneider, E. and Ruprecht, K. and Paul, F. and Oberwahrenbrock, T. and Brandt, A.U.
PLoS ONE 8 (8): e71145. 6 August 2013

Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis.
Schneider, E. and Zimmermann, H. and Oberwahrenbrock, T. and Kaufhold, F. and Kadas, E.M. and Petzold, A. and Bilger, F. and Borisow, N. and Jarius, S. and Wildemann, B. and Ruprecht, K. and Brandt, A.U. and Paul, F.
PLoS ONE 8 (6): e66151. 21 June 2013

Is metabolic flexibility altered in multiple sclerosis patients?
Mähler, A. and Steiniger, J. and Bock, M. and Brandt, A.U. and Haas, V. and Boschmann, M. and Paul, F.
PLoS ONE 7 (8): e43675. 28 August 2012

Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
Chanvillard, C. and Millward, J.M. and Lozano, M. and Hamann, I. and Paul, F. and Zipp, F. and Doerr, J. and Infante-Duarte, C.
PLoS ONE 7 (6): e39625. 29 June 2012

Patterns of retinal damage facilitate differential diagnosis between susac syndrome and MS.
Brandt, A.U. and Zimmermann, H. and Kaufhold, F. and Promesberger, J. and Schippling, S. and Finis, D. and Aktas, O. and Geis, C. and Ringelstein, M. and Ringelstein, E.B. and Hartung, H.P. and Paul, F. and Kleffner, I. and Doerr, J.
PLoS ONE 7 (6): e38741. 11 June 2012

Optic nerve head quantification in idiopathic intracranial hypertension by spectral domain OCT.
Kaufhold, F. and Kadas, E.M. and Schmidt, C. and Kunte, H. and Hoffmann, J. and Zimmermann, H. and Oberwahrenbrock, T. and Harms, L. and Polthier, K. and Brandt, A.U. and Paul, F.
PLoS ONE 7 (5): e36965. 15 May 2012

Brain viscoelasticity alteration in chronic-progressive multiple sclerosis.
Streitberger, K.J. and Sack, I. and Krefting, D. and Pfueller, C. and Braun, J. and Paul, F. and Wuerfel, J.
PLoS ONE 7 (1): e29888. 20 January 2012

The influence of physiological aging and atrophy on brain viscoelastic properties in humans.
Sack, I. and Streitberger, K.J. and Krefting, D. and Paul, F. and Braun, J.
PLoS ONE 6 (9): e23451. 12 September 2011

Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1.
Stricker, S. and Oberwahrenbrock, T. and Zimmermann, H. and Schroeter, J. and Endres, M. and Brandt, A.U. and Paul, F.
PLoS ONE 6 (7): e23024. 29 July 2011

Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells.
Waiczies, H. and Lepore, S. and Janitzek, N. and Hagen, U. and Seifert, F. and Ittermann, B. and Purfürst, B. and Pezzutto, A. and Paul, F. and Niendorf, T. and Waiczies, S.
PLoS ONE 6 (7): e21981. 19 July 2011

MRI pattern recognition in multiple sclerosis normal-appearing brain areas.
Weygandt, M. and Hackmack, K. and Pfueller, C. and Bellmann-Strobl, J. and Paul, F. and Zipp, F. and Haynes, J.D.
PLoS ONE 6 (6): e21138. 17 June 2011

Association of retinal and macular damage with brain atrophy in multiple sclerosis.
Doerr, J. and Wernecke, K.D. and Bock, M. and Gaede, G. and Wuerfel, J.T. and Pfueller, C.F. and Bellmann-Strobl, J. and Freing, A. and Brandt, A.U. and Paul, F.
PLoS ONE 6 (4): e18132. 8 April 2011

Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis.
Pfueller, C.F. and Brandt, A.U. and Schubert, F. and Bock, M. and Walaszek, B. and Waiczies, H. and Schwenteck, T. and Doerr, J. and Bellmann-Strobl, J. and Mohr, C. and Weinges-Evers, N. and Ittermann, B. and Wuerfel, J.T. and Paul, F.
PLoS ONE 6 (4): e18019. 6 April 2011

No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro.
Hohn, O. and Strohschein, K. and Brandt, A.U. and Seeher, S. and Klein, S. and Kurth, R. and Paul, F. and Meisel, C. and Scheibenbogen, C. and Bannert, N.
PLoS ONE 5 (12): e15632. 22 December 2010

Pain

Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study.
Heitmann, H. and Haller, B. and Tiemann, L. and Mühlau, M. and Berthele, A. and Tölle, T.R. and Salmen, A. and Ambrosius, B. and Bayas, A. and Asseyer, S. and Hartung, H.P. and Heesen, C. and Stangel, M. and Wildemann, B. and Haars, S. and Groppa, S. and Luessi, F. and Kümpfel, T. and Nischwitz, S. and Meuth, S.G. and Klotz, L. and Linker, R.A. and Zettl, U.K. and Ziemann, U. and Tumani, H. and Tackenberg, B. and Zipp, F. and Wiendl, H. and Gold, R. and Hemmer, B. and Ploner, M.
Pain 161 (4): 787-796. April 2020

Patient preference and adherence

Preferences, adherence, and satisfaction: three years of treatment experiences of people with multiple sclerosis.
Hoffmann, O. and Paul, F. and Haase, R. and Kern, R. and Ziemssen, T.
Patient preference and adherence 18 : 455-466. 22 February 2024

Physical Therapy

Association between frailty and free-living walking performance in people with multiple sclerosis.
Zanotto, T. and Galperin, I. and Mirelman, A. and Chen, L. and Regev, K. and Karni, A. and Schmitz-Hübsch, T. and Paul, F. and Lynch, S.G. and Akinwuntan, A.E. and Devos, H. and Hausdorff, J.M. and Sosnoff, J.J.
Physical Therapy 103 (5): pzad032. May 2023

Proceedings of SPIE

Automatic quality evaluation as assessment standard for optical coherence tomography.
Kauer, J. and Gawlik, K. and Zimmermann, H.G. and Kadas, E.M. and Bereuter, C. and Paul, F. and Brandt, A.U. and Hausser, F. and Beckers, I.
In: SPIE BiOS 2019, 2-7 Feb 2019, San Francisco, United States. 26 February 2019

Proceedings of the National Academy of Sciences of the United States of America

Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
Ostkamp, P. and Salmen, A. and Pignolet, B. and Görlich, D. and Andlauer, T.F.M. and Schulte-Mecklenbeck, A. and Gonzalez-Escamilla, G. and Bucciarelli, F. and Gennero, I. and Breuer, J. and Antony, G. and Schneider-Hohendorf, T. and Mykicki, N. and Bayas, A. and Then Bergh, F. and Bittner, S. and Hartung, H.P. and Friese, M.A. and Linker, R.A. and Luessi, F. and Lehmann-Horn, K. and Mühlau, M. and Paul, F. and Stangel, M. and Tackenberg, B. and Tumani, H. and Warnke, C. and Weber, F. and Wildemann, B. and Zettl, U.K. and Ziemann, U. and Müller-Myhsok, B. and Kümpfel, T. and Klotz, L. and Meuth, S.G. and Zipp, F. and Hemmer, B. and Hohlfeld, R. and Brassat, D. and Gold, R. and Gross, C.C. and Lukas, C. and Groppa, S. and Loser, K. and Wiendl, H. and Schwab, N.
Proceedings of the National Academy of Sciences of the United States of America 118 (1): e2018457118. 5 January 2021

MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis.
Kotelnikova, E. and Kiani, N.A. and Messinis, D. and Pertsovskaya, I. and Pliaka, V. and Bernardo-Faura, M. and Rinas, M. and Vila, G. and Zubizarreta, I. and Pulido-Valdeolivas, I. and Sakellaropoulos, T. and Faigle, W. and Silberberg, G. and Masso, M. and Stridh, P. and Behrens, J. and Olsson, T. and Martin, R. and Paul, F. and Alexopoulos, L.G. and Saez-Rodriguez, J. and Tegner, J. and Villoslada, P.
Proceedings of the National Academy of Sciences of the United States of America 116 (19): 9671-9676. 7 May 2019

Stress-induced brain activity, brain atrophy, and clinical disability in multiple sclerosis.
Weygandt, M. and Meyer-Arndt, L. and Behrens, J.R. and Wakonig, K. and Bellmann-Strobl, J. and Ritter, K. and Scheel, M. and Brandt, A.U. and Labadie, C. and Hetzer, S. and Gold, S.M. and Paul, F. and Haynes, J.D.
Proceedings of the National Academy of Sciences of the United States of America 113 (47): 13444-13449. 22 November 2016

Radiology

Histopathologic assessment of neurotoxicity after repeated administration of gadodiamide in healthy rats.
Schlemm, L. and Radbruch, H. and Brandt, A.U. and Scheel, M. and Paul, F.
Radiology 282 (3): 925-926. March 2017

Retina

Retinal lesion evolution in susac syndrome.
Brandt, A.U. and Oberwahrenbrock, T. and Costello, F. and Fielden, M. and Gertz, K. and Kleffner, I. and Paul, F. and Bergholz, R. and Doerr, J.
Retina 36 (2): 366-374. February 2016

Science

Cross-reactive CD4(+) T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
Loyal, L. and Braun, J. and Henze, L. and Kruse, B. and Dingeldey, M. and Reimer, U. and Kern, F. and Schwarz, T. and Mangold, M. and Unger, C. and Dörfler, F. and Kadler, S. and Rosowski, J. and Gürcan, K. and Uyar-Aydin, Z. and Frentsch, M. and Kurth, F. and Schnatbaum, K. and Eckey, M. and Hippenstiel, S. and Hocke, A. and Müller, M.A. and Sawitzki, B. and Miltenyi, S. and Paul, F. and Mall, M.A. and Wenschuh, H. and Voigt, S. and Drosten, C. and Lauster, R. and Lachman, N. and Sander, L.E. and Corman, V.M. and Röhmel, J. and Meyer-Arndt, L. and Thiel, A. and Giesecke-Thiel, C.
Science 374 (6564): eabh1823. 8 October 2021

Science Advances

Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation.
Andlauer, T.F.M. and Buck, D. and Antony, G. and Bayas, A. and Bechmann, L. and Berthele, A. and Chan, A. and Gasperi, C. and Gold, R. and Graetz, C. and Haas, J. and Hecker, M. and Infante-Duarte, C. and Knop, M. and Kümpfel, T. and Limmroth, V. and Linker, R.A. and Loleit, V. and Luessi, F. and Meuth, S.G. and Muehlau, M. and Nischwitz, S. and Paul, F. and Pütz, M. and Ruck, T. and Salmen, A. and Stangel, M. and Stellmann, J.P. and Stuerner, K.H. and Tackenberg, B. and Then Bergh, F. and Tumani, H. and Warnke, C. and Weber, F. and Wiendl, H. and Wildemann, B. and Zettl, U.K. and Ziemann, U. and Zipp, F. and Arloth, J. and Weber, P. and Radivojkov-Blagojevic, M. and Scheinhardt, M.O. and Dankowski, T. and Bettecken, T. and Lichtner, P. and Czamara, D. and Carrillo-Roa, T. and Binder, E.B. and Berger, K. and Bertram, L. and Franke, A. and Gieger, C. and Herms, S. and Homuth, G. and Ising, M. and Jöckel, K.H. and Kacprowski, T. and Kloiber, S. and Laudes, M. and Lieb, W. and Lill, C.M. and Lucae, S. and Meitinger, T. and Moebus, S. and Mueller-Nurasyid, M. and Nöthen, M.M. and Petersmann, A. and Rawal, R. and Schminke, U. and Strauch, K. and Völzke, H. and Waldenberger, M. and Wellmann, J. and Porcu, E. and Mulas, A. and Pitzalis, M. and Sidore, C. and Zara, I. and Cucca, F. and Zoledziewska, M. and Ziegler, A. and Hemmer, B. and Müller-Myhsok, B.
Science Advances 2 (6): e1501678. 17 June 2016

Science Translational Medicine

Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories.
Gross, C.C. and Schulte-Mecklenbeck, A. and Steinberg, O.V. and Wirth, T. and Lauks, S. and Bittner, S. and Schindler, P. and Baranzini, S.E. and Groppa, S. and Bellmann-Strobl, J. and Bünger, N. and Chien, C. and Dawin, E. and Eveslage, M. and Fleischer, V. and Gonzalez-Escamilla, G. and Gisevius, B. and Haas, J. and Kerschensteiner, M. and Kirstein, L. and Korsukewitz, C. and Lohmann, L. and Lünemann, J.D. and Luessi, F. and Meyer Zu Hörste, G. and Motte, J. and Ruck, T. and Ruprecht, K. and Schwab, N. and Steffen, F. and Meuth, S.G. and Paul, F. and Wildemann, B. and Kümpfel, T. and Gold, R. and Hahn, T. and Zipp, F. and Klotz, L. and Wiendl, H.
Science Translational Medicine 16 (740): eade8560. March 2024

Scientific Reports

CD4+ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis.
Cortes-Figueiredo, F. and Asseyer, S. and Chien, C. and Zimmermann, H.G. and Ruprecht, K. and Schmitz-Hübsch, T. and Bellmann-Strobl, J. and Paul, F. and Morais, V.A.
Scientific Reports 14 (1): 7507. 29 March 2024

Anti-aquaporin-4 immune complex stimulates complement-dependent Th17 cytokine release in neuromyelitis optica spectrum disorders.
Nishiyama, S. and Seok, J.M. and Wright, A.E. and Lotan, I. and Mikami, T. and Drosu, N.C. and Bobrowski-Khoury, N. and Anderson, M.R. and Bilodeau, P.A. and Schindler, P. and Paul, F. and Aoki, M. and Yeaman, M.R. and Levy, M.
Scientific Reports 14 (1): 3146. 7 February 2024

Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis.
Stiebel-Kalish, H. and Rubarth, K. and Shouchane-Blum, K. and Tiosano, A. and Lotan, I. and Hellmann, M.A. and Wilf-Yarkoni, A. and Bialer, O. and Flanagan, E.P. and Pittock, S.J. and Bhatti, M.T. and Schmitz-Hübsch, T. and Paul, F. and Asseyer, S. and Chen, J.J.
Scientific Reports 12 (1): 21312. 9 December 2022

Structure-function correlates of vision loss in neuromyelitis optica spectrum disorders.
Gigengack, N.K. and Oertel, F.C. and Motamedi, S. and Bereuter, C. and Duchow, A. and Rust, R. and Bellmann‑Strobl, J. and Ruprecht, K. and Schmitz-Hübsch, T. and Paul, F. and Brandt, A.U. and Zimmermann, H.G.
Scientific Reports 12 (1): 17545. 20 October 2022

Mechanical properties of murine hippocampal subregions investigated by atomic force microscopy and in vivo magnetic resonance elastography.
Morr, A.S. and Nowicki, M. and Bertalan, G. and Silva, R.V. and Infante Duarte, C. and Koch, S.P. and Boehm-Sturm, P. and Krügel, U. and Braun, J. and Steiner, B. and Käs, J.A. and Fuhs, T. and Sack, I.
Scientific Reports 12 (1): 16723. 6 October 2022

Protocol and reference values for minimal detectable change of MyotonPRO and ultrasound imaging measurements of muscle and subcutaneous tissue.
Muckelt, P.E. and Warner, M.B. and Cheliotis-James, T. and Muckelt, R. and Hastermann, M. and Schoenrock, B. and Martin, D. and MacGregor, R. and Blottner, D. and Stokes, M.
Scientific Reports 12 (1): 13654. 11 August 2022

Motor signature of autism spectrum disorder in adults without intellectual impairment.
Cho, A.B. and Otte, K. and Baskow, I. and Ehlen, F. and Maslahati, T. and Mansow-Model, S. and Schmitz-Hübsch, T. and Behnia, B. and Roepke, S.
Scientific Reports 12 (1): 7670. 10 May 2022

Patch individual filter layers in CNNs to harness the spatial homogeneity of neuroimaging data.
Eitel, F. and Albrecht, J.P. and Weygandt, M. and Paul, F. and Ritter, K.
Scientific Reports 11 (1): 24447. 27 December 2021

Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry.
Ohle, L.M. and Ellenberger, D. and Flachenecker, P. and Friede, T. and Haas, J. and Hellwig, K. and Parciak, T. and Warnke, C. and Paul, F. and Zettl, U.K. and Stahmann, A.
Scientific Reports 11 (1): 13340. 25 June 2021

SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients.
Ostendorf, L. and Dittert, P. and Biesen, R. and Duchow, A. and Stiglbauer, V. and Ruprecht, K. and Bellmann-Strobl, J. and Seelow, D. and Stenzel, W. and Niesner, R.A. and Hauser, A.E. and Paul, F. and Radbruch, H.
Scientific Reports 11 (1): 10299. 13 May 2021

COVID-19: a simple statistical model for predicting intensive care unit load in exponential phases of the disease.
Ritter, M. and Ott, D.V.M. and Paul, F. and Haynes, J.D. and Ritter, K.
Scientific Reports 11 (1): 5018. 3 March 2021

Lipid mediator profiles predict response to therapy with an oral frankincense extract in relapsing-remitting multiple sclerosis.
Stürner, K.H. and Werz, O. and Koeberle, A. and Otto, M. and Pless, O. and Leypoldt, F. and Paul, F. and Heesen, C.
Scientific Reports 10 (1): 8776. 29 May 2020

Multi-parameter immune profiling of peripheral blood mononuclear cells by multiplexed single-cell mass cytometry in patients with early multiple sclerosis.
Böttcher, C. and Fernández-Zapata, C. and Schlickeiser, S. and Kunkel, D. and Schulz, A.R. and Mei, H.E. and Weidinger, C. and Gieß, R.M. and Asseyer, S. and Siegmund, B. and Paul, F. and Ruprecht, K. and Priller, J.
Scientific Reports 9 (1): 19471. 19 December 2019

Contactless recording of sleep apnea and periodic leg movements by nocturnal 3-D-video and subsequent visual perceptive computing.
Veauthier, C. and Ryczewski, J. and Mansow-Model, S. and Otte, K. and Kayser, B. and Glos, M. and Schöbel, C. and Paul, F. and Brandt, A.U. and Penzel, T.
Scientific Reports 9 (1): 16812. 14 November 2019

Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis.
Dianzani, C. and Bellavista, E. and Liepe, J. and Verderio, Cl. and Martucci, M. and Santoro, A. and Chiocchetti, A. and Luca Gigliotti, C. and Boggio, E. and Ferrara, B. and Riganti, L. and Keller, C. and Janek, K. and Niewienda, A. and Fenoglio, C. and Sorosina, M. and Cantello, R. and Kloetzel, P.M. and Stumpf, M.P.H. and Paul, F. and Ruprecht, K. and Galimberti, D. and Martinelli Boneschi, F. and Comi, C. and Dianzani, U. and Mishto, M.
Scientific Reports 7 : 43718. 9 March 2017

Seizure

Perioperative fluctuations of lamotrigine serum levels in patients undergoing epilepsy surgery.
Paul, F. and Veauthier, C. and Fritz, G. and Lehmann, T.N. and Aktas, O. and Zipp, F. and Meencke, H.J.
Seizure 16 (6): 479-484. September 2007

Seminars in Immunopathology

Sex differences in autoimmune disorders of the central nervous system.
Gold, S.M. and Willing, A. and Leypoldt, F. and Paul, F. and Friese, M.A.
Seminars in Immunopathology 41 (2): 177-188. March 2019

Sensors

Instrumental assessment of stepping in place captures clinically relevant motor symptoms of Parkinson's disease.
Otte, K. and Ellermeyer, T. and Vater, T.S. and Voigt, M. and Kroneberg, D. and Rasche, L. and Krüger, T. and Röhling, H.M. and Kayser, B. and Mansow-Model, S. and Klostermann, F. and Brandt, A.U. and Paul, F. and Lipp, A. and Schmitz-Hübsch, T.
Sensors 20 (19): 5465. 1 October 2020

Sleep & Breathing

Fatigue and sleep disorders in multiple sclerosis: is obstructive sleep apnea a link?
Paul, F. and Veauthier, C.
Sleep & Breathing 16 (4): 949-950. December 2012

Sleep Disorders

Poor sleep in multiple sclerosis correlates with Beck Depression Inventory values, but not with polysomnographic data.
Veauthier, C. and Gaede, G. and Radbruch, H. and Wernecke, K.D. and Paul, F.
Sleep Disorders 2016 : 8378423. 2016

Sleep Medicine

Sleep disorders in multiple sclerosis and their relationship to fatigue.
Veauthier, C. and Paul, F.
Sleep Medicine 15 (1): 5-14. January 2014

Symmetry

Estimation and testing of Wilcoxon–Mann–Whitney effects in factorial clustered data designs.
Rubarth, K. and Sattler, P. and Zimmermann, H.G. and Konietschke, F.
Symmetry 14 (2): 244. February 2022

Theranostics

First in vivo fluorine-19 magnetic resonance imaging of the multiple sclerosis drug siponimod.
Starke, L. and Millward, J.M. and Prinz, C. and Sherazi, F. and Waiczies, H. and Lippert, C. and Nazaré, M. and Paul, F. and Niendorf, T. and Waiczies, S.
Theranostics 13 (4): 1217-1234. 5 February 2023

In vivo detection of teriflunomide-derived fluorine signal during neuroinflammation using fluorine MR spectroscopy.
Prinz, C. and Starke, L. and Millward, J.M. and Fillmer, A. and Delgado, P.R. and Waiczies, H. and Pohlmann, A. and Rothe, M. and Nazaré, M. and Paul, F. and Niendorf, T. and Waiczies, S.
Theranostics 11 (6): 2490-2504. 1 January 2021

Therapeutic Advances in Chronic Disease

Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations.
Malla, B. and Cotten, S. and Ulshoefer, R. and Paul, F. and Hauser, A.E. and Niesner, R. and Bros, H. and Infante-Duarte, C.
Therapeutic Advances in Chronic Disease 11 : 1-14. 2020

Therapeutic Advances in Neurological Disorders

Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry.
Frahm, N. and Ellenberger, D. and Stahmann, A. and Fneish, F. and Lüftenegger, D. and Salmen, H.C. and Schirduan, K. and Schaak, T.P.A. and Flachenecker, P. and Kleinschnitz, C. and Paul, F. and Krefting, D. and Zettl, U.K. and Peters, M. and Warnke, C.
Therapeutic Advances in Neurological Disorders 17 : 17562864241239740. 2024

Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort.
Salmen, A. and Hoepner, R. and Fleischer, V. and Heldt, M. and Gisevius, B. and Motte, J. and Ruprecht, K. and Schneider, R. and Fisse, A.L. and Grüter, T. and Lukas, C. and Berthele, A. and Giglhuber, K. and Flaskamp, M. and Mühlau, M. and Kirschke, J. and Bittner, S. and Groppa, S. and Lüssi, F. and Bayas, A. and Meuth, S. and Heesen, C. and Trebst, C. and Wildemann, B. and Then Bergh, F. and Antony, G. and Kümpfel, T. and Paul, F. and Nischwitz, S. and Tumani, H. and Zettl, U. and Hemmer, B. and Wiendl, H. and Zipp, F. and Gold, R.
Therapeutic Advances in Neurological Disorders 16 : 17562864231197309. 8 September 2023

A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.
Solomon, J.M. and Paul, F. and Chien, C. and Oh, J. and Rotstein, D.L.
Therapeutic Advances in Neurological Disorders 14 : 175628642110143. 9 May 2021

Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
Stroet, A. and Hemmelmann, C. and Starck, M. and Zettl, U. and Doerr, J. and Paul, F. and Flachenecker, P. and Fleischer, V. and Zipp, F. and Nueckel, H. and Kieseier, B.C. and Ziegler, A. and Gold, R. and Chan, A.
Therapeutic Advances in Neurological Disorders 5 (2): 75-79. March 2012

Tomography

Accelerated simultaneous T2 and T2* mapping of multiple sclerosis lesions using compressed sensing reconstruction of radial RARE-EPI MRI.
Herrmann, C.J.J. and Starke, L. and Millward, J.M. and Kuchling, J. and Paul, F. and Niendorf, T.
Tomography 9 (1): 299-314. 31 January 2023

Traffic

Assessing mitochondrial movement within neurons: manual versus automated tracking methods.
Bros, H. and Hauser, A. and Paul, F. and Niesner, R. and Infante-Duarte, C.
Traffic 16 (8): 906-917. August 2015

Trials

Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study.
Bahr, L.S. and Bock, M. and Liebscher, D. and Bellmann-Strobl, J. and Franz, L. and Prüß, A. and Schumann, D. and Piper, S.K. and Kessler, C.S. and Steckhan, N. and Michalsen, A. and Paul, F. and Mähler, A.
Trials 21 (1): 3. 2 January 2020

Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial.
Rosche, B. and Wernecke, K.D. and Ohlraun, S. and Dörr, J.M. and Paul, F.
Trials 14 : 112. 25 April 2013

Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial.
Schinzel, J. and Schwarzlose, L. and Dietze, H. and Bartusch, K. and Weiss, S. and Ohlraun, S. and Paul, F. and Doerr, J.
Trials 13 : 94. 28 June 2012

Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial.
Doerr, J. and Ohlraun, S. and Skarabis, H. and Paul, F.
Trials 13 : 15. 8 February 2012

Vaccines

Occurrence and risk factors of relapse activity after vaccination against COVID-19 in people with multiple sclerosis: 1-year follow-up results from a nationwide longitudinal observational study.
Fneish, F. and Frahm, N. and Peters, M. and Ellenberger, D. and Haas, J. and Löbermann, M. and Pöhlau, D. and Röper, A.L. and Schilling, S. and Stahmann, A. and Temmes, H. and Paul, F. and Zettl, U.K.
Vaccines 11 (12): 1859. 16 December 2023

arXiv

Harnessing spatial homogeneity of neuroimaging data: patch individual filter layers for CNNs.
Eitel, F. and Albrecht, J.P. and Weygandt, M. and Paul, F. and Ritter, K.
arXiv : 2007.11899. 23 July 2020

bioRxiv

Similar neural pathways link psychological stress and brain health in health and multiple sclerosis.
Schulz, M.A. and Hetzer, S. and Eitel, F. and Asseyer, S. and Meyer-Arndt, L. and Schmitz-Hübsch, T. and Bellmann-Strobl, J. and Cole, J.H. and Gold, S.M. and Paul, F. and Ritter, K. and Weygandt, M.
bioRxiv : 2022.12.19.521098. 20 December 2022

Vascular cognitive impairment in the mouse reshapes visual, spatial network functional connectivity.
Hall, G.R. and Boehm-Sturm, P. and Dirnagl, U. and Finke, C. and Foddis, M. and Harms, C. and Koch, S.P. and Kuchling, J. and Madan, C.R. and Mueller, S. and Sassi, C. and Sotiropoulos, S.N. and Trueman, R.C. and Wallis, M. and Yildirim, F. and Farr, T.D.
bioRxiv : 2020.11.04.366294. 5 November 2020

State-dependent signatures of anti-NMDA-receptor encephalitis: a dynamic functional connectivity study.
von Schwanenflug, N. and Krohn, S. and Heine, J. and Paul, F. and Pruess, H. and Finke, C.
bioRxiv : bioRxiv:2020.06.12.141945. 12 June 2020

Low-density granulocytes are a novel immunopathological feature in both multiple sclerosis and neuromyelitis optica spectrum disorder.
Ostendorf, L. and Mothes, R. and van Koppen, S. and Lindquist, R.L. and Bellmann-Strobl, J. and Asseyer, S. and Ruprecht, K. and Alexander, T. and Niesner, R.A. and Hauser, A.E. and Paul, F. and Radbruch, H.
bioRxiv 10 : 668160. 12 June 2019

Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosis.
Bernardo-Faura, M. and Rinas, M. and Wirbel, J. and Pertsovskaya, I. and Pliaka, V. and Messinis, D.E and Vila, G. and Sakellaropoulos, T. and Faigle, W. and Stridh, P. and Behrens, J.R. and Olsson, T. and Martin, R. and Paul, F. and Alexopoulos, L.G. and Villoslada, P. and Saez-Rodriguez, J.
bioRxiv : 541458. 20 March 2019

DeepWAS: Multivariate genotype-phenotype associations by directly integrating regulatory information using deep learning.
Arloth, J. and Eraslan, G. and Andlauer, T.F.M. and Martins, J. and Iurato, S. and Kühnel, B. and Waldenberger, M. and Frank, J. and Gold, R. and Hemmer, B. and Luessi, F. and Nischwitz, S. and Paul, F. and Wiendl, H. and Gieger, C. and Heilmann-Heimbach, S. and Kacprowski, T. and Laudes, M. and Meitinger, T. and Peters, A. and Rawal, R. and Strauch, K. and Lucae, S. and Müller-Myhsok, B. and Rietschel, M. and Theis, F.J. and Binder, E.B. and Mueller, N.S.
bioRxiv : 069096. 5 December 2018

Low frequency and rare coding variation contributes to multiple sclerosis risk.

bioRxiv : 286617. 23 March 2018

iScience

Similar neural pathways link psychological stress and brain-age in health and multiple sclerosis.
Schulz, M.A. and Hetzer, S. and Eitel, F. and Asseyer, S. and Meyer-Arndt, L. and Schmitz-Hübsch, T. and Bellmann-Strobl, J. and Cole, J.H. and Gold, S.M. and Paul, F. and Ritter, K. and Weygandt, M.
iScience 26 (9): 107679. 15 September 2023

Reduced mitochondrial respiration in T cells of patients with major depressive disorder.
Gamradt, S. and Hasselmann, H. and Taenzer, A. and Brasanac, J. and Stiglbauer, V. and Sattler, A. and Sajitz-Hermstein, M. and Kierszniowska, S. and Ramien, C. and Nowacki, J. and Mascarell-Maricic, L. and Wingenfeld, K. and Piber, D. and Ströhle, A. and Kotsch, K. and Paul, F. and Otte, C. and Gold, S.M.
iScience 24 (11): 103312. 19 November 2021

medRxiv

Synapsin autoantibodies during pregnancy are associated with fetal abnormalities.
Bünger, I. and Kreye, J. and Makridis, K. and Höltje, M. and Rasmussen, H.F. and Van Hoof, S. and Ullrich, T. and Sedlin, E. and Hoffmann, C. and Milovanovic, D. and Paul, F. and Meckies, J. and Verlohren, S. and Henrich, W. and Chaoui, R. and Kaindl, A. and Prüss, H.
medRxiv : 2022.09.23.22280284. 25 September 2022

Brain disconnectome mapping and serum neurofilament light levels in multiple sclerosis.
Rise, H.H. and Brune, S. and Chien, C. and Berge, T. and Bos, S.D. and Andorrà, M. and Valdeolivas, I.P. and Beyer, M.K. and Sowa, P. and Scheel, M. and Brandt, A.U. and Asseyer, S. and Blennow, K. and Pedersen, M.L. and Zetterberg, H. and Thiebaut de Schotten, M. and Cellerino, M. and Uccelli, A. and Paul, F. and Villoslada, P. and Harbo, H.F. and Westlye, L.T. and Høgestøl, E.A.
medRxiv : 2021.04.21.21255887. 27 April 2021

Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany - a first analysis of a prospective observational study.
Kedor, C. and Freitag, H. and Meyer-Arndt, L. and Wittke, K. and Zoller, t. and Steinbeis, F. and Haffke, M. and Gordon, R. and Heidecker, B. and Volk, H.D. and Skurk, C. and Paul, F. and Bellmann-Strobl, J. and Scheibenbogen, C.
medRxiv : 2021.02.06.21249256. 8 February 2021

SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of MS patients.
Ostendorf, L. and Dittert, P. and Biesen, R. and Duchow, A. and Stiglbauer, V. and Ruprecht, K. and Seelow, D. and Niesner, R.A. and Hauser, A.E. and Paul, F. and Radbruch, H.
medRxiv : 2020.12.18.20248500. 22 December 2020

This list was generated on Sat Apr 20 02:22:43 2024 CEST.
Open Access
MDC Library